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Abstract 
 
Neurons are the targets of injury and disease in many neurological conditions, 
and achieving neuronal survival/repair is a key goal for regenerative medicine. In 
this context, genetic  engineering of neurons offers a platform for (i) basic 
research to enhance our understanding of neuronal biology in normal, 
disease/and injury conditions; and (ii) for regenerative medicine to enhance the 
functionality of neurons. Although, a wide range of attempts have been made to 
promote gene delivery to primary neurons, these cells are still difficult to 
genetically engineer, and current methods rely heavily on viral vectors which pose 
safety considerations. Magnetic nanoparticles (IONPs) are currently of great 
interest in regenerative medicine including for non-viral gene delivery by the 
‗magnetofection‘ strategy, i.e when used with applied magnetic fields. This project 
aimed to examine (i) the influence of two novel uniaxial and biaxial oscillating 
magnetic field devices on primary neuronal transfection efficiency, and (ii) 
examine the safety of magnetofection using histological and electrophysiological 
studies. In order to do this, a robust protocol to derive primary cortical neurons 
was first established. 
A second issue is that surgical delivery of Neurons results in low survival. 
Additionally, most basic research has relied on neurons grown on ‗hard‘ 
substrates such as plastic, which do not mimic the mechanical properties of the in 
vivo microenvironment. To address these limitations, primary cortical neurons 
were grown in a 3-dimensional ‗soft‘ collagen hydrogel construct which can serve 
both as a protective cell delivery system and a ‗neuromimetic‘ substrate. The 
  
II 
safety of the established protocol was evaluated by electrophysiological analyses 
on neurons. 
The findings demonstrate that the safety of magnetofection is magnetic field 
dependent, and at optimal conditions, electrophysiological properties of the nano-
engineered neurons were normal. Secondly, I have shown that collagen 
hydrogels can support the 3D growth of neurons and electrophysiological studies 
can be carried out on the construct neurons; small differences were found 
between neurons grown on hard and soft materials. Finally, the amenability of 
genetic engineering of neurons within hydrogels using IONPs has been shown. 
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Abbreviation 
 
-Fe2O3 Maghemite iron oxide nanoparticle 
2D 2-dimensional monolayer culture 
3D 3-dimensional construct 
AAV Adeno-associated virus 
AD Alzheimer‘s disease 
ALS Amyotrophic lateral sclerosis 
AraC Cytosine arabinofuranoside 
BDNF Brain-derived neurotrophic factor 
cAMP Cyclic adenosine monophosphate 
cAMP Cyclic adenosine monophosphate 
CNS Central nervous system 
CQ Clioquinol(5-chloro-7-iodo-8 hydroxyquinoline) 
Cy3 Fluorophore-conjugated secondary antibodies 
DAPI 4',6-diamidino-2-phenylindole 
DG Dentate gyrus 
DIV Days in vitro 
DMEM Dulbecco's Modified Eagle Medium 
DMEM:F12 
Dulbecco's Modified Eagle Medium: Nutrient Mixture-
F12 
DN Dopaminergic neurons 
DNase I Deoxyribonuclease I 
EBSS Earle‘s balanced salt solution 
EPC7 Patch clamp amplifier 
ES Embryonic stem cells 
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F Frequency 
FBS Fetal bovine serum 
Fe3O4 Magnetite iron oxide nanoparticle 
GFAP Anti-glial fibrillary acidic protein 
GFP Green fluorescent protein 
HA Hyaluronic acid 
HBSS Hank‘s balanced salt solution 
HD Huntington‘s disorder 
HEPES N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid 
HFV Human foamy virus 
HSV Herpes simplex viruses 
HSV-1 Herpes Simplex Virus-1 
IONPs Iron oxide nanoparticles 
iPSCs Induced pluripotent stem cells 
Kcc2 potassium–chloride cotransporter  
LDH lactate dehydrogenase 
LV lentivirus 
MAG Myelin-associated glycoprotein 
MEF2 Transcriptional factor protein 
MRI Magnetic resonance imaging 
MSC Marrow stromal cell 
NBM-1 Neurobasal-1 
NBM-2  Neurobasal-2 
NDS Normal donkey serum 
NGF Nerve growth factor 
NSCs Neural stem cells 
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NT-3 Neurotrophin-3 
OMgp Oligodendrocyte/myelin glycoprotein 
OPCs Oligodendrocyte progenitor cells 
P/S Penicillin and streptomycin 
PAMAM Polyamidoamine 
PBL Peripheral blood lymphocytes 
PBL Peripheral blood lymphocytes 
PBS Phosphate buffer saline 
PD Parkinson‘s disease 
PDL Poly-d-lysine 
PEG Polyethylene glycol 
PEI Polyethylenimine 
PFA Paraformaldehyde 
PGA Poly glycolic acid 
PLA Poly lactic acid 
PMC Primary motor cortex 
PNS Peripheral nervous system 
PS/F Penicillin with streptomycin and amphotericin B 
rpm Round per minute 
RT Room temperature 
SCI Spinal cord injury 
SMN Survival of motor neuron 
SVZ Subventricular zone 
TBI Traumatic brain injury 
TIA Transient ischemic attack 
TTX Tetrodotoxin 
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Tuj-1 Anti-β III tubulin 
UK United kingdom 
USA United States of America 
VGCC Voltage gated calcium channel 
WHO World Health Organization 
δ-potential Zeta potential 
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General introduction  
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1.1. Neuron loss is common in nervous system damage 
The nervous system in mammals is complex in structure and function, and 
divided into two parts; the central nervous system (CNS, brain and spinal cord) 
and peripheral nervous system (PNS). The nervous system is vulnerable to 
various types of damage  which can result in permanent neurological deficits, for 
example (i) structural disorders such as traumatic brain (TBI) or spinal cord injury 
(SCI) (Sciarretta and Minichiello, 2010), (ii) vascular disorders such as stroke, 
transient ischemic attack (TIA) and (iii) neurodegenerative diseases such as 
Parkinson‘s disease (PD), Alzheimer‘s disease (AD) and Huntington‘s disorder 
(HD)(Asgharian et al., 2014) , and amyotrophic lateral sclerosis (ALS).  
Neurological disorders impact millions of people globally, for example around 2.5 
million  people  suffer from SCI (Thuret et al., 2006), and  the World Health 
Organization (WHO) has reported that annually, between 250, 000-500, 000 
people worldwide survive SCI (World health organization, 2013). Furthermore, 
during the last 10 years, around 35 million persons worldwide have suffered from 
neurodegenerative diseases and this figure is predicted to reach up to 150 million 
by 2050 (Kiaei, 2013).  All these disorders have a negative impact on the quality 
of life for patients who may experience long-term neurological deficit. As a 
consequence, people with neurological damage can require long term care which 
in turn can impact the economy. For instance, it has been reported that  over 
£500 million is spent each year in the UK alone on treating SCI patients, and in 
the US the annual cost is in the order of US$7.7 billion (Adams and Cavanagh, 
2004). 
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Many causative factors contribute to the damage of the CNS. For example, 
environmental and genetic defects contribute in developing neurodegenerative 
diseases, which differ according to the type of disease. However, they are 
strongly associated with advanced age (Sheikh et al., 2013). Traumatic CNS 
injuries are primarily due to mechanical trauma followed by biochemical 
mechanisms which will be discussed in (section 1.3). (Shoichet et al., 2008). 
Despite the variation of etiologies of neurological deficit, the most common 
impaired/or damaged cells are Neurons. Both the brain and spinal cord are 
composed of two types of tissue (i) the gray matter which consists of Neuron 
bodies; and (ii) the white matter consisting of myelinated axons. Positioning of 
gray and white matter are different in the brain and spinal cord, as in the brain the 
gray matter is the outer tissue while white matter is at depth. However, the 
sequence of tissue is reversed in the spinal cord (Mak, 2007). The severity and 
location of the insult are the determinants of the degree of impairment and 
whether they include the cell body or the axon or both, resulting in continued 
dysfunction and prolonged degeneration (Ambrozaitis et al., 2006, Thuret et al., 
2006). In neurodegenerative diseases, the death of several types of neurons 
within the cortical and hippocampal regions occurs  in AD, loss of medium spiny 
neurons in cortical and striatal regions is characteristic of HD (Asgharian et al., 
2014), loss of dopaminergic neurons DA in the substantia nigra results in PD, 
while ALS results from upper and lower motor neuron death and primary motor 
cortex (PMC) (Ross and Poirier, 2004, Rossi et al., 2010) CNS injury involves 
impairment  and /or damage to neurons that is associated with destruction of 
neuronal circuits including axons and dendrites (Pekna and Pekny, 2012). This 
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neuronal loss leads to the major functional deficits. Depending on the 
mechanisms and timeframe of the pathology, cell death may occur through 
necrosis or apoptosis (Golstein and Kroemer, 2007). To address this major, 
growing, and currently incurable healthcare problem, researchers across the 
world are focusing on investigating CNS deficit etiologies and novel treatment 
options. 
1.2. Nerve cells 
The nervous system consists of two classes of cells; nerve cells (neurons) and 
glial cells (glia). Glial cells are reported to outnumber neurons about 10-50 times, 
and the role of these cells lies in supporting neuronal development and function. 
The major glial cells types include: (i) Astrocytes are the most abundant type in 
the brain and their supportive role for neurons is structural and protective, in 
addition to their regulatory function for neurite outgrowth and synapse formation 
and maintenance (Mak, 2007) (ii) Oligodendrocytes are involved with myelin 
production in the CNS; myelin is a lipid-rich white substance forming electrical 
insulation by spiral wrapping of the myelin sheath around axons  of nerve cell in 
the central nervous system (White and Krämer-Albers, 2014) and (iii) Microglia 
are the primary immune cells of the nervous system, which transform into 
phagocytic cells when neuronal degeneration occurs (Gehrmann et al., 1995).  In 
this project the focus will be on Neurons.  
The neuron is the basic signalling unit of the nervous system. These cells are 
electrically excitable, and form the networks that detect, store and transfer  
information in the body as electrical and chemical signals that are essential to 
normal bodily function (Bray, 2017). Neurons are classified mainly as sensory, 
  
 
 
5 
motor or inter-neurons, according to their function. The main function of neurons 
is to process incoming signals, typically detected by structures known as 
dendrites, and to transmit signals to other cells using specialised projections 
referred to as axons (Figure 1.1).The typical regions of the neuron are: the cell 
body (soma), dendrites, the axon, and presynaptic terminals. Structural features 
of neuronal soma and the other cells in the body are similar. However, there are 
some differences that distinguish neurons. Neurons are distinguished by the 
presence of Nissl bodies (large granular bodies spread between the rows of 
endoplasmic reticulum combined with rosettes of free ribosomes and they are the 
site of protein formation). Neurons are rich in mitochondria because of the energy 
that is required for maintaining the transmembrane ionic gradients that are 
indispensable for neuronal signalling (Levitan and Kaczmarek, 2002). 
Neurons are generally described as asymmetric cells because individual neurons 
may produce dendrites anywhere on their surface, but there is only a single axon 
extending from the cell body, or as recently suggested, axon can extend  from 
other dendrites  of the neuron as in hippocampal pyramidal cells (Thome et al., 
2014). The axon varies in length from 0.1 millimetre to 3 meters and terminates 
with synapses. Synapses are highly specialized connection regions between two 
neurons. This connection can be electrical (transfer of electrolytes from one side 
of the cell to the other freely across small spaces called gap junctions), or 
chemical (connection occurs through the gap between the synapses of the pre 
and post synaptic neurons which is called the synaptic cleft), which facilitates 
signalling to other cells. These transboundary chemicals are called 
neurotransmitters. The first neuron (presynaptic) conveys information to the 
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second neuron (post synaptic) by these synapses, the nature of the connection is 
mostly chemical (Carnevale and Hines, 2006).  
The axonal plasma membrane contains ion channels, which are specialized 
proteins used to convey electrical impulses rapidly along the axon. Ion channels 
called voltage gated ion channels are concentrated between the end segment of 
the soma and the initial segment of the axon which called axon hillock, where the 
action potential is believed to be initiated (Levitan and Kaczmarek, 2002, 
Carnevale and Hines, 2006).The dendrites are highly branched projections, 
originating from the cell body, specialized for receiving electrochemical inputs 
from the other cells by finger like projections called ‗spines‘ at which the synaptic 
input region localized. These spines form part of a complex network called a 
dendritic tree. Dendrites are distinguished by having a cytoskeleton dissimilar to 
that of axons in terms of arrangement of the microtubules and actin filaments 
(Tamás et al., 2000). Dendrites like axons possess ion channels for conveying 
electrical information. It is worth mentioning that the dendrite structure is mutable 
according to the physiological condition (Kapitein and Hoogenraad, 2011). 
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Figure 1.1: Diagram of some structural features of neurons and its interaction with 
the other neural cells. (A) The neuron and (B) the neuron and the interaction with glial 
cells (astrocytes and oligodendrocytes). Adapted diagram from (National Institutes of 
Neurological Disorders and Stroke). 
1.3. Electrical signalling in neurons 
What follows is a simple overview of electrophysiological properties and its 
importance in neuroscience. 
In different brain regions and within each region neurons form neural circuits. 
Thus, neurons receive, modify, and transmit messages, including transfering 
information between two adjacent neurons and the different parts of the same 
cells. Studying and exploring the electrical activity, molecular and cellular 
processes that govern living neuron signalling is the discipline of neuroscience 
that is called electrophysiology. 
The key elements of neuronal function (i.e. signal reception and transmission) are 
located at pre and post synapse, where localized excitatory events trigger an 
action potentials (Carnevale and Hines, 2006). These action potentials flow in one 
or two directions. In the case of two directional action potentials, there is 
backpropagation, which is a retrograde action potential that possesses the ability 
to modulate synaptic activity. Intracellular recordings in vitro suggest that neurons 
can respond to backpropagation action potential. For instance, facilitating BDNF 
release from synapsis (Kuczewski et al., 2008), also invade the dendritic tree to 
create global Ca2+ signals  due to the  forward direction of action potential down 
the axons to the synaptic endings and backwards. As  global Ca2+ signals  are  
playing  a vital role in several biological processes including gene transcription 
and cell proliferation (Bootman et al., 2001). Generally, backpropagation initiation 
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is dendritic morphology, ion channel distribution, and synaptic input dependent  
(Murray and Holmes, 2011a).  
Generally the plasma membrane has a membrane potential which refers to the 
difference between the voltage inside and outside a cell.  A non-conducting 
neuron, when neurons at rest and the membrane potential here called resting 
membrane potential, is charged negatively on the inside with respect to the 
outside and has a typical value of -70mV. This charge variation results from the 
ion distribution across the plasma membrane. The most abundant ions on either 
side are chloride ions (Cl-), sodium ions (Na+) located outside the cell membrane, 
while, potassium ions (K+), and organic anions such as amino acids and proteins 
(A-) are highly concentrated within the cell. However, organic anions cannot move 
through the membrane due to their large size (Kandel et al., 2000). This negativity 
of the membrane potential results from the fact that at rest, there are more K+ 
channels open than Na+ channels, In another word, the membrane potential is 
principally determined by the distribution of K+ ions across the cell membrane.  
The membrane potential can change, for example in response to an excitatory 
stimulus. Therefore the neuron can be more polarized (hyperpolarization) or less 
polarized (depolarization). Accordingly, when membrane potential is less negative 
than the resting potential the neurons is in a state of depolarization, when it is 
more negative the neuron is in a state of hyperpolarization. The action potential 
is a result of a large change in membrane potential, up to 100 mV. In other 
word, a rapid electrical change represented by rise and followed by fall in voltage 
or membrane potential across a cellular membrane. Action potential events start 
by a stimulus that causes the voltage change and leads to move the membrane 
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potential toward threshold (approximately -55 mV). Threshold is the level at which 
many Na+ channels open resulting in an influx of Na+, and further depolarisation 
(Platkiewicz and Brette, 2010). This potential continues to reach to +30 mV, at 
which Na+ channels are inactivating automatically and close, this event is 
associated with K+ channels opening and  causes repolarization with an 
undershoot resulting from the absence of the depolarising influence of the 
background Na+ permeability (Hodgkin and Huxley, 1952).  
Generally, the shape and frequency of the action potentials varies among 
neuronal cell types. For instance, narrower spikes can be seen in the cortex and 
hippocampus, GABA (γ-aminobutyric acid)-releasing interneurons comparing to 
the recorded spicks of glutamatergic pyramidal neurons  (Bean, 2007) according 
to the location in the cell. Additionally, the action potential of cell body of neurons 
is different in shape than that of axon and dendrite trees. Basically, recording 
action potential from mature neurons describe as isopotential during the spike. 
However, there is a current flow between the cell body, dendrites and axon of the 
cell that change action potential shape to non-uniform of voltage. While, dendrites  
can influence  the form of cell body action potentials, partly by serving as a 
capacitive load that slows and truncates fast spikes, this variation is due to the 
variability in types of voltage-dependent ion channels which in turn allows 
neurons to encode information by generating action potentials with a wide range 
of shapes, frequencies and patterns (Figure 1.2) (Bean, 2007). 
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Figure 1.2 Action potential, plotting voltage measured across the cell membrane 
against time. Diagrams illustrating the action potential steps at left, (1) a stimulus that 
depolarizes the cell and shifts the membrane potential from rest state at -70 mV, toward 
the threshold, (2) then when the threshold of excitation is reached, all Na
+
 channels 
open, (3) the membrane depolarizes until the peak of action potential is reached, (4) here 
Na
+
 start to close and K
+ 
channels open and K
+ 
begins to move outside the cell 
(repolarize). The continuous movement of K
+
 to the outside cell membrane resulting in 
hyperpolarization. (5) The membrane resting potential restore due to K+ channels close 
This figure derived from (cnx.org, 2018). At right real action potentials recorded from 
different  neurons  derived from mouse (Bean, 2007).  
 
 Historically, nerve conductance were discovered by Luigi Galvani in association 
with electricity discovery in the middle of 18th century, when electricity was 
applied by metal wire inserted across the vertebral canal of frog, which showed 
that nerves and muscles themselves could produce electricity (Piccolino, 1997, 
Kazamel and Warren, 2017).This was followed by series of experiments by which 
the scientists tried to describe the conductance of nerve cell. Hence, in 19th 
century Cole and Curtis managed to demonstrate that there is increment in ionic 
permeability during propagation of an action potential (Hille, 1984). After 
equipment capable of amplifying and recording the fine bioelectric potentials was 
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invented in the early 20th century, Alan Hodgkin and Andrew Huxley in the 1950s, 
conducted a group of experiments on a squid giant axon and provided a 
quantitative description of membrane currents by voltage clamp  (Hodgkin and 
Huxley, 1952). This was followed by the invention of patch-clamp technique by 
Erwin Neher and Bert Sakmann at late in the 20th century (Verkhratsky et al., 
2006). 
In that context, the electrophysiological properties of neurons can be recorded 
both in vitro or in vivo at multiple sites by a technique called microelectrode 
array such as extracellularly in slice cultures (Obien et al., 2015)  or for a single 
cell recording using a patch-clamp technique which is based on measuring the 
tiny currents through ion channels in the cell membrane  (Molleman, 2003).The 
focus in this project will be on single cell recording via patch clamp, as it based on 
inserting long glass capillaries filled with saline to attach tightly to the cell 
membrane, causing an electrical isolation of a small patch of the membrane to 
reduce the current leakage, then measure the current flowing through ionic 
channels (Hodgkin and Huxley, 1952, Zhao et al., 2008). Current measurement 
can be through a single ion channel or the whole cell.  Figure 1.3 demonstrates 
the different forms of patch clamp and the purpose of each form. 
  
 
 
12 
  
 Figure 1.3: Forms of the patch clamp technique: (a) the cell-attached to the glass 
pipette; (b) patched membrane ruptured which allows access to the interior of the cell to 
measure the currents from all the ion channels (whole-cell recording); (c) outside-out 
form, due to pulling a patch of membrane from the whole-cell mode, this can be used for 
studying the extracellularly ligand gated ion channels; (d) inside-out form, due to pulling 
the pipette away from the cell in the cell-attached mode. This can be used for studying 
ion channels that are regulated by intracellular ligands. This figure is derived from (Zhao 
et al., 2008). 
 
The whole-cell recording is the form of patch clamp technique that is mostly used 
in research. This technique has been used for studying the electrophysiological 
properties of several type of neurons whether in culture or in slices. For example, 
it is used for investigating the membrane potential of pre and post-natal rostral 
nucleus of the solitary (rNST) tract neurons in rat. Where, Suwabe,et al (2011) 
have monitored the electrical events associated with the morphological changes 
of rNST from embryonic day 14 up to post-natal day 20, and they found that soma 
size, dendritic branch points, neurite endings, and neurite length all increase 
prenatally, however resting membrane potential decreased. Additionally, neurons 
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at prenatal stage appeared a low level of sensitivity to tetrodotoxin (TTX) which is 
a Na+ ion channel blocker, Thus the Na+ influx was low  prenatally  comparing to 
the postnatal stage  (Suwabe et al., 2011). Also the action potential responses of 
neocortical cells in vivo was recorded and showed considerable threshold 
variability, which demonstrated by  the variability of timing and rate. This 
variability results from variation in the relation between the timing of synaptic 
activities as well as the patterns of action potentials that resulted from these 
activities. These events results from the backpropagation of action potential 
spikes throughout the neuron after the  initiation of action potentials in the axon 
(Yu et al., 2008). 
Wang,et al 2008 studied the electrophysiological properties of cultured cortical 
progenitor neurons and in rat brain slices following intracerebral injection (Wang 
et al., 2008). They found that some of the transplanted neurons express Na+ 
current which is a characteristic of a mature neuron.  
Investigating the electrophysiological properties of neurons is an indicator for the 
functionality of neurons both in vitro and in vivo. For instance, electrophysiological 
study was conducted for mouse embryonic stem cells induced by transgene 
(proneural gene Neurog1) to generate glutamatergic neurons. This study was 
designed to establish the timeline for acquiring a functional neuronal phenotype 
in Neurog1-induced cells exhibiting a neuronal morphology associated with 
mature neurons functional properties. This study demonstrated the advantage of 
utilizing Neurog1 in neural repair process that require stimulation of functional 
neurons from pluripotent stem cells (Tong et al., 2010). 
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1.4. Neuronal death mediators and regenerative failure in 
nervous system disorders 
The common result of CNS disorders is death of neurons which is noted in 
(section 1.1.) neuron loss mechanisms vary according the cause of disorder and 
there are multiple mediators that lead to neuron death. In traumatic injuries, 
several mediators participate in neuron death, including electrolyte abnormalities, 
free radical formation, vascular ischemia, edema, posttraumatic inflammatory 
reaction, apoptosis or genetically programmed cell death (Sekhon and Fehlings, 
2001). In regard to neurodegenerative diseases, neuron death mediators include; 
protein mis-folding and aggregation, oxidative stress and free radical formation, 
metal dyshomeostasis, mitochondrial dysfunction, and phosphorylation 
impairment, all occurring  at the same time (Figure 1.4) (Sheikh et al., 2013). 
Correspondingly, neurons lose the coordination with reactive gliosis (astrocytes 
react post injury) due to the abnormal neuron to glia association  (Przedborski et 
al., 2003, Silver and Miller, 2004), undergo morphological changes due to process 
attrition, with soma and nucleus shape alteration, cytoplasmic vacuolation 
(formation of vacuoles in the cell cytoplasm that is synchronous with the presence 
of a cytotoxic stimulus) (Shubin et al., 2016), and chromatin condensation 
(Przedborski et al., 2003). All these events can lead to disease /injury type 
dependent neuronal death  which can be either apoptotic or necrotic cell death 
(Kanduc et al., 2002). 
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Figure 1.4: Schematic illustrating the factors that participate in neurodegenerative 
diseases. Figure adapted from (Sheikh et al., 2013). 
 
Neurons have limited potential for recovery post damage, because of two factors: 
(i) intracellular (i.e. inefficiency of neuronal regrowth mechanisms) as they are 
post-mitotic cells and they cannot divide and proliferate, and (ii) extracellular such 
as inhibitory factors of neurite outgrowth found in CNS myelin such as myelin-
associated glycoprotein (MAG) and oligodendrocyte/myelin glycoprotein (OMgp) 
and myelin glycolipid sulfatide (Silver et al., 2015). Therefore, the CNS has limited 
self-renewing capacity. Despite the evidence produced by the scientific 
community regarding occurrence of neurogenesis in adult mammalian brain and 
presence of proliferating neural stem cells (NSCs), the regenerative capacity of 
the brain is still insufficient for repairing damaged neurons  (Magavi et al., 2000).  
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Based on these reasons scientists have investigated different treatment options. 
Hence, much effort has been made to treat nervous system disorders. Some new 
therapeutic options were effective in alleviating some symptoms, but none cure 
the disease, and there are often limits to the duration of their effectiveness, with 
efficacy also decreasing gradually (Wu et al., 2010). As an example, this includes 
treatments by administrating L-DOPA and dopamine receptor agonists (Costa et 
al., 2008) for movement disorders in PD (Mizuno, 2014, Chen and Pan, 2015). 
This leaves an unmet need for truly regenerative therapies to treat neurological 
diseases. Therefore, the strategies to replace damaged neurons is currently a key 
goal of experimental neurology.  
1.5. Strategies to replace lost neurons in neurological conditions 
There are many clinical considerations associated with neurological injury and 
disease: (i) irreversible loss of neurons related to neurological disorders, (ii) 
persistent functional deficits, and (iii) the lack of treatment strategies, which are 
currently limited to saving the remaining healthy neurons and alleviating 
symptoms. There is a need therefore to conduct investigations for finding more 
sophisticated treatment strategies that can be the hope to achieve complete 
repair. Therefore, scientists have directed research towards adopting new 
therapeutic strategies that lie in replacing the damaged or injured cells with new 
ones; this strategy is termed ―cell replacement therapy‖.  
With regard to replacing neural cells, many studies report that the provenance of 
cells used for replacement is a critical determinant for the success of the 
treatment. For instance, cell lines (immortal tumour cells) which are used widely in 
research (Zhou et al., 2006, Gordon et al., 2013b) are not a suitable strategy as 
  
 
 
17 
transplants for clinical use because of the potential for the carcinogenic effects 
(Freshney, 2002).The second option is the direct use of the embryonic tissue for 
transplantation. It has been reported that there is a clinical improvement in PD 
patients who received embryonic cells derived from mesencephalic tissue from 
aborted embryos (Lindvall et al., 1990). Despite these promising results, there are 
technical and ethical obstacles that limit the use of this source of tissue for clinical 
use. 
In this context, the low survival rate of implanted cells is a critical obstacle. For 
example, not more than 3–5% of implanted DA neurons survive (Björklund et al., 
2002). This can be as a consequence of several factors including hypoxia, 
hypoglycaemia, mechanical damage during tissue preparation for transplantation, 
mainly the mechanical dissociation in order to prepare the tissue for injection, free 
radicals, growth factors deficiency in addition to the excitatory amino acids in the 
host tissue (Brundin et al., 2000) and mechanical trauma to cells during surgical 
transplantation procedures. This highlights the need to improve graft cell 
survival. Several procedures have been used for improving graft survival. One of 
them is increasing the number of embryonic tissue donors, but this triggers ethical 
concerns regarding the use of this strategy (Dunnett et al., 1997).  
Neural stem cells (NSCs) can offer a solution. The role of these cells in treatment 
of nervous system disorders lies in two main categories: (i) endogenous strategy 
and (ii) exogenous strategy. The endogenous category consists of recruiting cells 
from neurogenic niche (i.e. recruiting neurons generated from either NSCs from 
neurogenesic microenvironments including subventricular zone (SVZ) or dentate 
gyrus (DG) of the hippocampus (Taupin, 2006), or from regional cells). The 
  
 
 
18 
second is reprogramming of local cells and converting them into neurons by 
inducing transcriptional factors (gene expression regulatory proteins).The 
exogenous strategy includes grafting exogenous neurons which can be derived 
from neuronal lineage (Grade and Götz, 2017). The ultimate goal is reducing the 
functional deficit and restoration of lost neurons and functional networks.  
In this section (General introduction), the focus will be on TBI and 
neurodegenerative diseases rather than SCI because the attention of scientists in 
the latter condition is in finding therapeutic approaches related to glial cell 
replacement and axonal regeneration.  
The success of any of these strategies relies on the tools of success. Success 
outcomes are long–term survival, differentiation, synaptic integration and 
behaviour. These strategies are applicable at different developmental stages (i.e. 
can be performed at any developmental stage of the cells). A brief overview of 
each strategy and its limitation is now given. 
The endogenic recruitment of neurons: This process occurs naturally, where 
the activity of neurogenic mechanisms starts at the early developmental stages 
and continues to the early postnatal. Neurogenesis then undergoes a reduction 
throughout life, and this reduction increases during aging  (Donega et al., 2013). 
Neurogenesis can persist in specific brain niches. The SVZ of mouse produces 
neuroblasts that migrate to the olfactory bulb and integrate into the bulbar circuitry 
as granule or periglomerular interneurons (Lazarini and Lledo, 2011). It has been 
reported that the main function of this process is to accelerate difficult odor 
discrimination learning and memory improvement. In humans, interneurons 
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migrate from the SVZ to the striatum however the functional significance of this 
process is still unrevealed. These processes occur in normal conditions but the 
inflammatory environment caused by injury can impact neuronal integration and 
neurodegeneration leading to challenges for the newly integrating neurons. 
Following injury or diseases such as stroke, trauma and HD, experiments in 
animal models have shown that neuroblasts can migrate to the injury site, form 
synaptic connections and have normal functional characteristics  and survive for 
several months or they experience apoptotic cell death (Darsalia et al., 2006).  
Reprogramming endogenous cells: Glial cells such as astrocytes that are 
involved in scar formation post injury in neurodegenerative diseases, can in vivo 
generate neurons. The newly generated neurons can be used for transplantation 
to  reduce disease conditions (Berninger et al., 2007). Pericytes in the adult 
human brain can be transformed into neurons in vitro. For example, in stab 
injuries in the mouse neocortex, astrocytes and oligodendrocyte progenitor cells 
(OPCs) in the injury site can be reprogramed by forcing Neuro D1 expression 
leading to transformation of both cells into glutamatergic neurons generate, but 
only OPCs  generated GABAergic neurons (Guo et al., 2014).  
Another important endogenous strategy for repairing CNS disorders, relies on 
stimulating in vivo NSCs by trophic factors i.e. growth factors, hormones, and 
other signalling molecules for example by expression of brain-derived 
neurotrophic factor (BDNF) and nerve growth factor (NGF) involved in growth and 
maintenance of nerve fibres (Danzer et al., 2002, Murray and Holmes, 2011b). 
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 However, these strategies are still impeded by lack of information regarding the 
output and input connectivity of the induced neurons, and how they participate in 
behavioural improvement. In general, the main obstacle to these strategies is 
their restriction to specific brain regions. Due to the brain region restriction, 
scientists have turned to find exogenous sources by which lost neurons can be 
replaced with new ones from external sources, which can be utilised in both injury 
and diseases conditions and are widely applicable to nervous system disorders. 
There are limitations for transplantation strategies such as their suitability for 
some pathologies versus others, in addition to the influence of the source of cells 
used. Despite that, this strategy has received wide attention in recent times, for 
both basic science and clinical trials. 
Determining the neuronal type needed depends on the type disorder, for example 
in PD the required cells for replacement are DA neurons, while in HD, striatal 
medium spiny neurons are the target (Grade and Götz, 2017). In injury 
pathologies, many neuronal types may be affected, and providing multiple neuron 
types will be very challenging.  In addition, the presence of the glial scar might 
have an inhibitory effect on neurite outgrowth (Silver and Miller, 2004). The 
importance of choosing the appropriate cell source relies on ensuring the long 
survival, expandability and connectivity with the host tissue, ease of differentiation 
into the desired neurons, and reducing the immunogenic reaction of the host 
tissue. 
For this purpose, a variety of stem cells have been considered as the source for 
replacement therapy such as embryonic NSCs-derived neurons (Björklund et al., 
2002), multipotent or pluripotent stem cells (Dantuma et al., 2010), and induced 
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pluripotent stem cells (iPSCs) (Lindvall and Kokaia, 2010).These cells have 
demonstrated promising outcomes in both animal models and clinical trials. 
Another source of cells used for transplantation therapy is the primary fetal 
neurons which are derived from the brain region that corresponds to the area 
subjected to disease. This strategy has been tested in animal models, for 
instance, fetal midbrain DA neurons transplanted into the striatum of PD animal 
models (Grealish et al., 2010). The same strategy was tested in a clinical trial 
(Barker et al., 2013). In the two studies, transplanted cells displayed survival and 
complete maturation into desired neuronal subtype (DA neurons) within the host 
tissue. However, these results are associated with inconsistency and 
unpredictability relating to the source of cells harvested for transplantation which 
is non uniform in relation to both the number and type of neurons generated, and 
their integration to the host tissue (Donaldson et al., 2005).      
The idea of transplanting neurons is to deliver new neurons that have been grown 
in vitro (in a laboratory dish) into the damaged or injured area. Cells can be 
delivered in two forms, either by implanting NSCs directly where the internal 
signals from the host tissue guide them to mature and differentiated neurons. 
Alternatively, they can be  delivered after differentiation of NSCs in culture into the 
desired neuronal type before implantation (National Institutes of Health (NIH), 
2017).The process of cell transplantation so far still suffers from difficulties in cell 
handling and immunological rejection. Furthermore, cell preparation for 
transplantation depends on differentiating cells in 2D culture, which in turn has its 
limitations related to cell expansion and the loss of clonal and differentiation 
capacity due to long-term passaging (McKee and Chaudhry, 2017).  
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There is a need to minimize or overcome the accompanying obstacles of tissue 
transplantation in general, and for neurons specifically (Rossi et al., 2010). There 
is also a need to investigate and understand biomolecular mechanisms relating to 
neuronal development and physiology, for instance, forming fully functioning 
connections of grafted cells within the native tissue. Regenerative medicine has 
therefore become directed towards gene and tissue engineering strategies for this 
purpose which will be addressed in the next sections.  
1. 6. Combinatorial gene therapy is needed for CNS regeneration 
Despite the positive outcomes from experimental and clinical trials, it is desirable 
that the repair capability of implants is improved in order to enhance the 
regeneration of the CNS. This can be achieved by combining two or more 
strategies (Combinatorial therapy).Specifically, if implemented in the right 
sequence and at the right time,  in some conditions it can be considered to be 
more promising than a single therapy approach (Suter et al., 2006). In this 
context, many studies have used animal models to support this idea. For 
instance, Lohara, et.al and Lu, et. al have demonstrated the benefit of 
combinatorial treatment for repairing lesioned dorsal-column sensory axon 
projections in an animal model (Lu et al., 2004, Iohara et al., 2013). A group of 
sixty adult female F344 rats were included in this study, divided into control group 
injected with PBS and treated groups either with cyclic adenosine 
monophosphate (cAMP) or neurotrophin-3 (NT-3) 5 days before lesion. Another 
group was treated with both, then at day 5, bone marrow stromal cell (MSC) 
suspensions were applied in the lesion site. The dual combination of one of the 
treatments with the lesion site resulted in promotion of dorsal-column sensory 
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axon growth, while combining the three treatments  (cAMP and NT-3 with the 
grafted cells) produced a significant axonal growth beyond the lesion site (Lu et 
al., 2004) which occurred only when the three treatments were combined. 
Gene therapy also is emerged as a promising approach, using genetically 
engineered transplanted cells which termed ex-vivo gene delivery. Here, the 
transplants act as vehicles for delivery of   therapeutic biomolecules to the area of 
interest  (Rose et al., 2012). This approach covers research to enhance the 
understanding of various biological and physiological phenomena specifically 
related to degenerative and regenerative CNS cells. In this regard, neurons have 
had wide and special attention, particularly because they are the main cells 
affected in CNS, and due to their inability to proliferate and differentiate are not 
replaced. Furthermore, neurons are challenging in terms of  being both hard to 
transfect as post mitotic cells and showing high sensitivity to alterations in their 
microenvironment (Karra and Dahm, 2010b).  
1.7. Studies performed on genetic engineering of neurons 
Neuronengineering has received wide attention recently, in both the clinical and 
basic science research fields. In terms of the clinical benefits of engineering 
neurons, as discussed earlier, the main objective of transplanting neurons or 
neuronal precursors is to replace damaged neurons, and for grafted cells to 
become structurally and functionally integrated into the host brain. Immature 
neurons at the developmental stage when they have not formed an extensive 
axonal connection, have the ability to survive and integrate within either fetal or 
adult host brain. The probability of formation of  neural circuitry is greater during 
the fetal period than at the adulthood (Bjorklund and Lindvall, 2000, Falkner et al., 
  
 
 
24 
2016). In this context, establishing functional connectivity in the adult brain can be 
enhanced if the host circuitry is damaged, wherein host neurons may release 
axonal growth factors that stimulate axons to regenerate (Lindvall and Björklund, 
2004, Geral et al., 2013). Therefore, neurotrophic or neuroprotective factors can 
be produced by transplanted cells by genetically engineering these cells. Thus, 
degeneration can be counteracted, or regeneration can be promoted (Géral et al., 
2013).  Several studies demonstrate the benefit of genetically engineering 
neurons by introducing genes encoding neurotrophic factors such as brain 
derived neurotrophic factors (BDNF), nerve growth factor (NGF), and 
neurotrophin-3 (NT3), in animal model and clinical trials. For example, an in vitro 
study on a rat model was conducted in order to investigate the effect of BDNF on 
axonal regeneration in a spinal cord injury model which resulted in promoting 
rubrospinal axonal regeneration and functional recovery (Koda et al., 2004). 
Another study reported that BDNF released from dendrites and soma of neurons 
transfected  with the BDNF gene results in an increase in dendrite branching of 
neighbouring neurons, which are no more than 4.5 µm away (Horch and Katz, 
2002). Genetic engineering has also been used to express Nurr1 transcription 
factor important for  midbrain DA neurons development, or in embryonic stem 
cells (ES) leading to promotion of DA cell differentiation  (Chung et al., 2002). 
 For research, transfection of neurons in culture is important for studying 
biological and physiological processes in neurons. An example is the study  of 
protein function in neurons, such as the investigation of the function of  
transcriptional factor MEF2 protein in neurogenesis, specifically in controlling 
maturation by transfecting cortical neurons with a plasmid containing a gene 
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encoding a dominant-interfering form of MEF2 (MEF2CR24L) (Mao et al., 1999). 
It can also be used for studying gene function in normal and disease status, such 
as determining the role of methylated-CpGbinding gene (Mecp2) encoding 
MECP2 protein that recruits additional factors such as histone deacetylase to 
repress transcription gene deficiency, critical for normal function of mature 
neurons, and to delay maturation of hippocampal neurons by reducing 
presynaptic protein expression and dendritic spine density (Smrt et al., 2007). 
1.8. Genetic engineering techniques 
Naked DNA can be delivered to the target cell or tissue when directly applied or 
injected to various cell types (Luo and Saltzman, 2000b). However, it is inefficient 
for gene delivery due to low DNA concentration at the cell surface and it is 
appropriate just for some applications, such as DNA vaccination (Nayerossadat et 
al., 2012).  
Generally, in a gene delivery system, the access of the genetic material to the site 
of action either for gene therapy or a genetic engineering system requires 
crossing several barriers. These barriers are extracellular barriers which include; 
(i) degradation of free DNA in blood by serum nuclease when injected 
intravenously for gene therapy (Niven et al., 1998), (ii) the barrier imposed by the 
plasma membrane, as the gene needs to penetrate the cell membrane. Then, 
there are intracellular barriers, once the gene is internalized, and the plasmid 
travels through the cytoplasm by diffusion or active transport to reach the next 
barrier (iii) which is the nuclear membrane, then the transcription, translation and 
modification process starts (Vaughan et al., 2006).  
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For overcoming these barriers, various techniques can be introduced; (i) 
enhanced targeting process to increase gene uptake, (ii) in case of the uptake 
through endocytosis mechanisms, maintain the intracellular availability by 
enhancing the endosomal release, (iii) enhancing nuclear delivery (Ziello et al., 
2010, Varkouhi et al., 2011) (Figure 1.5). In this project the focus is going to be on 
enhancing targeting system by enhancing gene delivery techniques.  
Accordingly, several genetic engineering techniques have been developed, some 
of them viral and the other non-viral techniques. Nevertheless, so far there is no 
ideal gene delivery system effective for all cell types‘ specifically post mitotic cells, 
both in vitro and in vivo, without restrictions to the type of cells or side effects.  
Consequently, there is no established transfection technique for neurons that is 
suitable for both therapeutic and research applications.  In that context, the ideal 
gene delivery technique for cells and tissue specifically neurons should have the 
(i) capability to transfect all type of cells and tissues with high efficiency, (ii) 
facilitate transfection of genes of varying sizes, and co-transfection with multiple 
genes.(iii) low cellular toxicity (iv) be easy and safe to perform (Washbourne and 
McAllister, 2002). Accordingly, researchers have made an effort for the purpose 
of developing safe, reliable, highly efficient strategies for genetically engineering 
cells. As the viral vector was at the forefront of potential vectors, as they evolved 
to efficiently deliver their genetic material to a cell before magnetic nanoparticles 
being used as a vector. This goes back to the biology of different viruses that 
offers promising solutions to the challenges of gene engineering strategy, such as 
cell targeting, transgene expression processes (figure 1.5). However, there is 
  
 
 
27 
consideration regarding the natural biology of a vector that prevents them from 
being the most effective for a specific cells. 
 
 
Figure 1.5: Schematic to illustrate the main gene delivery barriers. (1) is the cell 
membrane barrier, the endocytic mechanism is proposed for delivering nucleic acid-
IONPs complex inside the neuron, so complex internalization occurs via cell membrane 
invagination then (2) forming intracellular vesicle, (3) endosome that process the complex 
and form materials that will release into the cytoplasm to make their own way to their 
target. Then (4) some of the materials will be degraded by fusion with the lysosome. (5) 
And some of them will reach to the nucleus membrane.   
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1.8.1. Viral transduction 
 Currently, delivering therapeutic nucleic acids into the cells using viral vectors is 
termed transduction, which consists of recombining the gene of interest with the 
bacterial plasmid, as a vector, and forming copies then transferring them into the 
nucleus of the host cells, in a highly  successful gene delivery approach (Lentz et 
al., 2012b). This approach has been used since the early 1970s (Friedmann and 
Roblin, 1972). Several types of viruses have been used  such as retrovirus, 
adenovirus (types 2 and 5), adeno-associated virus, herpes virus, poxvirus, 
human foamy virus (HFV), and lentivirus (Huang et al., 2011). The popularity and 
wide range of usage of this method are due to the robust transduction efficiency 
reached (up to ca. 95%) mainly for the most challenging cells such as the post 
mitotic neurons (Karra and Dahm, 2010b, Washbourne and McAllister, 2002).For 
example, adeno-associated viruses, lentiviral vectors, and herpes simplex viruses 
have been used to  transduce different types of neurons such as the neuron line 
PC12 (Sun et al., 2018), or primary neurons including hippocampal and cortical 
immature (Royo et al., 2008) and mature neurons (Dong et al., 2003), some 
examples of transducing are neurons listed in Table 1.1. 
Viral vectors have specific traits that make them attractive to scientists as a gene 
delivery system. The virions which envelope the viral genetic information provide 
protection and stability during passage through the human body. The virions can 
target the cell that the virus will enter by binding to external receptors of the host 
cell. Gene expression in the host cells can be controlled by viral genetic material 
(Lentz et al., 2012b). Another  advantage of viral vectors includes  the capability 
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to infect post mitotic cells such neurons both in vitro and in vivo (Karra and Dahm, 
2010a). 
 Despite the advantages of viral vectors for gene expression strategy, they have 
disadvantages that limit their usage. Firstly, transduction protocols are time 
consuming due to the multiple complex steps including the production of 
infectious virions in cell lines and then virus purification (Gardlík et al., 2005). 
Viruses can also have cytotoxic effects associated with a high expression such as 
the toxicity of Herpes Simplex Virus-1 (HSV-1) which is ―a neurotropic virus that 
can establish lifelong persistence in sensory neurons‖ (Epstein, 2009, White et 
al., 2002, Thomas et al., 2003). Secondly, the virions can sometimes be 
pathogenic because they are derived from viruses that are a source of disease, 
and the viruses possess the machinery to access the host cells and exploit their 
machinery to facilitate replication and toxicity  (Thomas et al., 2003). During the 
replication cycle of  herpes viruses, cells lyse as a part of the normal process 
(Lentz et al., 2012a), with immunogenicity and toxin production (Blömer et al., 
1997). Finally, some viruses (e.g. adenovirus) show preferential infection for 
some cell such as glial cells and limited transduction in neurons. The late onset of 
gene expression, which can take up to two weeks after infection to show 
transgene expression, can impact the experimental and therapeutic time window. 
Further, there is also a limitation on the DNA insert sizes of ∼5 kb, limiting the 
usage to a smaller transgene as in AAVs (Karra and Dahm, 2010a, Royo et al., 
2008). An example of the impairment effect of the viral technique of gene delivery 
is the suppression of sodium current of mammalian neurons up to 80% by herpes 
simplex virus-1 (HSV-1) helper virus 5dl1.2 (White et al., 2002). Many efforts have 
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been made to optimize gene delivery techniques for neurons. However, no 
technique has yet been suitable for all applications. For these reasons the hopes 
are directed towards the non-viral approaches.  
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        Table 1.1: Examples of viral vectors used for transducing neurons. 
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1.8.2 Non-viral transfection 
Any transfection techniques will have advantages and disadvantages, which are 
related to transfection efficiency, gene expression levels, cell survival, ease of 
use, reproducibility, cost, and applicability to a given experiment. Non-viral 
techniques are gene transfer methods which are an alternative to viral methods 
and they comprise of chemical, physical and electrical methods. These 
techniques have attracted researchers for gene delivery despite the presence of 
some extracellular and intracellular obstacles.  
The following is a brief overview of some of the non-viral transfection techniques:  
(i) Physical transfection methods: Microinjection: This is a direct technique 
based on injection of external genetic material cRNA into the cytoplasm or DNA 
into the nucleus of the host cell by a glass micropipette. The gene of interest 
recombines with its corresponding gene to express its function (King, 2004, Horii 
et al., 2014). This technique is a single cell dependent  and can be used for 
mature neurons and cell lines (Karra and Dahm, 2010a). However, it is 
associated with a poor survival rate, as the survival rate relies on the experience 
and the appropriate controlling every microinjection in order to not cause physical 
damage of the neurons. Thus, much experience is needed in order to achieve 
80% cell survival  (Zhang and Yu, 2008). Accordingly, it requires a high skill 
specifically with mammalian neurons, and therefore has not been used routinely 
in the clinic. 
(ii) Bio ballistics or Gene gun:  In this technique, the gene of interest is gold 
coated and can be injected directly to the cytoplasm of the host cell by gunshot 
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(hand-held Gene Gun introduced by Bio-Rad )(O'Brien et al., 2001) to find the 
nucleus and enters into it (Lo et al., 1994). Here, all brain cells types can be 
transfected but with low transfection efficiency, up to ca. 2%. This can be 
improved to ca. 10% of cultured neurons and reached up to ca 34% in brain slices 
(Karra and Dahm, 2010b). However, this technique faces the same problem of 
cell damage because of the particle size ranging between 40-180 nm, in addition 
to acceleration and high pressure of gold particles  (Murphy and Messer, 2001, 
O'Brien and Lummis, 2011). 
(iii) Electrical transfection methods: This is another direct gene entry technique 
where electrical stimuli are applied to the host cells which results in plasma 
membrane charge alteration. This facilitates the entry of the charged extracellular 
gene which crosses the cell membrane and enters the cytoplasm (Khattak et al., 
2012). The transfection rate of this method is low specifically in post mitotic cells 
such as neurons (15-20%), and can be enhanced but at the expense of cell 
survival therefore, it is limited to embryonic and dissociated neurons. This method 
is termed ‗electroporation‘  (Dib-Hajj et al., 2009). This technique has been 
developed to facilitate gene entry to the nucleus and is named ‗nucleofection‘. 
Despite the high transfection rate that can be achieved by this technique, it is 
limited to freshly isolated cells and cells in suspension (Zeitelhofer et al., 2007, 
Zeitelhofer et al., 2009). Therefore, there is a necessity for developing techniques 
that can introduce a nucleic acid to the cell using a membrane-crossing vector, in 
addition to consideration of the safety problems (i.e. to ensure efficient gene 
delivery to the target cells safely). 
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(iv) Chemical transfection methods: Ca2+-phosphate/DNA co-precipitation. 
Although this is considered to be one of the preferred techniques used for 
transfecting neurons at all developmental stages whether primary or cell lines, or 
mature neurons (post-mitotic), this is still challenging with cells difficult to 
transfect. Transfection efficiency in mature neurons ranges between 1-5% 
(Goetze et al., 2004). Its advantage relies on low cost with no specialist 
equipment needed. Its principle is a precipitation based method by assembling 
DNA crystals with the Ca2+ ions in the phosphate buffer. This buffer precipitates 
onto the cells (adheres to the cell membrane) and the crystals are then taken up 
via endocytosis (Washbourne and McAllister, 2002, Karra and Dahm, 2010b). 
1.9. Magnetofection 
This is a vector based delivering technique which uses applied magnetic fields to 
improve the transport of vector-plasmid complex, in order to interact sufficiently 
with the desired target structure (Figure 1.6). It is a recent technology that offers 
promise to overcome the limitations in nucleic acid uptake by the cell membrane. 
Magnetofection can be used for natural vectors (viral) (Table 1.1) and synthetic 
(non-viral nucleic acid) delivery (Table 1.2) (Plank et al., 2011b). Initially, 
paramagnetic nanoparticles (nanoparticles which have slight positive response to 
the magnetic field) were used for enhancing retroviral vectors delivery into the 
human erythroleukemia cell line (K562) (Hughes et al., 2001). Then Scherer and 
colleagues attached non-viral vector superparamagnetic iron oxide nanoparticles 
(IONPs) (smaller in size than paramagnetic nanoparticles and generate greater 
magnetization susceptibility; about 100 fold higher) (Herranz et al., 2011),which 
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were coated with polyethylenimine, for enhancing in vitro transfection efficiency in 
primary human peripheral blood lymphocytes ( PBL) cells (Scherer et al., 2002). 
This encouraged researchers to investigate and develop transfection techniques 
based on magnetofection specifically for primary cells. It is worth mentioning that 
enhancing the transfection efficiency should be associated with eliminating or 
reducing the associated toxicity which is an obstacle for both biological and 
electrophysiological studies.  
During recent years the attention on developing magnetofection technology has 
been growing, specifically for studying the etiology of neurodegenerative diseases 
and treatment methods. For example, an in vitro model was used for studying the 
mechanisms underlying axonal growth and motor neuron disease. As in  spinal 
muscular atrophy which  is one of the neurodegenerative diseases, characterized 
by a selective degeneration of spinal cord motor neurons which results from a 
reduction in the ubiquitously expressed survival motor neuron I gene (SMN1) 
leading to the reduction in survival of motor neuron (SMN) protein. SMN functions 
with partner proteins in the assembly of nuclear ribonucleoproteins (Burghes and 
Beattie, 2009). Magnetofection technology was used in characterizing the 
interaction between the reduction in SMN and mRNA-Binding Protein which is 
required at multiple points during neuronal development (Akamatsu et al., 2005, 
Fallini et al., 2011).  
The importance of magnetofection prompted scientists to develop this technology 
to test several cell types such as rat primary astrocytes derived from the cerebral 
cortex (Pickard and Chari, 2010a, Pickard et al., 2010), and neural stem cells 
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(Pickard and Chari, 2010b, Pickard et al., 2011). Additionally, to enhance the 
transfection efficiency metal-based nanoparticles and various magnetic fields 
(static, oscillating and pulsating magnetic) have been tested for transfecting 
different cell types and specifically for neuronal and neuroglial cells (Kamau et al., 
2006, Zheng et al., 2014, Tickle et al., 2015, Subramanian et al., 2017). For more 
detail please see the introduction of chapter 4. 
As described previously magnetofection is a promising technology that can 
contribute to achieving these goals in several cell types such as NIH 3T3 cells 
(Plank et al., 2003). Researchers are working on transfecting neurons and have 
using model neuron systems such as the SH-SY5Y cell line (Vernon et al., 2015) 
when it is difficult to generate primary neurons although the primary neurons are 
more mimetic to the in vivo environment than cell lines. So far, it is has been 
difficult and challenging to transfect primary neurons, which relates to their 
sensitivity to micro-environmental changes (Kim et al., 2006, Jiang and Chen, 
2006). From this perspective, choosing the appropriate magnetic particle and 
transfection technique is an important concern. Various experiments have been 
conducted using magnetofection in order to enhance the transfection efficiency by 
applying different techniques and reagents (Ohki et al., 2001, Scherer et al., 
2002), or gene expression time (Soto-Sánchez et al., 2015) and studying the 
uptake of magnetic nanoparticles (Petters and Dringen, 2015). However, little is 
known regarding the effect of magnetofection and nanoparticles on neuronal 
functionality, this needs further investigation.  
In this project, the effect of increasing the physical activity of IONPs on primary 
neuronal transfection efficiency using oscillating magnetic assistive devices will 
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be investigated. Moreover, the safety of using magnetic nanoparticle-
magnetofection technology for a transfecting primary cortical neuron will be 
evaluated in the terms of neuronal morphology viability and functionality.  
Two terms will be used referring to nanoparticles. One is magnetic nanoparticles 
(MNPs) which refer to the different types of magnetic nanoparticles including iron 
oxide nanoparticles, the second term specifically referring to IONPs.  
 
Figure 1.6: Schematic illustrates the magnetofection principle. The gene of interest 
is complexed with magnetic nanoparticle (vector), the effective ratio of gene /magnetic 
nanoparticles concentrations is cell type dependent. Gene-vector complex is applied to 
the desired cells, driven by magnetic force underneath the sample in order to enhance 
the complex attachment to the cell membrane.         
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1.10. Nanoparticle-based transfection 
 
1.10.1 Characteristics of IONPs 
Iron oxide nano-particles are nano-meter sized particles ranging from 1-100 nm 
(Zhang et al., 2007), which are classified according to their dimensions, shape, 
composition, uniformity and agglomeration, they are of great interest in many 
areas including as magnetic fluids (colloidal liquids made of nanoscale 
ferromagnetic, or ferrimagnetic, particles suspended in a carrier fluid), catalysis, 
magnetic resonance imaging, environmental remediation, biotechnology/ 
biomedicine and data storage. The best performance of IONPs is when their size 
ranges between 10-20 nm  (Lu et al., 2007) which is below the critical limit (76 
nm) (Li et al., 2017).They are characterized by being superparamagnetic (i.e. lose 
their magnetization when the external magnetic field is removed) therefore they 
play a vital role specifically in biomedical applications. Also, the risk of 
agglomeration under room temperature is very low (Gupta and Gupta, 2005). 
Generally, the high chemical activity of naked metallic IONPs and their oxidization 
in air necessitates their protection via coating with organic layers such as 
surfactants or polymers, or inorganic layers like silica or carbon. Coating layers 
can be made up of cationic or anionic poly amino acids. An example of these 
coating layers are : polyethylenimine (PEI), phosphorylated starch, DEAE dextran 
or similar compounds, organic polymer or inorganic metallic (e.g. gold) or oxide 
surfaces (e.g. silica or alumina), biopolymers like collagen (Sinani et al., 2003, 
Schillinger et al., 2005, Bao et al., 2016) or any other  molecules that make them 
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biocompatible such as poly ethylene glycol (PEG) and folic acid (Zhang et al., 
2002). 
This coating layer is not just acting to stabilize IONPs but also to functionalize 
them with other nanoparticles (e.g. iron oxide nanoparticles, coated with a silica 
shell that is functionalized with gold nanoparticles) or various ligands that can be 
varied according to the application. The coating layer also acts as an isolator to 
minimize the agglomerations that occur due to the hydrophobicity of the magnetic 
core (Lu et al., 2007).  
The specific physicochemical properties of IONPs include their nano size, large 
surface area to mass ratio, and high reactivity which make functionalized IONPs 
of great interest in biological and clinical applications. They have been used as 
fluorescent biological labels, in drug/gene delivery and targeting, stem cell 
targeting, bio-detection of pathogens, protein detection, probing of DNA structure, 
tumour destruction via heating (hyperthermia), separation and purification of 
biological molecules and cells, diagnostic imaging (to improve the sensitivity of 
magnetic resonance imaging (MRI) (as contrast agents) (Zhang et al., 2007, 
Tietze et al., 2015). Moreover, the utility of IONPs is still growing specifically for a 
range of regenerative applications for example cell transplant imaging (Bulte et 
al., 1999), tissue engineering and gene delivery using the advanced 
magnetofection technology (Cheong et al., 2009, Adams et al., 2013) and 
diagnostic imaging in neurological injury (Muja and Bulte, 2009). During recent 
years, there has been an increased interest in the use of IONPs in regenerative 
medicine and cell therapy as gene delivery vectors in gene engineering 
technology. The importance of IONPs lies in their nanoscale size, their magnetic 
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properties that can be manipulated by applying external magnetic force, and their 
capability to carry various biological entities linked to the coating layer such as 
nucleic acids, antibodies or drugs. Attaching therapeutic DNA to IONPs can be 
used for treating damaged DNA in some diseases by replacing the damaged area 
of the gene, or down-regulate the oncogene overexpression which promotes 
carcinogenesis by RNA interference (RNAi) (Kievit and Zhang, 2011). 
Furthermore, attaching drugs to the IONPs coating layer to act as drug delivery 
system has a wide range of uses because this can overcome several drawbacks 
starting from limited effectiveness, poor bio-distribution, and a lack of selectivity of 
blood brain barrier for the transit of the drugs into the brain parenchyma.                            
1.10.2. IONPs as a gene delivery vector 
Given the vast scope of using IONPs in nanomedicine, they have attracted great 
interest in this field with a vital role as vectors for gene delivery in gene 
engineering technology, specifically for transfecting neurons which will be the 
focus of this project. 
IONPs can be natural compounds or they can be synthesized in laboratories 
(Cornell and Schwertmann, 2003). The formulation protocol for IONPs impacts 
their size and shape which in turn leads to heterogeneity in action (Gupta and 
Gupta, 2005). Generally, sixteen  iron oxides have been recognised (Cornell and 
Schwertmann, 2003). The typical formulation of magnetic IONPs is an iron oxide 
core of either magnetite (Fe3O4) which is the most common usage specifically in 
the biomedicine field, or maghemite (-Fe2O3) and both have single domains of 
ferrimagnet (magnetization dose not vary across the magnet). They are 
characterized by possessing super magnetization properties and are widely 
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utilized in multiple applications that are listed in section 1.9.1. superparamagnetic 
IONPs (diameter ranges between  50–100 nm) and ultra-small 
superparamagnetic IONPs diameter <50 nm (Turcheniuk et al., 2013). Magnetic 
IONPs are characterized by their inexpensiveness to produce by either co-
precipitation of ferric and ferrous iron salts, thermal decomposition of 
organometallic precursors and the microemulsion method in which iron salts form 
NPs within microdroplets (Petters et al., 2014), physical and chemical stability, 
biocompatibility, and environmental safety. The shape such as ultrathin 
nanowhiskers, nanoplates and nanoflowers, nanocubes, and single crystalline 
nanoworms (Bao et al., 2016) and size of IONPs have an impact on their 
magnetic properties. γ-Fe2O3 and Fe3O4 display ferrimagnetism at room 
temperature, with the saturation magnetization reaching to 92 emu g−1 (Wu et al., 
2015).  
IONPs have been involved extensively in biomedical applications. Due to their 
super magnetization properties they have become popular for in vivo applications 
as they do not aggregate after exposure to a magnetic field  versus large domain 
magnetic and paramagnetic materials (Bonnemain, 1998, Wang, 2011). Also the 
importance of utilizing IONPs lies in their stabilization by choosing the appropriate 
coating layer (Figure 1.5). Generally, IONPs undergo opsonization on entry into 
the bloodstream and tissue systems which leads to stimulation of the immune 
defence system (reticulo-endothelial system). This is a major obstacle in particle 
targeting to the site of injury. Therefore there is an effort to overcome this barrier 
by using the nanoparticle ‗stealth coating‘ strategies such as using (PEG) that 
evade IONPs from immune clearance and prolong circulatory time thus facilitating 
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IONPs bioavailability and accumulation in the brain  (Kim et al., 2007). Moreover, 
our group reported that PEGylated nanoparticles evade all the immune and non-
immune cell populations in the brain (Jenkins et al., 2016). Stabilizing IONPs is 
necessary for targeting strategies and enhancement of their efficiency as delivery 
vehicles for various biomolecules (Figure 1.7). For example, several coating 
layers of IONPs have been tested and tailored in order to use IONPs as gene 
delivery vehicles.  Polyethyleneimine (PEIs) is one of the first transfection grade 
agents that has demonstrated its  ability to interact  with positively charged amine 
groups electrostatically with the negatively charged phosphate backbone of DNA 
efficiently (Plank et al., 2003). IONPs as a gene delivery vehicle are of  great 
interest in regenerative medicine and have been used to genetically engineer 
neural cells such as astrocytes (Tickle et al., 2016), oligodendrocytes precursor 
cells (Jenkins et al., 2011), and neurons (Petters and Dringen, 2015). Despite the 
advantages of using IONPs, there are concerns related to their potential toxicity. 
Specifically, using these particles in neurobiological applications can be a source 
of alterations in brain iron homeostasis which is strongly related to  human 
neurodegenerative diseases such as AD and PD (Hare et al., 2013). 
In general, IONPs toxicity depends on physiochemical parameters including  
particle size, shape, surface charge and chemistry, and composition (Li et al., 
2012). The toxicity of IONPs is still under investigation in several cell types. One 
of the explanations related to IONPs toxicity is associated with particle uptake and 
metabolism in CNS cells. Particle uptake starts with internalization of the particles 
by endocytic mechanisms, which results in formation of intracellular vesicles 
containing IONPs which are directed to the lysosomal compartment in which iron 
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can be liberated from IONPs due to the acidic environment of lysosomes which 
can lead to toxic effects (Petters et al., 2014). Also, it has been reported that 
moderate concentrations of IONPs ranging from 0.15 to 15mM of iron can reduce 
cellular viability (Pisanic et al., 2007).  
 
Figure 1.7: Schematic diagram which illustrates IONPs and interactions between 
functionalization layer and some biological entities. IONPs are often coated by 
organic polymers which generate charged surfaces that facilitate electrostatic interactions 
with components of the milieu. 
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               Table 1.2: Examples of non-viral vectors used for transfecting neurons. 
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1.11. Uptake mechanism 
Gene-vector internalization into the target cells relies on appropriate cellular 
interaction mechanisms which vary according to the vector characteristics. 
Further, delivering the genetic material into the target cell is a linked mechanism 
between uptake, intracellular trafficking and vector fate. Designing non-viral 
transfection techniques requires a comprehensive understanding of uptake 
pathways and the intracellular processing mechanisms. A brief overview of 
uptake pathways will be given here. 
The first barrier to transfection is the cell membrane which is hydrophilic, hence 
internalization of entities large in size and hydrophilic molecules is limited (Khalil 
et al., 2006). Accordingly, endocytosis (active transport mechanism by which 
extracellular molecules enter the cell through vesicles formed from cell 
membrane), is considered the main mechanism for the non-viral uptake (Friend et 
al., 1996).   
This mechanism encompasses two forms and is classified according to vesicle 
size; „pinocytosis‟ which means cell drinking, and is a process used in 
internalizing fluids and small molecules, hence the vesicles formed are of small 
size. For the larger molecule such as cell debris and whole microorganisms, large 
vesicles form by a mechanism termed „phagocytosis/cell eating. 
In terms of the gene-vector internalization, the small size of complexes tends to 
evoke the pinocytosis mechanism. Clathrin, caveolae, macropinocytosis, and 
clathrin/caveolae-independent endocytosis are well characterized entities that can 
mediate pinocytosis (Ziello et al., 2010). Regarding IONP uptake mechanisms in 
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various neural cell types, Fernandes and Chari (2014) have reported that there is 
dramatic variation in particle uptake and astrocytes were the dominant population 
performing uptake compared to neurons and oligodendrocytes (Fernandes and 
Chari, 2014). With regard to neurons, endocytosis is considered as an essential 
mechanism which regulates intercellular signalling such as initiating signal 
transduction via ligand binding to tyrosine kinases and G-protein-coupled 
receptors (McPherson et al., 2001), nutrient uptake and synaptic transmission 
(Blanpied et al., 2002). The uptake process in neurons is either through forming 
clathrin-coated vesicles or  a clathrin-independent mechanism which is still poorly 
understood (Cosker and Segal, 2014). These clathrin coated pits in immature 
neurons are spread throughout dendrites and at the tips of dendritic filopodia. 
They appear and disappear repeatedly and are present locally at active spots. 
While, clathrin-coats in mature neurons are stable in the dendritic spines, 
endocytic zones lie lateral to the postsynaptic density (PSD). This section has 
described a general overview of the main topics associated with genetic 
engineering of neurons. The subsequent sections will address the process of 
growing neurons in in vivo mimetic environments in order to be a useful platform 
for both scientific research and regenerative medicine. 
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1.12. 3D hydrogel models for neurodegenerative medicine and        
        basic research 
Cell or tissue engineering is an interdisciplinary field concerned with creating 
functional 3-dimensional combining scaffolds, cells and/or bioactive molecules for 
investigating the physiological and pathophysiological processes in vitro in 
addition to providing tissue mimicking constructs (Griffith and Swartz, 2006). Two 
main concerns have resulted in the need to develop neuronal 3-dimensional 
constructs.  
Firstly, to meet the needs of basic research: For more than 100 years, in vitro 
studies have been conducted on 2D monolayer cultures grown on  unnaturally flat 
substrates and associated standard cultivation conditions including temperature, 
sterilization technique, humidity and culture media (Khoruzhenko, 2011). Most of 
the previously described information of neuronal cellular biological and 
physiological processes, maturation, migration and proliferation, were obtained 
from experiments conducted in monolayer cultures that do not reflect the in vivo 
environment. Additionally, animal models cannot fully mimic or predict human 
responses and are costly, time consuming and ethically arguable. To that end, it 
has been necessary to develop ex vivo culture environments that can mimic the in 
vivo environment. In this context, the 3D approach is essential for reducing animal 
usage for testing drug effectiveness and toxicity screening such as in anticancer 
drugs and toxicology studies (Pampaloni et al., 2007).  
Secondly, to meet the needs of regenerative medicine: This is to sidestep the 
problems related to present treatment strategies in relation to organ 
transplantation as there  is potential for tissue rejection and lack of donors, and 
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mechanical devices cannot accomplish all the functions associated with the 
tissue; surgical reconstruction can also result in long term problems. The ultimate 
goal of regenerative treatment is reducing the functional deficit, restoration of lost 
neurons and functional networks. However, most treatment strategies rely on 
symptomatic treatments or slowing down disease development. Developing in 
vitro devices that can repair in vivo the damaged tissue can offer a solution to 
these issues.   
Cells delivered in 3D hydrogels have been used as a potential and promising 
treatment for neurons damaged due to injury /disease (Lindvall et al., 2004, 
Thompson and Björklund, 2015). The ultimate goal of replacing the damaged 
neurons with intact ones is repairing the brain that can be achieved by integrating 
the neurons into the brain circuitry and reconstruction of the structural and 
physiological connectivity of the damaged neurons. Basing on this goal, grafted 
immature neurons or neural precursors derived from embryonic stem cells or 
induced pluripotent cells have been tested on rodents since the 1970s. These 
experiments recently have been translated into the clinic such as by transplanting 
cultured human motor neurons into patients with basal ganglia stroke and 
reported its feasibility by showing a positive improvement in motor function  in six 
patients (3 to 10 points) and mean improvement up to 2.9 for all patients 
(Kondziolka et al., 2000). 
1.13. What is the influence of substrate on cellular response and 
morphology? 
The in vitro models used for expanding our understanding of cellular biological 
processes and pharmaceutical responses have been designated as two-
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dimensional (2D) cultures (on a flat substrate). Polystyrene or glass substrates 
are the most common material used for manufacturing the substrates for cell 
culture (Freshney, 2005). Despite the tremendous benefits of this model of cell 
culturing over the years, which has resulted in thousands of published studies, 
these also have significant drawbacks, mainly as they are unrepresentative of the 
in vivo environment. Therefore, it necessary to develop a model that reflects the 
biological and structural characteristics of the cells in vivo that can be termed 
three dimensional (3D) culture. Tissue engineering and growing cells in 3-
dimensional scaffolds is a promising strategy in order to bypass the limitations 
associated with current biological and medical studies and applications. 
In the early 1970s, efforts were made to explore the different responses of cells 
on flat surfaces for monolayers and 3-dimensional scaffolds. There was a clear 
difference in responses between cells cultured as 2D monolayer and those in the 
3D constructs. For example, it has been found that there is a significant variation 
in mammalian cell responses including cell polarity and enhanced migration along 
fibrils by providing contact guidance signal, cytoskeleton structure, distribution of 
receptors, response to a wide range of hormones, growth factors, and apoptotic 
factors (Tibbitt and Anseth, 2009, Kim et al., 2012) 
In monolayer culture, biological responses such as receptor expression, 
transcriptional expression, cellular migration, and apoptosis in addition to the 
histological organization differ from that of the in vivo environment. The two-
dimensional (2D) culture is simple and differs fundamentally from that of in vivo 
and 3D configurations, in terms of mechanical signals, access of nutrients, cell-
cell and cell-matrix interaction, and cellular distribution (Cullen et al., 2007a). For 
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example, embryonic sensory neurons, in vivo undergo morphological 
transformations; at the early stages these cells express a bipolar morphology with 
two-opposed neurites, and then transform to pseudo-unipolar axonal arbour at the 
late developmental stages. The transformation process of these cells is delayed 
or disappears in cells cultured on flat substrates (Langer and Peppas, 2003). 
Embryonic DA neurons displayed more viability in 3D environments than the 2D 
ones (Lee and Mooney, 2001), and variability in differentiation patterns as they 
possessed longer neurites (Cullen et al., 2007a). 
1.14. Cells interact with the extracellular environment 
Cells in living tissues are embedded in the extracellular matrix (ECM) that 
provides spatial and mechanical signals. The interaction of cells with the 
surrounding domains has attracted wide interest. Cells in vivo interact with the 
environment by the ECM proteins. Additionally, adjacent cells interact with each 
other by the basement membrane, which is rich in nano-topography. Nanoscale 
features such as pores and fibres sized 30-400 nm, are fundamental for cell 
function such as adhesion, migration, proliferation and differentiation (Bettinger et 
al., 2009). The mechanism of cell-in situ interaction has been attributed to the 
presence of integrin receptors, which act as a bridge between the extracellular 
environment and intracellular cytoskeleton, that underpin its substantial role in 
signal transduction mechanism between inside and outside the cell (Bettinger et 
al., 2009, Fisher et al., 2014).  
1.15. Three –dimensional (3D) biological models 
A variety of biomaterial matrices have been developed for 3D neuronal cell 
studies. For instance, self-assembling peptide scaffolds have demonstrated the 
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capacity for neuron (PC12) attachment and differentiation as well as extensive 
neurite outgrowth.  In addition there is evidence of functional synapse formation 
between the attached neurons (Holmes and de Lacalle, 2000). Another study 
reported the feasibility of growing cerebral cortex neurons with astrocytes in 
MatrigelTM and conducting electrophysiological studies (Irons et al., 2008). The 
approach has been used for studying the development of neurons derived from 
the rat superior cervical ganglion generated in methacrylamide chitosan with a 
gradient of a neurotrophic factor (Yu et al., 2007). These efforts are examples of 
the utility of hydrogel polymers as biomaterials for biological and medical 
applications. 
 Hydrogels can be classified into synthetic (chemically synthesized) such as poly 
glycolic acid) (PGA), poly (lactic acid) (PLA), and copolymers (PLGA), and natural 
(biologically-derived) and such as collagen, fibrin and hyaluronic acid (HA), 
alginate, agarose and chitosan (Lee and Mooney, 2001). Each has advantages 
and weakness. To select the appropriate type, the biomaterials should meet 
certain criteria to function appropriately. These criteria include biocompatibility 
with the host tissue, relevant mechanical properties that relate to the cell 
adhesion and gene expression, and degradation which can be due to hydrolysis 
(Lee et al., 2000, Lee and Mooney, 2001, Pathak et al., 2003).  
Efforts have been made to develop hydrogels to grow neurons in 3D constructs 
such as the Puramatrix peptide hydrogel which was used for growing neonatal or 
prenatal rat brain cortical slices, or cultured primary neuronal-glial cells 
(Shivachar, 2008). Interestingly, this study reported that cellular viability was 
around 60%. Mixed cortical cells displayed neuronal aggregation associated with 
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cell promotion of neuronal outgrowth and extension of dendrite processes, and 
synapse formation with the neighbouring cells (Shivachar, 2008). 
Neuronal arrangement in the hydrogel is also a concern where it is important to 
simulate neuronal arrangement in the brain. Accordingly, Ning Zhang and his 
group demonstrated the possibility of forming a tissue like neuronal construct by 
growing neurons derived from iPSC in the layers of hydrogel, with the presence of 
electrophysiological activity of these neurons post 3 weeks of construct formation 
(Zhang et al., 2016). 
1.16. Aims 
From the previously described information, the benefit of the 3D hydrogels is in 
bridging the findings between lab and clinical applications. The use of 3D 
substrates offers greater knowledge relevant to an in vivo environment than 
monolayer 2D cultures. Moreover, the combination of neurons and hydrogels as 
implants need further development by promoting multiple subtype of neurons to 
grow, survive, fully integrate and form intact and functional networks. As this is an 
emerging field, until recently no ideal protocol has been developed for growing 
neurons in an in vivo like environment. This raises a number of questions which 
my thesis will attempt to address. 
 How do primary cortical cells grow and distribute in a 3D environment 
compared to 2D flat substrates? 
 Is there any influence of the 3D environment on the neuronal 
electrophysiological characteristics compared to neurons grown on 2D flat 
substrate? 
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 Is it possible to genetically engineer cortical primary neurons on 2D and 3D 
substrates using the magnetofection technique? Can oscillating magnetic 
field devices assist in the process? 
Chapter 2 
Materials and Methods 
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Figure 2.1: A flow chart summarizing experimental sequences of thesis chapters, experiments conducted and parameters 
examined.
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2.1. Reagents and Equipment 
Cell culture: Culture grade plastics (24 well plates), 13 mm  glass coverslips 
(round), Hank‘s balanced salt solution (HBSS, calcium and magnesium free), B-
27 serum-free supplement, GlutaMAX, L-glutamine, Earle‘s balanced salt solution 
(EBSS) with MgCl2 & CaCl2, penicillin and streptomycin (P/S), penicillin with 
streptomycin and amphotericin B (PS/F), and TrypLE synthetic trypsin were 
obtained from Fisher (Loughborough, UK). Dulbecco's Modified Eagle Medium 
(DMEM), Nutrient Mixture-F12, Neurobasal, insulin- and transferrin were 
purchased from Life Technologies (Paisley, Scotland, UK). N-2-
hydroxyethylpiperazine-N-2-ethane sulfonic acid (HEPES) and poly-D-lysine 
(PDL) were from Sigma-Aldrich (Poole, Dorset, UK). Deoxyribonuclease I (DNase 
I) was from Roche (Welwyn, UK), normal horse serum was from A&B scientific 
(PAA), and foetal bovine serum (FBS) was from Dutscher Scientific, UK.  
Immunocytochemistry: Rabbit anti-glial fibrillary acidic protein (GFAP) antibody 
was obtained from Dako Cytomation (Ely,UK), rabbit anti- β III tubulin (Tuj-1) 
antibody was from Covance (Princeton, NJ). Fluorophore-conjugated secondary 
antibodies (Cy3 and fluorescein isothiocyanate, FITC) were from Jackson 
Immunoresearch Laboratories Ltd (West grove, PA, USA). Phosphate buffered 
saline (PBS) was from Sigma-Aldrich (Poole, Dorset, UK). Normal donkey serum 
was from Stratech Scientific. Vectashield mounting medium with 4, 6-diamidino-2-
phenylindole (DAPI, nuclear marker) was from Vector Laboratories 
(Peterborough, UK). All the experiments conducted have been summarized in 
(Figure 2.1). 
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Transfection experiments: pmax:GFP plasmid (3.5 kb in size; encodes GFP; 
(map shown in plasmid preparation section) was obtained from Amaxa 
Biosciences (Cologne, Germany) and prepared using Endofree ® Plasmid 
Maxiprep Kit which was from Qiagen (UK). Neuromag and FluoMag transfection-
grade magnetic nanoparticles (IONPs) were from Oz Biosciences (Marseilles, 
France).  
Hydrogel experiments: type I collagen, rat-tail, low concentrate (Corning–
No.354236; 100mg) was obtained from (Tewkesbury, MA, USA). MEM (10x) 
solution was made by combining 10.17 g MEM alpha powder with 2.2 g NaHCO3 
sourced from Life Technologies, and dissolving them in 100 mL distilled water.  
Magnetic arrays: Two oscillating magnetic array devices with a 24-magnet array 
(NdFeB, grade N42; field strength of 421 ± 20 mT) were supplied by Nano-
Therics Ltd (Stoke-on-Trent, UK). 
Safety experiments (live-dead) assay: Cell viability indicators were ethidium 
homodimer (high-affinity nucleic acid stain for dead cells) and calcein AM 
(fluoresces when metabolised in live cells), obtained from Invitrogen. 
Whole-cell recording experiments: Borosilicate glass for patch electrodes was 
from Harvard Instruments. An Olympus BX51WI microscope fitted with an x40 
objective (Olympus, NA = 0.8) was used, with images taken with a Watec 902B 
camera or Optimos camera. Signal software with a Power 1401 interface was 
from CED. Patch clamp amplifier (EPC7) was from HEKA. TTX was from Tocris 
(UK). The recording microscope was fitted with a filter block containing a dichroic 
  
 
 
57 
mirror and excitation filter suitable for fluorescein and GFP. The filter block and 
blue LED were purchased from Cairn Research (Faversham, UK).  
 
2.2. Ethical Approval  
The care and use of animals was in accordance with the Animals (Scientific 
Procedures) Act of 1986 (United Kingdom) with approval by the local ethics 
committee.  
2.3. Derivation of Primary Cortical cells  
For optimizing primary neuronal culture, three protocols were tested. In all 
protocols, cells were derived from CD1 mouse cortices at embryonic day 18-18.5 
(E18-18.5; Figure 2.2 A). Embryonic day was set from the first day of positive 
vaginal plug seen (E0).  
The dissection procedure was similar in all culture systems. Some adjustments 
have been made for each of: dissection medium, growth medium and cellular 
digestion process. The first protocol (Neurobasal-1) was tested alone. Thereafter, 
the second protocol (DMEM) and the modulated protocol (Neurobasal-2) were 
examined in parallel.  
Cervical dislocation was used for sacrificing all pregnant female mice in this 
study. The surgical scissors were sterilized with 70% ethanol and an abdominal 
incision was made; the uterus was exposed and transferred into a 60 mm petri 
dish filled with ice. The embryos were rapidly decapitated into a 50 mL tube 
containing ice-cold dissection medium. Briefly, dissection medium used in the 
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Neurobasal-1 protocol comprised of EBSS, HEPES and PS/F, growth medium 
(Neurobasal, horse serum, B-27 supplement, L-Glutamine and P/S). For cellular 
digestion, the cells were incubated with trypsin (2.5%) in a 37°C water bath for 20 
min.   
For the DMEM protocol, dissection medium consisted of HBSS, HEPES and P/S, 
while growth medium was composed of basic medium (DMEM/F12, L-Glutamine 
and HEPES), insulin, transferrin and PS/F). Cells were digested using Triple-
DNase-I and incubated on a rotary shaker at 37°C for 20 min. Compositions of all 
media are detailed in Table 2.1. 
The subsequent process is for the optimal protocol (Neurobasal-2). Dissection 
medium was comprised of 0.025 M HEPES, 97.5% HBSS (with MgCl2 & CaCl2) 
and 1% of Penicillin (50U/mL) streptomycin (50µg/mL).  
For all three protocols, brain removal and cortices isolation was conducted 
aseptically in a laminar flow hood. One head at a time was transferred into a 35 
mm Petri dish, which was placed on a stereomicroscope stage. 
Each head was covered with ice-cold dissection medium, and then straight 
forceps were inserted into the eye sockets to hold the skull steady. A cross-
shaped incision was made in the skull using fine surgical scissors (Figure 2.2 B & 
C), and the whole brain was removed by Chattaway‘s spatula (Figure 2.2 D). The 
olfactory bulbs, brain stem and the hippocampus were removed (Figure 2.2 E) in 
order to obtain the cortex. Then cortical tissues were minced using a sterile 
scalpel (Figure 2.2 F); subsequently the tissue was incubated in digestion solution 
(5 ml working solution: 0.5 ml Tryple, 4.345ml HBSS, 125 µL of 0.2 M MgCl2 and 
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40 µL DNase-I; 0.25 ml/brain). Tissue was incubated for 20 min at 200 rpm on an 
orbital shaker incubated at 37°C. 1 ml of FBS was added to stop enzymatic 
activity. Residual serum was eliminated by washing the cells three times with 
serum-free growth medium, followed by centrifugation for 3 min at 2000 rpm. The 
cells were then dissociated mechanically with a 10 ml pipette followed by 1 mL 
pipette for 5 mins. Dissociated cells were strained with 70-µm then 40-µm 
strainer. 0.5-1 ml of the medium was placed on the strainer in order to pre-wet the 
filter, then made up to the final volume of 3 ml.  
Cell viability counts were performed prior to seeding by mixing 10 μl of cell 
suspension with 10 μl of 0.4% trypan blue, which stains dead cells blue, then 
transferring 10 μl of the cell mixture into a haemocytometer, which was examined 
microscopically. Cells were seeded in 24 well plates with 400 µL growth medium 
per well, and maintained in a standard humidified incubator (37°C, 95% air/5% 
CO2), with the cells allowed to adhere to the coverslip for less than 1 h. 
Subsequently, the medium was replaced with 600 µL fresh growth medium, with 
50% medium changes every 2-3 days.   
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Figure 2.2: Diagram demonstrating the main dissection steps for derivation of cortical neuronal cultures. (A) 18-day embryo under 
the stereomicroscope. (B) decapitated head and the cross-shaped incision in the skull for brain exposure. (C) Skull cut and exposed brain. 
(D) The brain released from the skull. (E) The cortex separated from the olfactory bulbs and brainstem. (F) The cortices collected in a 35 
mm petri dish and minced into small pieces by a scalpel. (G)The tissue processed into a cell suspension in 50 mL tube. (H) Cells seeded in 
the plate and incubated for the required time. (I) Neurons immunostained with Tuj-1 antibody and astrocytes with GFAP antibody which will 
be detailed in immunostaining section.
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Table 2.1: Comparison of primary cortical neuronal culture protocols: Neurobasal-1 (NBM-1), DMEM:F12 (DMEM), and Neurobasal-
2 (NBM-2). The table includes dissection and growth media in addition to some technical steps. 
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 2.4. Primary cortical cell culture conditions 
Several factors govern the distribution of dissociated cells seeded onto coverslips 
and the purity of the culture (neurons /astrocyte proportions), which affect the 
reproducibility of culture conditions. An evenly dispersed culture is important in 
order to facilitate cellular identification and quantification. Therefore, cell density 
and coverslip coating technique were adjusted in these protocols. Several cell 
densities were examined (330, 250, 160, 80, 60 and 30 x103 cell/cm2), and 
compared with different reported neuronal protocols as density references 
(Lesuisse and Martin, 2002, Xu et al., 2012)  
In order to promote cellular adhesion on coverslips, as well as reduce cellular 
migration and neuronal cluster formation, two coating protocols were examined. 
The first protocol was as follows: the coverslips were washed with nitric acid then 
coated with PDL. The initial NBM1 protocol involved washing with 1% nitric acid 
(3 h on a shaker). The final protocol was changed to 65% nitric acid overnight 
was applied, then washed with distilled water (3 h; water was changed every 20–
30 min), and sonicated (each time for 30 min: three times in distilled water, three 
times in 70% ethanol, 3 times in 95% ethanol). A PDL coating was applied (10 
µg/ml working solution, 250 µL/well), incubated overnight at room temperature 
(RT), washed 3 times in deionised (dH2O) and allowed to dry 1-2 min prior to cell 
plating. In the optimized protocol, PDL and Laminin were utilized. 10 µg/ml of PDL 
incubated on the coverslips at 37°C overnight as first coating layer, then 5μg/mL 
laminin was added as a second layer for 2 hr at 37°C, prior to adding the cells.  
Another important factor in cell dispersion is the seeding technique. Neuronal 
cortical cells were seeded using a specific technique, namely dropwise in a spiral 
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pattern, starting from the middle of the slip ending at the edges (Figure 2.3.), in 
order to ensure even coverage of the entire coverslip.  
 
Figure 2.3: Schematic showing cortical neuronal culture seeding technique.   
 
 
Serum concentration in culture is a critical factor in determining the proportion of 
astrocytes that survive and proliferate (Price and Brewer, 2001). Accordingly, 
several serum levels were tested: 10%, 1%, 0.25% and 0% (serum-free medium). 
Cultures were examined at three time point [3, 5 and 7 days in vitro (DIV)]. Table 
2.2 summarises the parameters (cell density, serum level and time points) 
examined, which are also stated in the experimental design (Figure 2.4). 
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      Table 2.2:The examined parameters for optimizing primary cortical culture. 
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Figure 2.4: Schematic elucidating the experimental design for examining the effect 
of serum level, cell density and observation time point on generating reproducible 
primary cortical neuronal cultures. „Low‘ refers to a cell density of 30x103 cells/cm2 
and ‗high‘ refers to 60x103 cell/cm2. 
 
2.5. Magnetic nanoparticle mediated gene transfer to primary 
cortical cells 
 
2.5.1 Magnetic arrays 
Two oscillating magnetic array devices were tested, each with a 24-magnet array 
(NdFeB, grade N42; field strength of 421 ± 20 mT). The first device magnefect-
nano oscillating magnetic array system (herein referred to as ‗uniaxial‘) oscillates 
in one horizontal axis (X plane). The second version, which has an additional 
horizontal axis perpendicular to X, is referred to as ‗biaxial‘ and oscillates 
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alternately in the X and Y planes (switching after each single oscillation). Both 
versions are adapted to fit 24-well culture plates. The oscillation frequency (F) 
and amplitude can be adjusted via a computerised program. Frequency in all 
transfection experiments was set to 4 Hz, as this has been reported to be the 
optimal frequency for neural cells including oligodendrocyte precursor cells, OPCs 
(Jenkins et al., 2011). The amplitude was set to 0.2 mm as this has been 
previously reported as effective for various neural cell types ((Tickle et al., 2015) 
(Figure 2.5). 
 
 
Figure 2.5: Photographs and corresponding diagrams illustrating the two types of 
magnetic arrays. (A & C) photograph and corresponding diagram for uniaxial magnetic 
array, (B & D) photograph and corresponding diagram for biaxial magnetic array. 
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2.5.2. Magnetic nanoparticle characterization  
NeuroMag and Fluo Mag particles are proprietary and patented by the company 
Oz Biosciences. Both particles are characterized positively charged, and relatively 
homogenous and round in shape. Neuromag  particle size range reported by the 
company is between 140-200 nm, with average size 160 nm, associated with  
homogeneity in shape and size, δ-potential +48.16 (Pickard and Chari, 2010a, 
Vernon et al., 2015). FluoMag size is 200 nm, polydispersity index is about 0.027,    
dynamic light scattering DLS is often expressed in terms of the Z-average.  Which 
in turn is expressed as the intensity based harmonic mean, Z-average mean is 
203 nm, and Z-average range 199-205 nm. Hydrodynamic diameter and zeta 
potential of Fluo Mag δ-potential measured in our laboratory  was ( +40.3 mV) 
(Pickard and Chari, 2010a, Fernandes and Chari, 2014). 
2.5.3. Pmax plasmid preparation 
Plasmid (pmax; 3486bp; Figure 2.6) encoding a reporter transgene (green 
fluorescent protein, GFP) was used for monitoring transfection efficiency. A 
bacterial colony was prepared by bacterial streaking technique using kanamycin-
treated agar (50 mg/ml),  incubated overnight at 37°C, then one colony per 15 ml 
tube containing 5 ml Luria-Brentani broth (LB broth) was transferred and 
incubated overnight (37° C, 180-200 rpm on an orbital shaker). Broth (1 ml) was 
transferred into an Eppendorf tube then centrifuged for 5 min /1000 rpm. 250 µl of 
P1 (reagent in Qiagen kit) was added to the pellet followed by 250 µl P2, with 
gentle mixing of the solution. Buffer N3 was added (350µl) and centrifuged for 10 
min /13000 rpm. The resulting supernatant was poured into a filter column tube 
and centrifuged for 30-60 s. The supernatant was discarded and 0.5 ml of PB 
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buffer was added on top of the filter and centrifuged for 1 min/13000 rpm. The 
supernatant was removed again and 750 ml PE buffer solution was added. After 1 
min the filter column was emptied and re-centrifuged for 1 min to evaporate the 
ethanol. The top part of the column was transferred to a new Eppendorf and 50 µl 
of EB buffer to the centre of filter and incubated at RT 1-10 min, followed by 
another 1 min centrifugation at 12-13000 rpm. The pellets in Eppendorfs were the 
DNA, which were stored for 2-3 months at -20°C.   
The manufacturer‘s instructions of Endofree® Plasmid Maxiprep Kit were followed 
for generating abundant amounts of plasmid DNA, similar to the process 
described above. Bacterial pellets were re-suspended and lysed by adding 
buffers P1 and P2 respectively. Buffer P3 was added in order to neutralize the 
lysis reaction. Clear lysate was obtained by filtering the previous mixture, then ER 
(endotoxin removal) buffer was added and incubated for 30 min. After that, the 
lysate was added to a DNA purification column, washed with buffer Q3 and eluted 
by buffer QN. DNA precipitation was carried out by adding isopropanol, then the 
DNA pellet was washed with 70% ethanol, and dissolved in buffer TE. This 
yielded highly purified plasmid DNA free of contaminating endotoxins from the 
Escherichia coli host. 
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Figure 2.6: Schematic representation of plasmid map for pmax GFP. GFP reporter 
gene encodes for green fluoresent protein, and expression indicates transfected cells. 
Adapted from amaxa Nucleofactor® technology literature. 
 
2.5.4. Magnetofection procedures 
The magnetofection protocol was performed using cells derived via the NBM-2 
protocol. Cells were seeded at 60x103 cell/cm2 in serum-free media, with particle-
plasmid complexes (described below) applied at 3 and 7 DIV. All the experiments 
were conducted in 24 well plates. On the day of transfection, 1 h prior to 
transfection, the full volume of medium was replaced with 225 µL of Neurobasal-2 
medium (free of P/S and serum, in order to reduce the adverse effect of antibiotic 
and serum on transfection efficiency) (Asgharian et al., 2014).  
MNP-plasmid complexes were formed by diluting 178 ng pmax GFP plasmid in 75 
µL base medium (DMEM: F12), adding 0.63 µL Neuromag or FluoMag, then 
incubating for 20 min (RT; volumes are for 1 well). These complexes were added 
drop-wise to the well, with gentle swirling of the plate, 75 µL (DMEM: F12) 
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medium free of complex were added to the controls. Plates were incubated using 
the standard incubation environment as mentioned earlier for 30 min on 
magnefect-nano oscillating magnetic array system (uniaxial and biaxial) with an 
oscillating frequency at 4 Hz (Figure 2.7). Cells were further incubated (without 
magnetic array) for 48 hr post-magnetofection, and then fixed, and assessed for 
transfection efficiency. Toxicity assessment (viability quantification) was also 
conducted 48 hr post-transfection. Electrophysiological studies were conducted at 
24 hr post-magnetofection.   
To evaluate culture purity, each DAPI-positive nucleus was identified as having a 
neuronal (Tuj-1+), astrocytic (GFAP+), or undetermined (Tuj1-/GFAP-) phenotype, 
and to determine transfection levels, each cell was also assessed for GFP 
expression. The immunostaining procedure was performed as detailed in section 
2.7.Magnetofection toxicity was assessed by determining the percentage of 
viable, calcein-positive (live) cells, and by counting pyknotic nuclei (chromosomal 
condensation of necrotic or apoptotic cells) (Jenkins et al., 2016). 
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Figure 2.7: Schematic describing magnetofection process. (1 and 2) are 
nanoparticles and plasmid solutions, mixed to form (3) particle-plasmid complexes, (4) 
complex added dropwise to the well containing cortical cells, (5) plate placed on the 
oscillating magnetic array (4 Hz), (6) photograph showing biaxial oscillating magnetic 
array. 
   
 2.5.5. Cellular Uptake of IONPs  
The capacity of primary cortical neurons to take up IONPs was determined by 
labelling cortical cells at 7 DIV with FluoMag in the presence of a uniaxial 
magnetic field. Assessment of uptake was conducted by visualizing FluoMag 
under a fluorescent microscope. The red channel was used for particle 
visualization, while GFP expression was visualized in the green channel. 
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Assessment was conducted by identifying fluorescent IONPs close to the cell 
body of either neurons or astrocytes, which were identified morphologically.  
2.6. Preparation of 3-dimensional (3D) hydrogel constructs 
containing neurons 
The material used for preparation of 3D neuronal hydrogel constructs was 
collagen I. It is a triple-helical protein formed of 67-nm periodic polypeptide chains 
with a total molecular weight near 300 kDa. Collagen bundled fibre diameter 
typically ranges between 12–120-nm, self-assemble at neutral pH, and can form 
crosslinks to produce a hydrogel in the presence of a water (Antoine et al., 2014). 
Collagen molecules are comprised of three α chains that assemble together, 
Collagen I molecular formula is α 1 (I) and α 2 (I) (Antoine et al., 2014). 
The feasibility of applying a collagen hydrogel as a substrate for neuronal cultures 
was initially tested using a 2-dimensional (2D) model (i.e. on a coverslip coated 
with thin layer of hydrogel). The second model was 3D construct classified as (i) 
surface seeded model where cells were seeded on top of the gel construct and 
(ii) entrapped model where cells were mixed with the gel and forming internal 
multilayer seeded construct as illustrated in (Figure 2.8). The hydrogel synthesis 
procedure was as described in (Phillips and Brown, 2011). 
On the day of conducting a gel experiment, coverslips were sterilized with 70% 
ethanol, then kept hydrated with dH2O at RT and the ethanol was aspirated just 
prior to depositing the gel solution. Cells were derived as described in Section 
2.3. All the hydrogel experiments were conducted in 24-well plates in sterile 
conditions. Coverslips were used for 2D and 3D cultures, as for 3D gels this 
facilitated lifting gels from the well for the purpose of imaging. In 2D-monolayer 
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experiments, coverslips were coated with 50 µL gel at concentration of 1 mg/mL, 
forming a thin layer. Regarding 3D constructs both surface seeded and entrapped 
hydrogel models were made up to the final volume of 400 µL/well. Collagen 
Hydrogel I post polymerization can be characterized as substrate with a multi-
layered and porous fibrillary collagen network (Tickle, 2017) 
For 3D cultures, several variations in gel stiffness were tested in order to 
determine the optimal construct capable of supporting even and homogeneous 
distribution of the cells. The varying stiffnesses were achieved by tuning the gel 
concentration (0.4, 1 and 2 mg/ml). The assembly of the gel solution was based 
on varying proportions of the following components. In 1 ml final volume (FV) 80% 
is collagen in acetic acid, 10% modified Eagle‘s medium (MEM) alpha (10x) for 
biocompatibility and 10% cell suspension (cells in standard culture medium 
(NBM-2) for the entrapped model or medium free of cells for the gel construct 
used for the surface seeding model as the cells seeded post gel setting at the 
density 4x105 cell/cm2. Finally, NaOH was added to neutralise the acetic acid. 
The formulas for calculating required volumes are listed in Table 2.3. 
The collagen hydrogel components were kept at 4°C until use. The gel solution 
was prepared in a 25 ml tube, and swirled gently after each addition in order to 
ensure thorough mixing. The following sequence in adding the components is 
critical for gel formation: acetic acid for diluting the collagen, then MEM alpha was 
added, followed by NaOH dropwise with gentle swirling, to bring the solution to 
neutral pH. This is indicated via a colour change to red, due to phenol red, which 
is one of the MEM alpha components. Neutralized gel solution was applied to 24-
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well plates immediately, and incubated at 37°C (5% CO2 / 95% humidified air). 
After 30-60 min, 600 µL serum-free medium was added on the top of the gel.  
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Figure 2.8: Schematic illustrate cell seeding models of hydrogel construct. (A) Cells 
plated on top of the gel, (B) cells mixed within the gel solution, dispersed throughout the 
construct. 
 
 
Table 2.3:Formulae for calculating collagen solution formation for 2D and 3D.  
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2.7. Immunocytochemical procedures  
For all experiments, the primary antibody used for detection of neurons was 
monoclonal mouse anti-β III tubulin (Tuj-1), while astrocytes were detected via 
polyclonal rabbit anti-glial fibrillary acidic protein (GFAP). Secondary antibodies 
were FITC (green)-labelled donkey anti-mouse or anti-rabbit IgG and Cy3 (red)-
labelled donkey anti-rabbit or anti-mouse IgG. For culture characterization 
experiments, either in 2D-monolayer or 3D construct experiments, double staining 
was required. For transfection experiments, single staining with Tuj-1, for 
identifying neurons, was sufficient.    
For immunostaining procedures in 2D-monolayer cultures (PDL-Laminin coated 
coverslips), cells were washed with PBS three times, fixed with 4% 
paraformaldehyde (PFA) at RT for 20 min, then washed again three times with 
PBS. The staining procedure started with incubating the cells with blocking 
solution (5% normal donkey serum (NDS) with 0.3% Triton-x100) for 30 min at 
RT.  
Primary antibodies were diluted in blocking solution at the concentrations 1:1000 
for Tuj1 and 1:500 for GFAP, both antibodies mixed in one tube with blocker, with 
150 μl added per well, then incubated at 4°C overnight.  
The following day, cells were washed three times with PBS. Cells were incubated 
with blocker solution (200 μL/well) at RT for 30 min, then secondary antibodies 
diluted in blocking solution to 1:200 for Cy3/FITC for 2 hr at RT and protected 
from light. Samples then washed three times in PBS for 5 min /wash. Nuclei were 
stained by adding vectashield mounting medium with 4',6-diamidino-2-
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phenylindole (DAPI), then the coverslips were mounted on glass slides and 
sealed with nail varnish for imaging by fluorescence microscopy. 
2.8. 3D hydrogel construct immunostaining  
Hydrogel samples (2D collagen coated coverslip and 3D constructs) underwent 
the same stages of immunostaining for 2D culture as detailed in Section 2.7. 
However, there is a problem associated with imaging process post staining. 
Where, the stain diffuses throughout the gel which prevents obtaining clear 
images. Therefore, there were some modifications in the protocol were needed in 
order to facilitate imaging process. These modifications included; (i) the blocking 
solution was 5% NDS with 0.5% Triton-X100 (ii) the blocking solution volume was 
doubled at all immunostaining staining stages; (iii) all incubation times were 
doubled whether for fixation or with antibodies; (iv) hydrogels were transferred 
into 6 well plates during the immunostaining process, which allows for better 
removal of the residual primary and secondary antibodies from the hydrogel 
constructs; (v) hydrogels were washed with 2 ml of PBS on a shaker for 15 min. 
 2.9. Viability assessment  
For assessing the proportion of viable cells, cultures were exposed to live/dead 
stains. At 48 hours post-magnetofection, samples of control and transfected 2D 
cultures (PDL-Laminin) were gently washed with PBS three times. To each well, 4 
mM Calcein-AM (stains live cells green) and 2 mM ethidium homodimer-1 (stains 
dead cells red) were added, incubated for 5 min at 37oC, and then washed twice 
with PBS. Live imaging was conducted using fluorescence microscopy; the 
samples were kept in the 24 well plate during imaging. 
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For hydrogel samples (2D and 3D surface seeded and entrapped model), viability 
assays were performed at defined time points (3 and 7 DIV). The protocol was 
similar for surface seeded and entrapped models, although the final volume 
added to each well of 3D samples was doubled, as was the incubation time. 
 2.10. Microscopy and image analysis 
Three different microscopes were used for 2D- (PDL-Laminin) and hydrogel (2D 
gel-monolayer and 3D gel constructs) samples imaging. A Leica DM IL LED 
inverted microscope equipped with a DFC 420 C digital camera and a pE-300 W 
Cool LED fluorescence unit, was used for cell viability counting prior to cell 
seeding. For images capturing from well plates for 2D-monolayer, the Leica 
Application Suite imaging software, version 3.3.1 was used. Fluorescence images 
from cell monolayers on coverslips were captured using an AxioScope A1 
microscope equipped with an AxioCam ICc1 digital camera, and utilising 
Axiovision imaging software by Carl Zeiss MicroImaging, GmbH (Germany). An 
Axio Observer.Z1microscope equipped with an AxioCam MRm powered by Zen 2 
was used for imaging of 2D gel-monolayer, 3D-surface seeded model and 3D- 
entrapped model. 
For the purpose of analysing the results of 2D-monolayer samples, 
coverslip/hydrogel fluorescence images were captured at 20 x magnification, from 
three fields (locations): two at the edges and one at the centre of the sample. 
Three individual fluorescent images were merged for each field, using Adobe 
Photoshop CS2 (Version 9.0) for all 2D-monolayer samples, while 2D gel-
monolayer and 3D constructs models were merged by Zen 2 (blue edition) 
software (Carl Zeiss MicroImaging GmbH, Goettingen, Germany). 
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Imaging of the 3D-Surface seeded model and entrapped model was as follows; 
Each sample was transferred onto a rectangular glass coverslip (thinner than a 
standard microscope slide, to improve image quality), the sample was flipped 
upside down, and three imaging locations were captured for 3D-surface seeded 
model as mentioned previously.  
The same process was used for 3D entrapped model. However, the images were 
captured as a series through the depth of the gel .This technique, called z-stack 
imaging, facilitates composition of a series of images within specified fixed 
distance. The beginning and ending points for imaging through the depth of the 
gel was determined manually, and then the microscope focus was shifted upward 
until the first cell nuclei became clear and in focus, and then continued to rise until 
the last nucleus went out of focus. Based on this, the vertical depth of gel was 
determined. 
 In 2D-monolayer and 2D gel-monolayer experiments, individual fluorescence 
images were captured and merged for quantification using ImageJ (v1.48). The 
cells in the 3D surface seeded and entrapped models were quantified manually.  
To provide data relating to cellular distribution throughout the depth of the gel, 
three ‗layers‘ were identified according to the equation: 
                              . This result in measurements at an upper, 
middle and lower layer, and at either the edge or the centre of the gel, as shown 
in (Figure 2.9). 
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Figure 2.9: Schematic demonstrating fluorescence imaging location for the gel 
constructs. For 3D-surface seeded construct limited to the top layer, entrapped gel 
model image location is shown throughout the depth of the gel.       
 
2.11. Whole-cell electrophysiological recording 
Electrophysiological recordings were conducted by the assistant with Dr Michael 
Evans, Keele University using the single cell patch clamp technique (single-cell 
recording). 
Whole-cell recordings were made at RT; the samples (grown either on coverslips 
or on hydrogels) were placed in the centre of lid of a 35mm cell culture dish that 
acted as a chamber. Patch pipette electrodes were pulled (using Narishige 
Vertical Puller) from borosilicate glass and the shanks coated with wax to reduce 
their capacitance. The back end of the pipette was gently fire-polished to preserve 
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the silver chloride coating of the silver wire used to establish electrical contact 
between the amplifier and the pipette filling solution. Pipettes had a resistance of 
4 MΩ when filled. Voltage-clamp protocols were run using Signal software with a 
Power 1401 interface, a patch clamp amplifier (EPC7) and a standard laboratory 
computer. The pipette, filled with the K+-based intracellular solution contained 
(mM): KCl 140, Na2ATP 2.5, MgCl2 3.5, EGTA 1, and HEPES 10, buffered to pH 
7.4 with KOH., was advanced towards the cell body until touching, at which point 
a small dimple was observed in the cell membrane. Positive pressure was then 
released and negative pressure applied by mouth until a seal was obtained. The 
patch was then clamped at the holding potential (usually -70 mV) and the pipette 
capacitive transient was cancelled using the amplifier controls. A whole cell 
recording was obtained by additional pulsatile suction, and once established the 
cell capacitance and the series resistance were measured and noted. A series of 
voltage-clamp or current clamp protocols were then run in order to record voltage-
dependent Na+ and K+ currents or spiking behaviour respectively. Occasionally 
the cell capacitance and series resistance were re-measured, as there was a 
tendency for the latter to increase over time. If necessary additional suction could 
be applied to reduce series resistance, but often at the expense of an increase in 
holding current.  
Switching from voltage-clamp to current clamp was done by altering the amplifier 
controls. Hyperpolarizing current injections were applied from the resting 
potential. Spikes could then be observed at the end of the step, when the cell 
"jumped" back to its resting potential.  
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 2.11.1. 2D monolayer (PDL-Laminin) whole-cell recording   
Genetically engineered (GFP+) and control non-engineered neurons (GFP-) (e.g. 
unmagnetofected) were cultured on circular coverslips that were secured, using a 
small drop of Sylgard, in the centre of the lid. The lid was filled with Neurobasal 
basic medium and placed on the stage of the microscope. Neurons were 
identified by the presence of neurites extending from the cell body. The presence 
of fluorescence under blue excitation light identified individual neurons as GFP+ 
(transfected) or GFP- (untransfected). The Na+ channel blocker, TTX was 
prepared as a 1mM stock solution in citrate buffer, frozen in aliquots, and 
dissolved in Neurobasal basic medium on the day of use. It was applied to the 
neuron from a second pipette positioned about 10 µm from the cell body as 
illustrated in (Figure 2.10), and ejected using a pico pump (PV820, WPI) either 
manually or via a trigger pulse.  
2.11.2. 3D-surface seeded whole-cell recording   
Gels were viewed in the chamber (lid of cell culture dish) under a binocular 
dissecting microscope (Leica). Neurobasal medium was gently added so that the 
gel was completely immersed. Small metal weights were used to hold down the 
gel. One U-shaped weight (cut from a paper clip) was positioned at the centre of 
the gel and four smaller straight weights were positioned roughly equidistant 
around the gel, pointing towards its centre. The chamber was then transferred to 
the recording microscope stage and was rotated so that the recording pipette was 
aligned to within about +/- 20 degrees of the long sides of the U-shaped weight 
and pointing down the U, although occasionally other angles were used. The 
weight tended to depress or indent the gel immediately beneath, which in turn 
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provided a convenient mound within the U along which to search for accessible 
cell bodies, with the focus adjusted as required. When recording from un-
transfected cells, the microscope lamp was on continually and its brightness 
adjusted to obtain a good image. When recording from transfected cells, the 
microscope lamp was turned down (although still on) and the blue LED was 
triggered to be on for about 0.5-1.0 s every 3-4 s, to allow identification of GFP 
neurones while still observing the gel and its surface seeded cells.  
 
 
Figure 2.10: Schematic exhibiting recording and blocking (passing TTX blocker 
through) electrode positions in relation to primary neurons during the electrical 
signal recording by patch-clamp technique.  
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2.12. Statistical analysis 
All experimental data were analysed using Prism statistical analysis software 
(GraphPad, USA; version 7.0) and all data are presented as mean ± standard 
error of the mean (S.E.M). Data were analysed by one and two-way ANOVA with 
post-hoc analysis carried out using Bonferroni‘s multiple comparison test 
(MCT).The statistical analysis used in electrophysiological studies was Student‘s 
t-test.  
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Chapter 3 
Primary cortical cell culture optimization 
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3.1. Introduction 
Over the years, many advances in neuroscience have been based on the 
evolution of highly sophisticated neural cell culture systems. For example, 
understanding neural electrical activity (Bardy et al., 2015), expanded the 
perception regarding cellular maturation and interaction (Biffi et al., 2013), gene 
identification and modulation (Blömer et al., 1997), understanding the biological 
mechanisms of neurogenesis, maturation and the opposite mechanisms which 
related to deterioration and death (Branton and Clarke, 1999, Donega et al., 
2013). The capacity to produce in vitro neurons and glia is indispensable for our 
understanding of the nervous system assembly and function at the molecular 
level. 
Despite the long history of in vitro cell culture, originating with primary nerve cells 
by Harrison in 1907, primary neuronal culture is still a challenging technique since 
mature neurons are non-mitotic (do not undergo cell division). The development 
of neuronal cell lines, from neuron derived tumours, has been the predominant 
model and a valuable source for deriving ‗neurons‘ (Gordon et al., 2013a).The 
popularity of using cell lines in experimental neuroscience research is based on 
several factors such as the ease of growing these cells, cost efficacy, highly pure 
cultures, the production of an unlimited cell number that increases the probability 
of obtaining a continuous culture. These provide a reproducible result avoiding 
the ethical concerns linked with animal use (Kaur and Dufour, 2012).  
Different types of cell lines have been relied on as a model to study several 
biological concepts related to the nervous system. These have been used in 
vaccine production, pharmacological research, such as testing drug metabolism 
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and cytotoxicity, antibody production, synthesis of some therapeutically usual 
proteins, gene function and neural cells engineering researches (Macdonald, 
1990, Schurr et al., 2009, Gomez-Lechon et al., 2003, Pisanic et al., 2007). For 
example, SH-SY5Y neuroblastoma cells (Påhlman et al., 1984) and PC12 cells 
derived from pheochromocytoma of the adrenal medulla (Andrews, 1988) have 
been used. It is important to highlight the fact that some of these cells undergo 
manipulation by the addition of different agents such as retinoic acid, phorbol 
esters,or dibutyryl cAMP to display a neuronal phenotype. For instance, the SH-
SY5Y line was originally derived from a human metastatic bone tumour biopsy of 
cell line SK-N-SH by June Biedler in the 1970‘s (Biedler et al., 1973, Biedler et al., 
1978) and can be used in two forms, (i) undifferentiated cells, which express 
immature neuronal markers (neuroblast-like morphology)(Björklund et al., 2002), 
and (ii) differentiated cells as they settle in G0 phase of the cell cycle and express 
mature neuronal markers (primary neuron morphology) (Pahlman et al., 1984). It 
is worth mentioning that although the cell lines are a useful tool in research, these 
are associated with considerable disadvantages and requires caution in relation 
to their use.  
One of the problems of using cell lines is the contamination either with other cell 
lines or mycoplasma (microorganisms which are characterized by their lack of a 
rigid cell wall and resistance to antibiotics) such as penicillin and streptomycin 
which just work to mask but do not remove mycoplasmas) (Drexler and Uphoff, 
2002). The identity of the cell line is a critical element for reliable results. Walter 
Nelson-Rees in the 1970s exposed the unfortunate truth that the majority of the 
cell lines that being used in research were misidentified due to the cross-
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contamination with HeLa cell line which has been propagated by cell banks 
worldwide (Nelson-Rees et al., 1981). This problem extended over the next 40 
years (Chou and Langan, 2003, Gstraunthaler, 2003).The contamination by HeLa 
cells can be detected after few passages while by mycoplasma can be 
undetectable for long time and can alter the cell behaviour and gene expression 
extensively (Nelson-Rees et al., 1981). 
A great deal of research work has been conducted in misidentified cell lines 
(Hatton, 2002, Pisanic et al., 2007). Buehring and his group conducted a 2004 
survey of 483 cell lines used by culture workers (Buehring et al., 2004). This 
survey indicated that 9% were accidentally using cell lines contaminated with 
HeLa cell line, 33% were not using verified cell lines, and 35% had obtained their 
samples from another laboratory. It has been reported that the incidence of 
contamination in  primary cell cultures does not exceed 1-5% , while 15-35% cell 
lines were contaminated with mycoplasma (Peters and Palay, 1991, Drexler and 
Uphoff, 2002, Zille et al., 2012). 
Generally, cell lines should possess structural and functional features as close to 
the corresponding primary neurons in vivo. This can be difficult to achieve, since 
there is no full understanding of the primary cells‘ functional properties. Further, 
cell lines can be obtained either from immortal cells (e.g. cancer cells) or a cell 
population that has been induced to become immortal by process called 
‗transformation‘ (Freshney, 2002, Gstraunthaler, 2003, Ruponen et al., 2003). In 
either situation, cells are genetically altered and this can change their native 
phenotype and the functional properties. Once they are passaged, cells with the 
highest proliferative capacity predominate, and produce cultures characterized by 
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phenotypic and genotypic uniformity. This results in a culture unrepresentative of 
the biological variations that exist in the in vivo environment (Oupicky et al., 
2000). The phenotypic and genotypic alteration can be the source of misleading 
results, which impact the cellular responsiveness to stimuli and  increase their 
resistance to toxins and cell death (Freshney, 2002, Hughes et al., 2007). 
Despite all these considerations, cell lines are still a powerful tool in neuroscience 
research and widely used today. This does not preclude that primary cells, 
despite their complexity, are still preferable because they are not tumour cells and 
not genetically altered, therefore more likely to reflect the characteristics of 
neurons in vivo. Their derivation is challenging, particularly for neurons as these 
are not proliferative hence limited cell numbers will be obtained, adding to that the 
necessity of obtaining ethical protocol approval for animal and human cells. 
Moreover, primary cells show difficulty in transfection in contrast to cell lines 
(Karra and Dahm, 2010a).The original tissue is heterogeneous (i.e. composed of 
several different types of cells) requiring separation of the cell type of interest to 
obtain purified cultures.  
Many protocols have been described for isolating and cultivating primary neurons 
to pave the way for developing culture conditions that meet experimental needs 
(Braun et al., 2006, Xu et al., 2012, Todd et al., 2013, Chen et al., 2013, Hui et al., 
2016). The majority of the methods focus on increasing the neuronal culture purity 
which is advantageous for cell-type specific biological interactions, such as in 
pharmacological studies. The purity of neuronal cultures in some studies has 
been reported to be up to 99% neurons and these are described as a neuron-
enriched cultures (Ziello et al., 2010, Xu et al., 2012) 
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The first parameter to be considered in primary neuronal cultures is the choice of 
tissue age for cell derivation. The cell production schedule in the developing 
nervous system varies according to the cell type, and at the embryonic stages the 
production of neurons exceeds the production of glia (Jhon and Andrade, 1973). 
Glial production primarily occurs postnatally. For instance, mouse cerebral cortex 
formation begins around embryonic day 12 (E12) and reaches a peak around 
E15. Astrocyte genesis commences at E16 and oligodendrocyte production 
around birth (E 20), but the majority are generated during the first postnatal month 
(Qian et al., 2000, Jacobson, 2013). Furthermore, the age of donor tissue can be 
a determinant of cell type, for example, postnatal hippocampal tissue is 
composed of a high percentage of GABAergic neurons (Pathak et al., 2003) while 
the embryonic age group is composed mainly of pyramidal neurons  (Ma et al., 
2004). 
A second avenue of research has been directed towards reducing the number of 
astrocytes, despite the neuro-supportive effect of these cells. Astrocytes in culture  
have a fundamental role in the regulation of extracellular fluid homeostasis via (i) 
recycling of neurotransmitters (Kimelberg and Nedergaard, 2010) and regulating 
extracellular potassium (Wong et al., 2006) (iii) secreting amino acids, 
neuropeptides and neurotrophic factors (Murphy and Messer, 2001). The aim is to 
generate biologically controlled co-culture. Approaches have been developed for 
reducing astrocytes and improving the purity of the neuronal culture, for example 
by adding glial cell inhibitors (i.e. eliminating dividing astrocytes by adding the 
DNA-synthesis inhibitor) such as cytosine arabinofuranoside (AraC). However, 
this increases the susceptibility of neurons to glutamate (Ahlemeyer et al., 2003), 
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and this approach has proved to be cytotoxic to neurons. Another approach 
considered safer than the approaches that use AraC, is where serum free 
medium has been used to suppress astrocyte proliferation. Astrocytes are 
proliferative cells, and serum deprivation can arrest them in the (G0) phase of the 
cell cycle (Aizenman and de Vellis, 1987). 
Therefore, culture conditions have an important impact on neuron viability and 
behaviour. It should be noted here, that while efforts are focused on purifying 
neuronal cultures, a major point of view is that astrocyte presence is fundamental 
for neuronal survival and growth, to create an environment that closely mimics 
physiological conditions. This is because astrocytes play a critical role in neuronal 
protection against glutamate toxicity in mixed astrocyte /neuron cultures and 
astrocytic dysfunction promotes neuronal toxicity (Voloboueva et al., 2007). 
Stoppelkamp and his group have suggested that the reduction of astrocytes in 
culture has a negative impact on neuron excitability (Stoppelkamp et al., 2010). 
Additionally, growing neurons optimally relies on basic environmental 
requirements, which include controlled temperature, appropriate growth medium, 
and the cell attachment substrate (Xu et al., 2012, Todd et al., 2013, Chen et al., 
2013). Acritical step in neuronal culture is selecting the appropriate growth 
medium: the source of nutrients and energy, in addition to its effectiveness in 
maintaining a balanced pH and osmolality. The most widely used media for 
primary neuronal culture currently are DMEM, DMEM:F12 and Neurobasal basic 
media, which was developed by optimization of  DMEM:F12 (Brewer et al., 1994) 
, and either serum-containing or serum free media (Arora, 2013). 
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Serum is one of the most important components of growth media, and is 
composed of albumin, growth factors and growth inhibitors (Lane and Miller, 
1976). Using serum in media has advantages of supporting cell growth and 
function and it is important for cell attachment to the seeding surface, acting as a 
cell spreading and buffering agent. However, disadvantages of serum in the 
media also exist, such as the variability in serum composition necessitating the 
test each batch before use , it is likely to contain inhibiting factors, and it can be 
more susceptible to contamination (Arora, 2013).  
To this end, development of new media and supplement components was 
required. Accordingly, Neurobasal medium was developed with optimized 
concentrations of alanine, asparagine, cysteine, glutamate, proline, and vitamin 
B12 which are found in DMEM:F12 composition but not found in DMEM alone 
(Brewer et al., 1993). Further, B27 supplement was developed as an alternative 
to the serum in media, consequently serum free media have become available for 
studies when there is no need for the presence of  serum for avoiding its side 
effects (Brewer et al., 1994).  B27 supplement can be used in combination with 
Neurobasal but not with DMEM or DMEMP:F12 media composition (Brewer et al., 
1994). The variation in media composition showed an impact on the growth of 
neurons in culture (Harrill et al., 2015). Long term survival (four weeks) has been 
achieved when the growth medium used composed of Neurobasal medium 
supplemented with B27 reached up to  90% for hippocampal neurons and 80% 
for brainstem, in contrast to the media consisting of DMEM: F12 supplemented 
with B27 (Brewer et al., 1993, Kivell et al., 2000).  
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Neurons also have the tendency to aggregate and self-organise as clusters (Shefi 
et al., 2002). This is considered to be a problem that hampers the ability to image 
neurons for quantification purposes. This has prompted scientists to use 
automated software for imaging such as Matlab Boost Graph Library package and 
the Brain Connectivity Toolbox (de Santos-Sierra et al., 2014). Alternatively, 
previous studies have plated cultures of neurons at low densities (150,000 cells 
per 60-mm dish) to enable single cell study (Kaech and Banker, 2006) 
My PhD required the development of a methodology to derive and maintain a 
biologically balanced culture (i.e. neuron/astrocytes) using rodent cells, to be 
used for further testing in subsequent experimental chapters. It should be noted 
that the culture methodologies for neuron derivation did not exist in the 
laboratory. Therefore, my first goal was to establish a reproducible 
technique for primary mouse neuron culture in the group. 
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3.2. Objectives 
The main aim of the research described in this chapter is to obtain reproducible 
primary neuronal cultures. 
The desired criteria for these cultures are (i) reproducibility (the ability to routinely 
obtain cultures with similar features), (ii) ability to distinguish morphological 
features of individual cells and (iii) support of the maturation of neurons (clear 
detection of neurite outgrowth). 
In the first section of this chapter, the objective was to identify dissection and 
culture techniques that would reproducibly derive primary cortical co-cultures.  
In the second section of the chapter, tailor the culture system to generate cultures 
that more closely meet the desired criteria, which are:  
(i) Quantifiable cultures; in other words, obtaining evenly distributed cells in the 
culture to facilitate analysis of individual cells. For this, three variables will be 
adjusted: 
(a) The seeding density of the cells. 
(b) Different substrates.  
(c) Time in culture, to evaluate neuronal dispersal and maturation. 
(ii) Obtaining a balanced co-culture of neurons and astrocytes, by lowering the 
contamination of astrocytes by reducing the serum level and avoiding the toxic 
effect of chemical reagents (anti-mitotic agents), employed to limit proliferation of 
non-neurons.  
 
  
 
 
95 
  
 
 
96 
3.3. Experimental procedure and analysis  
2D primary cortical culture derivation and optimization protocols have been 
described (Section 2.3), as has dispersing primary neurons in culture at low and 
high cell densities (Section 2.4). Culture characterization was carried out by the 
immunolabeling procedure as described in (Section 2.7).  
 
3.4. Results 
Several protocols for primary neuronal culture were identified in the literature 
(Millet and Gillette, 2012), and the one selected for initial trials was obtained from 
another group termed NBM-1. 
3.4.1. The NBM-1 protocol was unsupportive of primary cortical 
culture 
 Cell death associated with this protocol was high on every occasion, up to 90% 
(Ca.10-15 attempts). Fluorescence microscopy of cortical co-culture post 7 days 
incubation time showed a low number of neurons and astrocytes in addition to 
poor neuronal network formation (Figure 3.1.A). 
3.4.2. The DMEM protocol was unsupportive of primary cortical 
culture 
Following NBM-1, the next protocol tested was termed DMEM. Pilot studies using 
the DMEM protocol showed unsatisfactory results. This included lack of genesis 
of neurons and poor immunolabeling that limited cell identification (Figure 3.1B).  
3.4.3. NBM-2 optimized protocol was supportive of the primary 
cortical    culture 
Cortical culture generated by a NBM-2 protocol was feasible and met the desired 
criteria of the culture (In house made). Microscopic investigations revealed that 
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cell viability was elevated dramatically (up to Ca. 95%). Neurons were identifiable 
and often individually distinguishable post-immunostaining. The soma and 
neurites immunostained positively with Tuj-1 antibody, thereby the morphological 
characteristics of neurons could be assessed. Increasing the culture time to 7 
days in vitro, showed a good maturation level that appears as an elongation in the 
neuron processes, and a complex network formation as shown in (Figure 3.1C). 
However, some of the neurons over time tended to aggregate and form clumps. 
These clusters limited the visualization and quantification of individual cells. 
Despite these minor limitations, NBM-2 media produced cultures suitable for 
analysis, and was utilized in all neuronal culture experiments conducted in the 
following experimental chapters. The outcomes of the primary cortical culture 
protocols in terms of media tested, are summarised in (Figure 3.1D).   
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Figure 3.1: Fluorescence micrographs show the validity of primary neuronal 
cultures derived according to three different protocols. (A) Neuronal cortical culture 
generated according to Neurobasal-1 (NBM-1) protocol, neurons stained for NMDA 
receptor subunit NR2A and DAPI. Neuronal cortical cultures generated according to (B) 
DMEM and (C) NBM-2 protocols, neurons stained with Tuj-1 antibody. (D) Schematic 
summarizing the criteria adopted to determine validity of the tested protocols. 
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3.5. Neuron distribution and characterization 
This section represents the findings from optimization of primary cortical culture, 
conducted in order to facilitate analysis and quantification of cells. 
 Seeding density and substrate: Fluorescence imaging of cells plated on 
coverslips coated with just PDL as a coating layer at the density 1 x106 cell/cm2 
revealed the tendency of neurons to aggregate and form clusters, limiting the 
identification of individual cells. However, reducing cell density to 60 x103 cell/cm2 
and 30 x103 cell/cm2 resulted in better identification of cells but was still 
insufficient to be quantifiable specifically at the higher density 60 x103 cell/cm2. It 
has been reported that plating density affects the neuron maturation level, but not 
their distribution on the coverslip (Biffi et al., 2013) .The two densities 60 and 30 
x103 cell/cm2 have been monitored along two incubation time points. After 3 DIV 
the observations revealed that Neurons at the higher density culture extended 
long neurites and formed complex networks. On the contrary, neurites extended 
from Neurons seeded at lower density were short and did not form any network at 
the same time points (Figure 3.2 A & C).  Post 7 days of incubation time, neurons 
formed longer processes in cultures seeded at low density and assembled a 
complex network. Neurons in cultures at the higher density demonstrated more 
complex (greater density of neurites) network in comparison to the network of low 
density culture at the same time point (Figure 3.2 B & D).  
The combination of cell density reduction and using PDL-Laminin as a second 
coating layer on coverslips, assisted in dispersing Neurons uniformly over the 
coverslip area. Figure 3.3 A, B, C & D display the cellular distribution and the 
extent of neuronal processing at the different time points and cell densities. 
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Time in culture: Cells were well dispersed at the time of seeding, and were 
spread evenly across the culture well. However, cultures always exhibited 
aggregation of neurons, to some extent. For the chosen conditions (3 and 7DIV) 
in cultures coated with PDL alone, and there was a neuronal aggregation that 
preventing analysis.  
In, cultures that were incubated for 3 and 7 DIV and the coating was PDL-
Laminin, the neurons did not aggregate or formed clusters that prevent 
quantification.  
The extended culture time had a pronounced effect on the neuronal network 
formation and its complexity. The neurites were observed to be relatively short at 
3 days post seeding compared to 7 days, at either the low seeding density (Figure  
3.3 A & B) or higher seeding density (Figure 3.3 C& D).  
With regard to cellular characterization, the fluorescence images of cultures 
revealed that there were two types of cells composed the primary cortical culture. 
Cells which were positive for Tuj-1 antibody (Tuj1+) and extended multiple 
processes (neurites) were identified as neurons. GFAP positive (GFAP+), 
flattened/star-shaped cells were identified as astrocytes. Some of the cells were 
of undetermined identity, as they were negative for both Tuj-1 and GFAP cellular 
marker and termed (Tuj-1-/GFAP-).
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 Figure 3.2: Cortical neuron distribution and growth. Neurons formed clusters when 
seeded on coverslips coated with PDL and showed highly branched and complex 
networks at the higher seeding density. (A & C) Neurons stained with Tuj-1 and DAPI at 
30x103 cell/cm2 and 3 days post seeding. (B & D) neurons seeded at 60 x 103 cell/cm2 
incubated for 7 days in vitro. 
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Figure 3.3: Distribution and growth of the cortical neurons plated on the substrate 
coated with PDL and Laminin. Neurons spread almost individually on PDL-Laminin 
coated coverslip for both densities, low density 30 x103 cell/cm2 and high density 60 x 103 
cell/cm2 and at the two-time points (3 and 7 days in vitro). The neurons showed a neurite 
extension regardless of the incubation time. However, the neurite length and complexity 
varies according to the length of incubation time and density of culture. At low density 30 
x103cell/cm2 and incubated for 3 and 7days post plating (A & B) was less than their 
length and complexity at high density 60 x 103 cell/cm2 (B & D). Neurons stained with 
Tuj1 and nuclei with DAPI.  
 
Serum concentration in media: At 7 DIV incubated culture, the reduction in 
serum concentration in the growth media from 1% to 0% (Figure 3.4) resulted in 
no significant effect on cortical cells in culture with respect to (a) the proportions 
of neurons and astrocytes, as judged by the percentage of Tuj-1 and GFAP-
labelled cells respectively, (b) number of cells per microscopic field, as judged by 
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number of neurons and astrocytes per microscopic field. The numbers of 
neurons/field were (86 ± 14) for cultures treated with serum free medium and (81 
± 15) for cultures treated with serum (1%) containing medium, while astrocytes 
were (67 ± 33) and (72 ± 6) per field respectively for both serum free  and  serum-
supplemented media, the neurons and astrocytes appeared morphologically 
similar by visual inspection (Figure 3.4).  
 
Figure 3.4: Serum in media influence on the proportion of cortical cells in culture. 
Tuj-1 labeled cells (Neurons) and GFAP labeled cell (astrocytes) proportions and 
morphology do not appear to be affected by the alteration in serum concentration in 
media, (A) 1% and (B) 0% serum in growth medium. 
 
3.6. The influence of culture incubation time on the proportions 
of neurons vs astrocytes 
At all incubation times tested, the proportion of primary cortical cells (Tuj-1+ and 
GFAP+) was calculated as the cell type out of the total number of healthy nuclei. 
There were no significant differences in the proportion of Tuj-1+ cells in culture 
over the three incubation times (Figure 3.5). However, the proportion of GFAP+ 
cells was significantly increased at day 7 of incubation time comparing to the 3 
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and 5 DIV (1 ± 1% and 6 ± 3 %) respectively (P <0.05) see (Figure 3.5). The 
findings also demonstrated presence of (Tuj-1-/GFAP-) healthy, unidentified cells. 
 
 Figure 3.5: Primary cortical cell proportions in cultures treated with serum free 
growth medium over three time points (3, 5 and 7 DIV). Bar graph of the percentages 
of primary cortical cells in culture. Green bars represent the percentage of Tuj-1+ cells 
(neurons) which demonstrated negligible difference over the three incubation time points, 
while orange bars represent the percentage of GFAP+ cells (astrocytes), which displayed 
a significant increase at day 7 (P<0.05). (n=3) 
 
 
The conditions that have been tested in order to generate primary cortical culture 
and the optimal conditions which will be utilized for the subsequent experiments in 
the following chapters are summarised in Figure 3.6. 
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Figure 3.6: Schematic representing the approved culture protocol for deriving 
neuronal primary cortical cells in addition to the optimal culture condition which 
chosen according to experimental criteria needed.
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3.7. Discussion 
As detailed in section 3.1, data from primary cultures will be of greater biological 
relevance than will data from cell lines. Primary neuronal culture derivation is 
known to be challenging, but a procedure to derive neuronal culture was 
successfully established, after careful optimization of the methods. From 
continuous observation during the experimental process for optimizing primary 
cortical culture, the success of growing the cells optimally relies on basic 
environmental requirements, which included mainly: (i) tissue processing 
reagents (medium and tissue digestion reagents) and appropriate technique, (ii) 
growth media, and (iii) adherent culture system  of  plating surface ((see materials 
and methods chapter). In the first part of this chapter, the optimal primary cortical 
culture protocol was established.  
The stability of pH of the culture medium is a critical factor when propagating cells 
for a long time. Accordingly, the choice of media is critical for maintaining a stable 
pH. If the pH increases over 8, cell viability will decrease. Such an effect was 
shown by Eagle in 1973. In culture media that contain bicarbonate, the pH may 
increase to 8.5 after 1 hour of incubation (Lelong and Rebel, 1998). Poor cell 
survival results when the pH rises above 8 (Eagle, 1973). Therefore, choosing 
media containing low sodium bicarbonate is preferable specifically for cultures 
designated for pharmacological and toxicological studies. Hanks' Balanced Salt 
Solution is one of these buffers that contains sodium bicarbonate (NaHCO3) 
compared to Earle's Balanced Salt Solution. Furthermore, buffering capacity can 
be improved by adding HEPES (Lelong and Rebel, 1998). 
The cell dissociation protocol including enzymes contributes to determining the 
viability of cultures (Volovitz et al., 2016). According to the manufacturer's 
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instructions (See Chapter 2 Section 2.1), the utilized tissue dissociation enzyme 
(Tryple) is gentler on cells (protect cell‘s surface proteins) than trypsin (Schwartz 
et al., 2011). Also, the digestion enzyme DNase I was used because it was 
necessary for removing the DNA traces of lysed cells that can hamper further cell 
digestion (Chen et al., 2011, Xu et al., 2012). Strainers were used to remove dead 
cells from surrounding medium. Tissue dissociation including enzymatic and 
mechanical dissociation can induce apoptotic cell death which is characterized by 
plasma membrane rupture leading to local inflammation (Branton and Clarke, 
1999). 
As a growth medium is designed to be the source of energy and cell cycle 
regulators (Arora, 2013), selecting the appropriate growth media for cultivating 
primary cortical cells should be built on a solid foundation. Providing nutrients 
(complement of amino acids, vitamins, inorganic salts, glucose, and serum as a 
source of growth factors, hormones, and attachment factors) and maintaining 
stable pH and osmolality are the main requirements for the culture (Arora, 2013). 
NBM-2 medium was the optimal composition that supported cortical culture, in 
contrast to the NBM-1 and DMEM media as detailed in table 2.1. The basic 
elements in the media are Neurobasal or DMEM: F12. If we look closely at the 
composition of these media, we find that Neurobasal medium is developed from 
DMEM: F12 by optimising the concentration of alanine, asparagine, cysteine, 
glutamate, proline, and vitamin B12. Furthermore, the osmolality, glutamine and 
sodium bicarbonate were optimised (Brewer et al., 1993, Brewer et al., 1994). Our 
results confirmed Gregory J. Brewer‘s findings in 1994 and showed that the 
Neurobasal in combination with B27 performance was superior to DMEM: F12 for 
survival and maintenance of Neurons. Brewer also reported that serum free 
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Neurobasal media complemented with B 27 supported the survival of Neurons in 
cultures and obtained survival up to 70%, however, that was brain region 
dependent (Brewer, 1995). That goes back to the idea that DMEM: F12 medium 
has potential excitotoxic amino acids such as glutamate and aspartate (Brewer et 
al., 1994, Price and Brewer, 2001). Where, the excitotoxicity is defined as ―cell 
death resulting from the toxic actions of excitatory amino acids‖ (Dong et al., 
2009). This toxic action results from prolonged exposure to glutamate which 
considered as the major excitatory neurotransmitter that causing over activations 
of receptors for the excitatory neurotransmitter glutamate, such as the NMDA 
receptor (Berliocchi et al., 2005) .This process  associate with excessive calcium 
influx which casing  the activation of enzymes that degrade proteins including 
phospholipases, endonucleases, and proteases such as calpain. These enzymes 
degrade proteins, membranes and nucleic acids and result in damage cell 
structures such as components of the cytoskeleton, membrane, and DNA (Dong 
et al., 2009) . 
Growth media using theNBM-1 protocol was improved to NBM-2 growth media by 
replacing, L-glutamine supplements to GlutMax-I and horse serum to foetal 
bovine serum. According to the manufacturer (Fisher), L-Glutamine is a 
supplement that spontaneously degrades, generating ammonia and pyrrolidine 
carboxylic acid as a product of the reaction (Ozturk and Palsson, 1990, Bray et 
al., 1949). GlutaMAX-I is a developed supplement that does not spontaneously 
degrade (Christie and Butler, 1994). The substituted supplements are 
recommended according to the literature, where FBS enhanced fibroblast cell 
passage number in addition to preserving the cellular morphology (Franke et al., 
2014). For the purpose of experimental quantification, it was necessary to obtain 
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almost individually distributed cells; proceeding from this need, the cellular 
substrate was adjusted to control the neuronal dispersal in culture.  
Cultivated Neurons on PDL-coated coverslip formed clusters at all the 
developmental stages examined regardless of the cell seeding density. The 
cellular interaction with the substrate relies on the ability of a family of 
transmembrane glycoproteins named integrins (mainly β1 family) to bind to the 
binding sites of the extracellular components such as collagen, fibronectin and 
Laminin (Clyman et al., 1990, Hynes, 1992). Therefore, poor coverslip coating 
can influence the neuronal cell distribution. Hence, PDL as one coating layer, was 
insufficient to provide the consistency for cellular distribution.This is in agreement 
with the study that reported the physical bounds between PDL and the surface 
was insufficient for neuronal cell adhesion enhancement and promoting neuronal 
growth and neurite outgrowth  (Kim et al., 2011). According to this, adding laminin 
as a second coting layer enhanced cellular adhesion and reduced neuronal 
aggregation and cluster formation. On the basis that astrocytes are supporting 
cells to the neurons by protecting them from various forms of cytotoxicity 
(Desagher et al., 1996), maintaining a quantity of astrocytes in culture was 
deemed necessary.  
 Obtaining biologically controlled culture was achieved by serum starvation, in 
turn trying to reduce number of astrocytes but not totally eliminating them, 
avoiding by that means the toxicity that can result from the glial cells inhibitors, 
such as the anti-mitotic agents arabinosylcytosine C (AraC) (Geller et al., 2001, 
Ahlemeyer et al., 2003). The findings here demonstrated that the influence of 
serum starvation on the percentage of astrocytes was obvious when the serum 
level reduced from 10 % to 1% as visually determined. However, there was no for 
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further effects on percentage of astrocytes following further reduction in serum 
from 1% to 0%. The findings here are inconsistent with those of Chou & Langan 
during their study on regulation of cell division cycle. As in their study they 
demonstrated the influence of serum starvation on the cell division mechanism, 
astrocytic cells treated with 10 % bovine calf serum in DMEM medium first, then 
cells reached the desired confluence up to (30-50 %), the second step was 
reducing serum in medium to 0.1%, by that astrocytes arrested in the G0 phase of 
the cell cycle (Chou and Langan, 2003). Then for re-entering astrocyte to the cell 
cycle the serum level up-shifted again to 10%. These findings suggested that the 
astrocytes can be arrested and exit the cell cycle by reducing the serum below 
10% (i.e. astrocyte entering into G0 phase can be either stimulated with low 
serum or serum free medium). 
Taken together, the findings from the three examined protocols for generating 
primary cortical neuronal cultures suggested that NBM-2 protocol for obtaining 
reproducible culture was the best. Furthermore, the optimal parameters which 
included seeding density (60 x103cell/cm2), coverslip coating (PDL-Laminin), 
serum level in media (0%) and time points (3 and 7 DIV) suggested to serve the 
need for obtaining survive, mature, quantifiable, purified safely without using 
cytotoxic inhibitors neuronal culture. This optimization process was conducted in 
order to configure the neuronal culture to be used for the subsequent experiments 
which encompass gene engineering, electrophysiological analysis in addition to 
growing neurons in 3D constructs, which will be demonstrated in the next 
experimental chapters. 
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Chapter 4 
Evaluating the safety of magnetofection for primary 
cortical neurons  
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4.1. Introduction 
The limited capacity of the CNS for endogenous repair following injury or disease, 
in which the low capacity of neurons to regenerate is a major factor, has 
motivated researchers to develop basic research in this area (Bjorklund and 
Stenevi, 1979).  Researchers have enhanced the understanding of many aspects 
of neuronal biology by investigating gene and protein function that can promote 
neuronal survival and function, in order to inform the development of novel 
therapeutic interventions (Tuszynski and Steward, 2012). In this respect several 
technologies to genetically modify neurons have developed as discussed earlier 
in the general introduction. However, there are two technical issues that need to 
be considered in delivering the gene to the neuronal population, namely, 
successful gene targeting and safety.  
 Neurons derived from E18 (embryonic) are known to be challenging in terms of 
introducing and expressing exogenous genes. This is related to their sensitivity to 
alterations in their microenvironment including temperature, pH, changes in 
osmolarity, and physical stress (Lelong and Rebel, 1998, Karra and Dahm, 
2010a). Accordingly, choosing the appropriate neuronal gene engineering 
technique is critical for successful outcomes. Since the main obstacle to the 
process of gene delivery is the limited diffusion of the gene across the cellular 
barriers, several methodologies have been optimized and tested for gene delivery 
into Neurons including viral and non-viral approaches. Despite these techniques 
being efficient at delivering genes to cells they have their limitations (discussed 
previously in the General Introduction). Here, some examples for transfecting post 
mitotic Neurons using (i) viral and (ii) non-viral techniques, will be presented 
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together with a summary of viral versus non-viral techniques for genetic 
engineering of neurons, as discussed more widely in the General Introduction. 
 The herpes simplex virus (HSV) was the first viral gene vector used for 
transfecting neurons (Washbourne and McAllister, 2002), for example cultured rat 
superior cervical ganglia and dorsal root ganglia (Geller and Breakefield, 1988). 
This type of viral vector possesses special qualities that facilitates a high level of 
gene delivery and subsequent transfection of neurons as they can transfect 
neurons efficiently, and can be utilized as neuronal pathway tracers due to their 
ability to be transported across synapses in a retrograde way. Moreover, protein 
expression possesses a long lasting ability that can persist for up to a year. 
However, their major limitation is their high toxicity level in vitro and local immune 
response in vivo (Bergen et al., 2008).  
The biolistic technique is a mechanical non-viral technique using a hand-held 
gene gun for transfecting neurons in organotypic mouse cerebellum slices 
(O'brien and Lummis, 2006). Nucleofection is a method developed from the 
biolistic technique, for the transfection of hippocampal neurons. Both techniques 
display a high transfection efficiency of up to 95%. However the main drawbacks 
are related to the type of targeted cells, in that  the biolistic technique is limited to 
tissue slices, and nucleofection is successful only for immature cultured neurons 
that have not produced neurites (Zeitelhofer et al., 2007). Although these 
transfection techniques produce high transfection efficiency, each of these 
methods has a number of limitations.   
The process of delivering gene to the target cells is limited by multiple barriers 
confronting the entry of the gene-vector complex into the cell to manipulate 
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nucleic acid in the targeted cells. These include (i) vector-cell contact; (ii) 
transport across the plasma membrane-which is considered a barrier for 
molecules that are not actively imported by cells; (iii) endo/lysosomal clearance; 
(iv) nuclear membrane, and in addition (v)  the limited targeting ability of the gene-
vector complex i.e. the non-specific interaction with non-target cells or organs and 
the probability of systemic spreading of the vector in in vivo application (Kim et al., 
2002) and (vi) vector inactivation due to non-specific and rapid interaction with 
undesired components  (i.e. defence complements or immune system) in in vivo 
milieu (Ogris et al., 1999). Toward enhancing transfection efficiency, research 
efforts focused on developing DNA carriers such as synthetic vectors that can 
mediate efficient gene delivery to the target cells or tissue such as polymer 
carriers, lipid, polypeptides and nanoparticles (Bergen et al., 2008) as discussed 
in the General Introduction. The other method was by designing physical assistive 
methods that accelerate vector-DNA complex in the direction of the target cells, 
and so enhance vector- cell contact.   
Vector-cell contact is an accumulation of nanoscale particles such as viruses and 
IONPs within the cell which, to a great extent, relies on a diffusion-limited 
process. Efforts have been made to facilitate vector- surface bound biomolecule 
(virus or gene) delivery to the target cells/ tissue instead of the random 
orientation. However, conventional transfection reagents such as polyamidoamine 
(PAMAM) are toxic to cells specifically with long time exposure. Consequently, 
just a few fractions of DNA could be internalized into the cells (Haensler and 
Szoka Jr, 1993). Luo and Saltzman have managed to enhance transfection 
efficiency about 8.5 fold over the conventional methods utilising a method 
designed to increase DNA concentration at the cell surface by relying on gravity 
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of nanoparticle-association with vector–DNA complexes to facilitate sedimentation 
of DNA onto cell surface (Luo and Saltzman, 2000a).This offers an explanation of 
why large and heavy particles have demonstrated more efficient transfection 
levels than smaller particles (Luo and Saltzman, 2000a). In this respect, Bunnell 
and his group have successfully used  centrifugal force for enhancing vector-cell 
contact (Bunnell et al., 1995). To that end ‗magnetofection‘ - as defined previously 
within the General Introduction - has been considered as the most promising 
approach for enhancing neuronal transfection efficiency (Plank et al., 2011a). 
Accordingly, Furlani and Ng (2008) have developed a method using  a magnetic 
field that is based on applying magnetic force that can attract the magnetic 
particles-surface bound gene to the target cells (Furlani and Ng, 2008).This 
technique offers the advantages of enhancing transfection efficiency via rapid and 
efficient gene transfer, protein expression level, production scalability, and 
reduction in cost, technical complexity and toxicity (Karra and Dahm, 2010a).  
With respect to transfection of neurons using magnetofection, several neuron 
types have been tested, using both neuronal cell lines and primary neurons, for 
expression of reporter genes and physiologically relevant biomolecules. 
Examples include transfection of motor neurons with a plasmid encoding the F-
actin reporter Lifeact-GFP for the purposes of inspecting any morphological 
changes associated with magnetofection technology, as well as  delivering (GFP) 
reporter gene for investigating nanoparticle uptake  (Fallini et al., 2010, 
Fernandes and Chari, 2014) ; expression of potassium–chloride cotransporter 
KCC2 in immature hippocampal neurons derived from P0 for studying KCC2‘s 
role in GABAergic network formation (Chudotvorova et al., 2005); and study of the 
protein localization and transport of axonal proteins such as spinal muscular 
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atrophy protein (SMN) (Ang et al., 2011) in embryonic primary motor neurons 
(Fallini et al., 2010).   
The magnetic carrier‘s formulation and the mode of the applied magnetic field are 
the two determinants of magnetofection efficiency. Mah et al (2000), have 
reported magnetically enhanced AAV vector transfect by linking the virus to 
magnetic microsphere mediated gene delivery to C12S cells (Mah et al., 2000). 
The deployment of a static magnetic field (Scherer et al., 2002) through 
application of high–field /high-gradient magnets underneath culture plates can  
promote particle sedimentation over cells that leads to rapid and efficient 
transfection (Schillinger et al., 2005, Buerli et al., 2007). However, a non-uniform 
distribution of IONPs-gene complex on the surface of cultured cells was apparent 
when a static magnetic field was used. Therefore, some refinements have been 
made by different groups in order to achieve uniform particle distribution 
promoting targeting and efficiency specifically for Neurons. Baryshev and his 
group (2011) developed ―DynaFECTOR‖ which is a dynamic gradient magnetic 
field, using a rotating platform assembled with magnets of the orbital shaker to 
provide the movement. Although this technique promoted transfection efficiency 
in human liver hepatocellular carcinoma cell line HepG2 over the static field, it has 
a limitation in a lack of precise particle directing toward cell surface (Baryshev et 
al., 2011). Hence, a series of attempts to develop oscillating magnetic fields have 
been made. Pulsating magnetic field termed ―electromagnet‖ has also been 
developed and also produced high transfection efficiency within minutes of 
exposure. However, this method was associated with an increase in temperature 
up to 42.5 OC which in turn can lead to cell death (Fouriki et al., 2010b).  
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Magnetic actuator was another magnetic device developed that provides linear 
movement of the magnet producing variable magnetic fields (Oral et al., 2015).  
This device has been tested on different cell types but not yet on neurons. To this 
end, it has been reported that the overall transfection level using magnetofection 
is four times greater than that of other techniques like cationic-lipid based 
reagents (Lipofectamine 2000TM) (McBain et al., 2008). An oscillating magnetic 
array of cylindrical stacks of high-gradient NdFeB magnets utilises both frequency 
and amplitude to produce a lateral movement to the MNP-gene complexes 
(McBain et al., 2008). Use of specific frequency and amplitude parameters with 
this device has been reported to enhance transfection efficiency in 
oligodendrocyte precursor cells (Jenkins et al., 2011); neural stem cell 
suspension cultures (Adams et al., 2013); neuronal cell line SH-SY5Y and 
primary hippocampal neurons (Subramanian et al., 2017). Furthermore, 
fluorescence intensity was affected by the magnet distance. Thus, using an 
oscillating magnetic array with magnetic distance no less than 3 mm and no more 
than  5 mm  from the cell culture plate demonstrated high fluorescence intensity in 
comparison to a static array (Fouriki et al., 2010b).The basic mechanisms 
believed to participate in enhancing transfection efficiency by applying magnetic 
fields are:  
(i) Applying permanent magnetic field increase IONPs sedimentation rate on the 
cell surface and accelerates transfection in in vitro experiments. In vivo, utilization 
of magnetic fields not only increases transfection efficiency but enhances 
therapeutic gene targeting to the desired tissue or organ (Dobson, 2006). 
Regarding oscillating magnetic field, the lateral movement of magnetic field 
directs the magnetic vector (IONPs) to contact the cells in culture within a given 
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time. (ii) It is believed that an oscillating field can stimulate the endocytic 
mechanism of the cell membrane (Fouriki et al., 2010a). (iii) The other proposed 
mechanism of action of oscillating fields is the facilitation of the endosomal 
escape of IONPs by disrupting endosomal processing (McBain et al., 2008). A 
further advantage of enhancing transfection efficiency by using the oscillating 
magnetic field that is characterized by high field strength and gradient associated 
with limited heat production; the magnetic force results in a translational force on 
the particles acting in the direction of the applied field, resulting in rapid 
sedimentation of particles over the cell monolayer, versus other similar 
techniques, for example the electromagnetic system used by Kamau and others 
has weak field strength and gradient and produced significant heating which may 
have a negative effect on cell viability (Kamau et al., 2006, Pickard and Chari, 
2010a).   
One of the key factors that determines the suitability of the magnetofection 
strategy is safety. Despite the efforts made by a wide range of laboratories that 
investigated the adverse effects of magnetofection approach on Neurons, 
validation  was based on simple histological read outs, phenotypic evaluation, live 
/dead staining, viable cell counts using flow cytometry, mitochondrial toxicity 
assays and lactate dehydrogenase (LDH) (Pisanic et al., 2007, McBain et al., 
2008, Petters and Dringen, 2015). However, further assessment is needed to be 
related to neuronal functional properties. Rosen reported that the moderate-
intensity static magnetic fields (SMF) altered membrane calcium ion Ca+2   flux 
and Na+2 channels in cultured GH3 cells which are cell line derived from rat 
pituitary cells. The effect was in the form of a delay in alteration of  ion  kinetics 
through the channels ( increase in the activation time constant) due to altering 
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channel activation kinetics which results from ionic channels deformation (Rosen, 
2003). In this project it was important to evaluate the effect of the oscillating 
magnetic field on the functional properties of neurons, in order to determine 
whether there is an adverse effect of magnetofection on neuron excitability and 
signalling.  
It is important to address this issue as some nanoparticles can exhibit a 
neurotoxic effect in a particle type dependent manner and disturb neuronal 
electrical activity although the morphology is not affected.  For instance, the effect 
of carbon black (CB), hematite (Fe2O3), and titanium dioxide (TiO2) IONPs on 
primary murine cortical network activity cultured on a microelectrode array was 
concentration dependent (i.e. there was a reduction in the general electrical 
network activity, spiking and burst rate, in low dose associated with 
decomposition of the network oscillation at 20µg/cm2), but there were no features 
of damage or injury to Neurons (Gramowski et al., 2010). Also, whole –cell patch 
clamp recorded a significant alteration in action potential of CA1 hippocampal 
neurons in a concentration dependent manner when silver nanoparticles were 
applied (Liu et al., 2009). Therefore, it‘s important to investigate the effect of 
magnetofection on neuronal excitability, as it includes a combination of IONPs 
and magnetic fields.
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4.2. Objectives  
From the previous overview of magnetofection developments and strategies it is 
necessary to: 
1-Compare the effect of using two oscillating field devices (uniaxial versus biaxial) 
on MNP based transfection efficiency of neuronal and glial cells in primary cortical 
culture at two different time points. The two different oscillating field devices have 
been detailed previously (please see Materials & Methods), however to 
summarise, both devices have the same aim which is to increase the 
sedimentation rate of particles. The uniaxial employs a one-direction lateral 
movement while the biaxial imparts lateral motion in two axes which has the 
potential for wider distribution of the particles over the cell layer, thus enhancing 
particle: cell contact. 
 
2-Examine the safety of using magnetofection as a bioengineering strategy by 
evaluating the electrophysiological activity of primary nanoengineered Neurons.    
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4.3. Experimental procedure and analysis 
 
All experimental procedures included in this chapter were described in materials 
methods chapter. As magnetofection experiments has been described in (section 
2.5.4), nano-particles internalization in (section 2.5.5), immunostaining in (section 
2.7), and finally safety assessments including cell viability examination in (section 
2.9) while electrophysiological properties assessment in (section 2.11).  
 
 
4.4. Results 
 
4.4.1. The influence of oscillating magnetic field on transfection 
efficiency of primary cortical cells (Uniaxial VS Biaxial magnet) 
Investigation of the effect of incubation time points on the transfection efficiency of 
cortical cells transfected by uniaxial and biaxial was conducted in parallel. In any 
control cultures (plasmid only) reporter gene GFP expression was not observed. 
In cultures transfected with IONP-plasmid complex, GFP expression was 
observed in both Tuj1+ and Tuj1- cells. The timing of the peak of protein 
expression was at 48 h post-transfection. Application of uniaxial magnetic field 
resulted in no significant effect on the level of GFP expression in both Tuj1+/Tuj1- 
cells at 3 DIV incubation time point comparing to 7 DIV (3.2 % ±1.2 and 3.6 % ± 
1.4) and (4.8 % ±1.9 and 6.3 % ± 2.9) respectively. Application of biaxial magnetic 
fields showed no significant differences in GFP expression level  for Tuj1+ cells 
between the two time points. However, GFP expression level in Tuj1- cells 
enhanced about two folds at 7 DIV comparing to GFP expression in cells 
incubated for 3 DIV in culture (4.2 % ±1.1 and 14.5 % ±1.7) respectively (P <0.01) 
(Figure 4.1).  
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Investigating the effect of the magnetic field on the protein expression was at two 
different time points. Statistical analysis revealed that the variation in the nature of 
magnetic field oscillation had no influence on the percentages of transfected cells 
whether they were Tuj1+ / Tuj1- at 3 DIV.  This included Tuj1+ transfected at 7 DIV, 
however magnetic device effect appeared on Tuj1- cells in cultures transfected at 
7 DIV (P < 0.005) (Figure 4.1). 
 
 
 
Figure 4.1: Magnetofection facilitates transfection of primary cortical cells. Bar 
chart showing the percentage of Tuj1+ and Tuj1- cells transfected by magnetofection 
technique at 3 & 7 DIV using the uniaxial and biaxial magnet in parallel. Two factors (7 
DIV time point and magnet) facilitate number of Tuj1- cells expressed GFP protein 
elevation to approximately double comparing to Tuj1- at 7 DIV transfected using a 
uniaxial magnet. (n=3), P < 0.01. 
Magnetofected cortical cells immunostained with Tuj-1 antibody showed a typical 
Neuron morphology and similar to the morphology of the counterpart cells in un-
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transfected cultures. Non-transfected neurons at 3 DIV expressed Tuj-1 (red) 
antibody and displayed healthy neuron body and extended short processes. 
Transfected neurons in addition to exhibiting healthy neuronal morphology, co-
expressed both GFP (green) and Tuj-1 antibody to give yellowish colour that can 
be the indicator of transfected neurons. Moreover, Neurons had formed a 
complex network of cultures incubated for 7 DIV before transfection and 2 more 
days post transfection (Figure 4.2 A, B, C & D). Astrocytes showed a flattened, 
hexagonal morphology typical of astrocytes in 2D culture and as has been seen in 
the Non-transfected cells. 
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Figure 4.2: Uniaxial magnetic field supported primary cortical cells transfection. (A & B) Fluorescent micrographs show GFP 
expression of magnetofected primary cortical cells, white arrows point to Neurons expressing GFP at 3 & 7 DIV, maximum incubation time 
post transfection was 48 h. C & D) demonstrated the typical morphology of Neurons at the normal maturity level that has been seen in un-
transfected cultures. Neuron processes demonstrated normal morphology and level of complexity according to the incubation time. 
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4.4.2. Confirmation of intracellular IONP internalization     
Phase contrast microscopy of 7 DIV cortical culture treated with fluorescent 
IONPs suggested that IONPs were internalized into the neurons and astrocytes in 
both transfected and non-transfected cells (Figure 4.3 A & C).However, it was 
difficult to precisely determine particle internalization without using GFP protein 
expression in cortical cells as indicator. Accordingly, there is a need to more 
sophisticated technique such as transmission electron microscope to determine 
location of fluorescent particles for cell. The micrographs also revealed that 
fluorescent IONPs were distributed in culture, however they aggregated in some 
areas and formed different size aggregates (Figure 4.3 B). 
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Figure 4.3: The susceptibility of primary cortical cells to internalize iron oxide magnetic nanoparticles. (A,B & C ) Phase contrast 
and fluorescent images demonstrate that the fluorescent Neuromag magnetic nanoparticles distributed in culture homogeneously despite 
particle aggregation in some areas. Those cells in culture that expressed GFP are circled in a white dashed line. Cells that took up particles 
without showing any gene expression are circled with a red dashed line.      
  
128 
The expression of GFP was not closely associated with the level of uptake of 
particles internalized by cortical cells. Low uptake of fluorescent nanoparticles by 
neurons was sufficient to result in high intensity GFP expression (Figure 4.4 A). 
Astrocytes that expressed GFP showed high uptake of fluorescent magnetic 
nanoparticles versus neurons (Figure 4.4B).  
 
Figure 4.4: Magnetic nanoparticles uptake is cell type dependent. (A) Neurons can 
express high intensity GFP with a low level of particle uptake. However, level of magnetic 
nanoparticles taken up by astrocytes was higher, associated with a low intensity of GFP 
expression (B). 
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4.4.3. Safety assessment of magnetofection technology 
  
4.4.3.1. Cell viability for magnetofected cortical cells  
Applying a uniaxial magnet to cortical cultures at 7 DIV and incubation with 
IONPs-gene complex for 48h had no cytotoxic effects as judged by live/dead 
assay, versus incubation with a plasmid in medium alone (control) (59.7 % ± 6.2, 
65.3 % ± 3.9, respectively). Applying biaxial magnet had an adverse effect on the 
cell viability, (57.7 % ± 1.5, 32.3 % ± 7.5) (Figure 4.5 & Figure 4.6 A & B).  
No differences were noted between magnetofected and control cultures with 
respect to pyknotic nuclei for cultures transfected by applying uniaxial (38.7 % ± 
2.1, 35.3 % ± 5.5), or biaxial magnet (51 % ± 5.5, 48 % ± 7.3). 
  
 
Figure 4.5: Uniaxial oscillating magnetic field is a safe technique.The graph 
represents the safety of magnetofection is magnetic device type dependent, no alteration 
seen in the percentage of cell viability when uniaxial magnetic device applied however 
cell viability reduced when biaxial magnetic device applied. (n=3) 
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Figure 4.6: Uniaxial oscillation magnetic field is a safe technique. The graph represents the safety of magnetofection is magnet type 
dependent, micrographs for (A) uniaxial and (B) biaxial magnet. There was no cytotoxic effect of magnetofection (uniaxial magnet) on 
cortical cells comparing to the cytotoxic effect of a biaxial magnet on the cortical cells. (n=3) 
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  4.4.3.2. Histological evaluation of the safety of magnetofection for 
transfected neurons 
All assays exhibited no toxic influence on the cells (Figure 4.7 A, B, and C). 
Neurons also displayed a typical healthy morphology in comparison to neurons 
exposed to neither IONPs nor magnetic fields (Figure 4.6 D, E, and F).  
 
 
Figure 4.7: Uniaxial oscillating magnetic field is safe for transfecting primary 
cortical neuronal culture. The graph shows no alteration in (A) cell viability, (B) 
percentage of pyknotic nuclei, (C) neuronal number. Fluorescence micrographs of 
cortical cultures after 7 days in vitro. (D) Neurons (Tuj1+) display small rounded soma 
with long processes, astrocytes (GFAP+) are flat, membranous, and unbranched. (E) 
Pyknotic nuclei show condensed chromatin in cortical co-culture. The inset shows more 
clearly a neuron with condensed chromatin (arrowed). (F) Neurons after magnetofection 
co-express Tuj1 and GFP. The inset shows a GFP+ astrocyte (orange arrow) and a 
Tuj1+/GFP+ neuron (white arrow). (n=3) 
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 4.4.3.3. A comparative assessment of electrophysiological 
characteristics between transfected and non-transfected 
neurons       
Magnetofected and non-magnetofected (control) neurons which were included in 
this experiment have been identified under blue light (excitation wavelength 495 
nm). The morphological features of neurons were similar to what has been 
elucidated in section 4.3.1 (see Figure 4.8 E). 
In voltage-clamp experiments, biphasic currents were generated by depolarizing 
voltage-clamp steps. These currents comprised of both early inward current 
followed by a delayed outward current. The inward current reached a peak at 
around 2ms after the step, while the outward current activated over 5–10 ms 
(Figures. 4.8 A & B). In order to validate that the inward current resulted from Na+ 
channels activity, the sodium channel blocker TTX (25 μM) was added that 
resulted in rapid blocking of the early inward current. This confirms that this 
inward current is a voltage-dependent Na+ current (Figure 4.8 D). The delayed 
outward current was maintained for the duration of the voltage step. The reversal 
potential of this current was negative to –60 mV, based on an outward tail current 
polarity at –60 mV. Therefore, it was believed that it was due to a K+ current 
(Figure 4.8 A). Currents carried by K+ would be expected to have a reversal 
potential of –83 mV (the calculated K+ equilibrium potential under our recording 
conditions). The membrane potential was held to –60 or –70 mV so that Na+ and 
K+ currents were visible in response to depolarizing steps. The currents started to 
be seen around –40 mV. After that rapid current activation (1-3 ms) occurred and 
reached a maximum at about –20 mV. A comparison between GFP+ neurons and 
GFP– neurons revealed no differences between current amplitudes or resting 
membrane potential (Table 4.1). In current clamp experiments, following a 
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depolarizing current injection step, small spikes appeared, their amplitude ranged 
between 15 to no more than 30 mV (i.e. did not reached or exceed 0mV) (Figures 
4. 9 A & B). Spontaneous depolarizations that increased in amplitude with 
hyperpolarization were noticed in a few cells (Figures 4.8 A & B).  
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Figure 4.8: Representative ionic currents were seen in response to voltage steps 
from a holding potential of –60 mV from both magnetofected (GFP+) and non-
magnetofected (GFP–) neurons. (A) Voltage steps (top) and corresponding ionic 
currents are shown for GFP+ and GFP–neurons as indicated (bottom two rows). (B) 
Leak-subtracted records shown on a faster time scale to reveal early inward (Na
+
) 
currents followed by late outward (K
+
) currents. Holding currents have been subtracted. 
Same cells as (A). In (A) and (B) the horizontal (time) and vertical scales are shown at 
the bottom and on the left respectively. (C) I–V plots of early inward and late outward 
currents from GFP+ (top) and GFP– neurons (bottom). The late currents (squares) were 
measured from the records shown in (a) at the 40-ms time point, the early currents 
(circles) were measured as peak inward currents from the records in (B). (D) The inward 
(Na
+
) current seen in response to a 40 mV depolarizing voltage-clamp step, from a 
holding potential of –70 mV (left), is blocked by TTX (2 µM, right). The voltage steps are 
shown above the current records. (E) Micrographs of magnetofected neurons (GFP+) 
used for whole-cell recording taken under normal transmitted light conditions (left) and a 
combination of low transmitted light and fluorescence excitation (right), also showing the 
recording and drug-application pipettes. Scale bars = 10 µm. 
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Figure 4.9: Representative current clamp recordings from magnetofected (GFP+) 
and non-magnetofected (GFP–) neurons showing spike-like activity. (A) Current 
steps (top) and corresponding voltage responses (middle) from a GFP+ neuron. The 
arrows indicate spike-like voltage transients (blue arrows) and spontaneous 
depolarizations, probably reflecting synaptic activity (black arrows). The bottom panel 
shows the response to the largest depolarizing current injection on an expanded scale. A 
negative holding current was applied to hyperpolarize the neuron, and the injection 
begins at 50 ms. (B) An equivalent recording from a GFP– neuron. 
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Table 4.1: Comparison of voltage-dependent Na
+ 
and K
+
 currents in GFP+ and 
GFP– neurons in voltage-clamp. Current amplitudes were measured at the voltages 
indicated. For the measurements made at –30 mV, records were made using leak 
subtracted records. Membrane potential (Em) measurements are also shown, measured 
by linear interpolation of I–V curves at I = 0. There were no significant differences 
between the means for GFP+ and GFP– neurons (Student‘s t test). Values are mean ± 
SEM, given to the nearest whole number. 
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4.5. Discussion 
Adding lateral movement in one direction (uniaxial) for the nanoparticle/gene 
complex has been shown to be successful for improving the overall transfection 
efficiency in different cell types such as human airway epithelial cell line (McBain 
et al., 2008), astrocytes  (Pickard and Chari, 2010a, Tickle et al., 2015), microglia 
(Pickard and Chari, 2010b), and neural stem cells (Pickard et al., 2011). 
Furthermore, some groups successfully enhanced neuronal cell line (SH-SY5Y 
cells) and primary neuronal transfection efficiency up to 10-15% with low 
associated cytotoxicity with this technique (Subramanian et al., 2017). Primary 
neuronal transfection efficiency using magnetofection is relatively  low compared 
to  other cell types such as oligodendrocyte precursor cells (OPCs) which ranged 
from 15.9-26.3% (Jenkins et al., 2011). Up to 80 % transfection efficiency, but  
low viability, of hippocampal neurons, was reported when the electroporation 
technique was used for gene delivery (Rathenberg et al., 2003). 
Several studies have addressed several magnetic device parameters. Some 
measured range of frequencies/amplitudes (McBain et al., 2008), while others 
determined the optimal working distance of the magnetic field (field strength) 
which was 3 mm for oscillating magnetic fields (Fouriki et al., 2010a). However, to 
the best of our knowledge, our work is the first to introduce a bidirectional lateral 
motion (biaxial) to the particles to enhance MNP-gene complex delivery to cells of 
primary origin such as neurons. 
In that respect, it was necessary to compare the efficiency and the safety of this 
developed device on transfecting primary cortical neurons and comparing it to the 
unidirectional oscillating lateral motion provided by a uniaxial device.  
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Multiple factors can be predicted to influence transfection efficiency, including: 
developmental stage, conditions of cell culture, for example type of media used, 
physicochemical structure of vectors, and vector: DNA ratio (Buerli et al., 2007, 
Fallini et al., 2010, Jenkins et al., 2013a) These factors are likely to account for 
the differences in observations between studies. 
The findings of this study indicated that transfection efficiency was about 10% 
when the applied magnet was uniaxial and about 15% when the applied magnet 
was biaxial. These results are considered low in comparison to those reported by 
some groups for various neuronal types including primary cortical neuronal 
cultures, up to 46% using non-viral approaches combined with high DNA 
concentrations (Fallini et al., 2010). However these results are within the range 
reported by other groups for example Buerli et al (2007) have achieved ca. 5% 
and Subramanian et al (2017) ca.15% transfection efficiency.  
With regard to cellular uptake, the experiments revealed that there is no apparent 
correlation between extent of particle uptake and GFP expression, (i.e. some 
cortical cells took up the nanoparticles but GFP expression was not noted). This 
might be related to a defect in the mechanisms that determine the fate of the 
gene post internalization inside the cells, which is discussed in the General 
Introduction.   
Transfection-based bioengineering strategies for neural repair will require both 
efficient, preserving function and safe protocols. Therefore, further investigation 
which related to the neuron's signalling has been conducted here. To our 
knowledge, this is the first study investigating the electrophysiological properties 
of magnetofected primary neurons in comparison to non-magnetofected neurons. 
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Generally, the neuron‘s membrane potential, and ability to spike (all functions of 
ion channels), and its ability to secrete chemicals or neurotransmitters is a 
prerequisite for normal neuronal function in any environment, including within the 
host tissue post transplantation and even in the absence of functional synaptic 
contacts. Studies have shown that metal or carbon-based nanoparticles influence 
spiking frequency and bursting patterns, based on neurochip extracellular 
recordings (Gramowski et al., 2010), and with alterations in Na+ current amplitude 
and activation range in whole-cell patch recordings. These effects are apparently 
concentration-dependent and are subtle at low concentrations of nanoparticles, 
including iron oxide core nanoparticles (Gramowski et al., 2010). However, our 
observations revealed that the Na+ and K+ channels in cortical neurons were not 
obviously influenced by magnetofection. Furthermore, there were spontaneous 
excitatory synaptic potentials, indicating that synaptic contacts are functional in 
these neurons.  
Particle uptake into the cells is highly dependent on particle size and cell type, 
therefore it will be difficult to make comparison between studies in terms of metal 
or particle concentration. The IONPs employed here, at ~160 nm diameter 
(Pickard et al., 2015), and with an additional chemical envelope for plasmid 
attachment, are relatively large, but these and similar particles have a well-
documented safety profile across a range of neural cell types (Pinkernelle et al., 
2012, Pickard et al., 2015, Fernandes and Chari, 2016, Jenkins et al., 2016). 
Interestingly, the findings confirmed the notion that the IONP internalization 
amount by cortical cells is cell type dependent. The relative amount of iron oxide 
nanoparticles taken up by Neurons was low compared to astrocytes. Cell specific 
particle uptake level is also dependent on  the endocytic capability of the cells 
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(Ziello et al., 2010). Where clathrin-mediated endocytosis is the suggested  
pathway that participates in  IONPs uptake by neurons (Petters and Dringen, 
2015), these clathrin coats in neurons are abundant in the synaptic areas (pre 
and post synaptic) (Blanpied et al., 2002). Whereas, astrocytes which possess 
higher levels of endocytotic activity (Tickle et al., 2016, Ziello et al., 2010) can 
handle higher magnetite content than neurons (Bareford and Swaan, 2007, 
Cosker and Segal, 2014). However, the mechanism of IONP internalization by 
Neurons is still poorly understood.  The high levels of endocytic activity in 
astrocytes in line with their homeostatic functions in the nervous system, results in 
documented ‗competitive uptake dynamics‘ for nanoparticle uptake, which in co-
cultures would limit neuronal transfection (Jenkins et al., 2013b, Jenkins et al., 
2016, Jenkins et al., 2015). As discussed previously (please see Chapter 3), 
specific cell culture conditions were chosen to facilitate pure neuronal cultures i.e. 
that would limit astrocyte numbers and proliferation. To summarise, (i) by deriving 
cultures from embryonic tissue, astrocyte numbers can be kept low, as it is 
estimated that > 90% of cells at this developmental time point are neurons 
(Murphy, 1990, Bandeira et al., 2009). (ii), the use of serum free medium can 
enhance the purity of neuronal cultures by reducing astrocyte proliferation and 
provide greater definition of experimental conditions by removing confounding 
variation in serum composition (Langan et al., 1994, Evans et al., 1998) and 
therefore, eliminates the need to use chemical inhibitors of astrocytes such as 
arabinosylcytosine C (AraC) (Geller et al., 2001, Ahlemeyer et al., 2003). 
Nevertheless, in our hands it proved difficult to fully eliminate  astrocyte 
contamination; approximately 35% of the astrocyte population can re-enter the 
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cell cycle after serum deprivation, likely accounting for the high proportions of 
astrocytes in these cultures (Murphy, 1990).  
 With respect to the safety of the two oscillating magnetic fields examined, the 
results indicated that using uniaxial magnetic field was a safe technique for 
transfecting primary cortical cells. This agrees with other studies conducted for 
primary neurons (Subramanian et al., 2017) and neurons derived from stem cells 
(Fernandes and Chari, 2014) in addition to variable cell types has been reported 
(Pickard and Chari, 2010a, Adams et al., 2013, Oral et al., 2015).   
The new biaxial magnetic field did not enhance transfection efficiency. 
Furthermore, it displayed low levels of safety for transfecting primary cortical cells. 
The mechanism behind the inefficiency and lack of safety necessitates further 
study. The mechanism by which oscillating fields produce high transfection 
efficiency is not fully understood. However, the theory behind  it is that the IONPs 
gain lateral motion resulting from oscillating magnetic fields (McBain et al., 2008). 
This motion transfers to the  IONPs across the cell membrane, or  leads to 
vibration of membrane-bound particles in order to facilitate internalization  of 
IONPs, and/or may mechanically stimulate endocytosis (McBain et al., 2008, 
Pickard and Chari, 2010a, Adams et al., 2013).  Accordingly, the author‘s 
assumption here is that the exposure to additional lateral motion in the orthogonal 
direction (biaxial), may have impacted on the cell membrane integrity or caused 
cell detachment due to the physical stress that might result from the rapid 
sedimentation of IONPs-gene complexes.  
In summary, we provide the first complementary electrophysiological and 
histological analyses supporting the concept that iron oxide nanoparticles and 
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uniaxial applied magnetic fields can be safely deployed for genetic modification of 
primary neurons for basic research and translational applications. However, 
further investigation should be directed towards more mature cells and to track 
changes post-transfection over more extended time periods. 
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Chapter 5  
Hydrogels are a promising neuromimetic substrate for 
primary cortical cells   
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5.1. Introduction  
The two disciplines, Neuron transplantation in regenerative medicine and neurons 
in basic research, have challenges that require the development and utilization of 
neuronal 3-dimensional constructs. This emerging strategy is vital for developing 
therapeutic and research applications. 
On the one hand it is difficult to transplant post-mitotic neurons, which are 
generated in a 2D environment (Kondziolka et al., 2004), so the 3D environment 
is vital for overcoming the limitations that hinder the integral recovery process 
post-transplantation, and provide support and protection of transplant cells during 
the delivery into the host parenchyma. Further, it has been reported that neurite 
outgrowth and electrical signals of human pluripotent stem cell-derived neurons in 
scaffolds were improved by gene engineering them (Carlson et al., 2016). Thus, 
genetically engineering primary neurons maybe more beneficial as they are more 
relevant to the host environment. These efforts have focused on reducing the 
drawbacks of mechanical cell damage during delivery into the host tissue 
(Kondziolka et al., 2004).  
On the other hand, most laboratories are conducting biological experiments to 
investigate neuronal survival, neurite outgrowth, network formation, 
synaptogenesis and functionality using monolayer cultures on 2D polystyrene or 
glass substrates (Flanagan et al., 2002, Ould-yahoui et al., 2009). The nature of 
cell attachment in 2D monolayer cultures is ‗one sided‘, i.e. one side of the cells 
attach to the hard substrate and the other side faces the medium. Thus, 2D 
culture is un-representative of in vivo physiological conditions as the hard 
substrate is not representative of the extracellular matrix. In turn, cellular 
response in 2D, such as receptor expression, cell polarization, transcriptional 
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expression, cellular migration, and apoptosis, differ from that in the original in vivo 
environment (Khoruzhenko, 2011).  Furthermore, 2D monolayer culture is very 
primitive regarding the anatomy, gene and protein expression, and diffusion of 
soluble molecules such as nutrients and growth factors (Smalley et al., 2006, 
Pampaloni et al., 2007).   
It is also worth mentioning that animal model responses cannot fully mimic or 
predict human response, and are costly, time-consuming and ethically arguable 
(Sala et al., 2013). Therefore in order to reduce the use of animal models for 
biological testing purposes, it is essential to develop 3D cell culture models. This 
culture should possess, as far as possible, the features of the in vivo environment 
from an anatomical, morphological and physiological perspective.3D animal 
models are considered to be a preliminary step to lay the foundations for a 3D 
model of human cells that can be usable in clinical trials, and to bridge the gap 
between 2D cell culture and animal models for basic research.  
Several parameters need to be considered including the choice of material for the 
scaffold, the source of the cells, the formation method, and the design of the 
scaffold which are all crucial for recreating the in vivo environment (Pampaloni et 
al., 2007). Further, the scaffold should possess biophysical, biomechanical and 
biochemical cues that facilitate cellular proliferation, differentiation, maintenance 
and function (Dutta and Dutta, 2009). In this regard, it should be noted that 
electrophysiological responses of primary embryonic neurons to 3D hydrogel 
constructs currently has not been widely studied.  
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5.1.1. The suitability of collagen-based hydrogels as a neuromimetic 
substrate 
The ECM is a net-like structure, consisting of amino acid and sugar-based 
macromolecules (i.e. proteins and glycoproteins). Its importance lies in supporting 
the physical adhesion of cells, acting as a biological scaffold, and controlling 
biomolecule diffusion such as nutrients and growth factors (Vecino and Kwok, 
2016). As well biomechanical traits of the CNS are influenced by ECM 
composition and mechanical properties, and any defect in these two factors  
leads to loss of the regenerative capacity of CNS as this process is connected to 
the physiochemical property of the ECM (Haycock, 2011, Vecino and Kwok, 
2016). Therefore, choosing a polymer scaffold is a critical step in assembling 
hydrogels that mimic the ECM found in tissues. Additionally, the nature of the 
polymer utilized for 3D matrix formation is a significant determinant of cell 
responses (O'Brien and Lummis, 2011, Baker and Chen, 2012). 
Various polymer types are used in research and clinical applications (Liu and Ma, 
2004, Karageorgiou and Kaplan, 2005). Synthetic polymers widely used in 
medical applications include poly-lactic acid (PLA), poly-glycolic acid (PGA), and 
copolymers (PLGA); however, there are limitations and restrictions on their use in 
these applications. Using a synthetic polymer in tissue transplantation has 
drawbacks including the need to create a relatively large incision to deliver the 
scaffold into the target site due to its mechanical properties (Lee and Mooney, 
2001) and the risk of rejection. They can also be the causing factor for necrotic 
cell death due to degradation processes with polymers such as PGA  being 
degraded by hydrolysis that results in carbon dioxide production and leads to a 
reduction in local pH causing cell death (O'Brien and Lummis, 2011). In order to 
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overcome these drawbacks, an alternative injectable polymer has been used. 
Collagen is a biologically-derived polymer as it is the main component of the 
extracellular matrix, and the most abundant protein in mammalian tissues (Drury 
and Mooney, 2003). It is considered optimal for developing in vitro models for the 
following reasons: (i) it can be modulated in response to ionic strength or 
temperature (Mahoney and Anseth, 2006), (ii) it  can be  injected into the body 
using a minimally invasive approach, (iii) it posesses low antigenicity, excellent 
biocompatibility, and can be degraded by collagenases and serine proteases 
facilitating its local degradation by the cells in the engineered tissue (Chevallay 
and Herbage, 2000, Han et al., 2010, Drury and Mooney, 2003). Its chemical 
structure, molecular architecture and morphology validated its use in medical and 
biological applications, in particular, the crosslinked form of hydrophilic polymers, 
and it is considered a biodegradable scaffold (Jhon and Andrade, 1973). Collagen 
hydrogels have many characteristics that mimic the ECM to facilitate cellular 
infiltration and nutrient transport. Moreover, hydrogels have an affinity to water 
without dissolving in it because of their chemical and physical cross-linked 
network (Langer and Peppas, 2003). They are highly porous biomaterials that 
allow the cells to grow and develop into tissue (Smalley et al., 2006).Collagen 
hydrogels have been used for regenerating various tissues such as liver, skin, 
blood vessels, bone (Peppas et al., 2006, Wang and Stegemann, 2010) and for 
spinal cord regeneration (Han et al., 2010). Additionally, it is utilized as a scaffold 
for generating neurons in a 3D environment (see section 1.14).  
In general, extrinsic signals from the ECM have an impact on cell characteristics, 
both morphological and functional. Several studies demonstrated the influence of 
environmental stimuli on the functions of various cell types (Kiryushko et al., 
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2004, Schindler et al., 2006). Accordingly, it has been reported that the cell 
behaviour in 3D constructs is more representative of the in vivo environment than 
cells cultured in 2D monolayers (Schindler et al., 2006). For example, voltage 
gated calcium channel (VGCC) function was examined in 2D and 3D cultures of 
superior cervical ganglion neurons and cells in the freshly dissected tissue. 
Cultures were exposed to high K+ to compare the increment in Ca+ concentration 
amongst these three models, concerning intracellular calcium increase in 
response to high K+ depolarization. The findings demonstrated that the calcium 
increases were identical for 3D-cultured and freshly dissected tissue, but 
significantly higher for 2D-cultured cells (Lai et al., 2012). In this context, the 
axonal growth cone of neurons has importance in axonal growth by sensing 
extracellular environment signals via integrin (a transmembrane protein) that 
transduces mechanical stimuli from the surrounding environment to the 
cytoskeleton. This stimulius results in changes in gene expression, in turn 
influencing the functional properties of neurons such as differentiation, migration, 
and survival (Li and Gundersen, 2008, Witte and Bradke, 2008). Consequently, 
extracellular mechanical properties are a critical determinant of cellular responses 
(Discher et al., 2005). To that end few studies have tested the 
electrophysiological properties of neurons in soft substrates.  
The main aim of the research reported in this chapter was to develop a 3D 
neuronal construct within a hydrogel and test its safety via cellular viability and, 
specifically, neuronal functionality using the patch clamp technique on single 
cells. This 3D construct can be used for basic research studies and for 
transplantation of Neurons. Developing this model is considered a preliminary 
step before genetically engineering cortical neurons in 3D hydrogels where it will 
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be a vital tool with applications in regenerative medicine. In this respect, several 
challenges needed to be faced regarding developing such system. 
The first challenge is adjusting the hydrogel stiffness as a tight matrix leads to cell 
death due to (i) inhomogeneity of the cells, (ii)  lack of oxygen and nutrients 
penetrating throughout the matrix and removing waste products from within the 
hydrogel (Mertens et al., 2014) which results in necrotic cell death (Malda et al., 
2004).The second challenge is resolving inhomogeneity within the cell graft 
following delivery (Pearse et al., 2007) which is considered to be one of the 
challenges within a 3-dimensional construct (Unsworth et al., 2003). Cellular 
inhomogeneity results in cell death which, in turn, inhibits cellular network 
functionalization and electrical conduction to the regenerative environment 
(Wakatsuki and Elson, 2002). The third challenge is studying neuron conductivity 
in a 3-dimensional environment (Xu et al., 2009) as delivering functional neurons 
is a major challenge for the regenerative environment. In order to meet these 
challenges, the objectives of this study were set as in the next section. 
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5.2. Objectives  
Type I collagen gels were used to develop primary cortical neuron culture that 
mimics the in vivo environment in order to be used as a model for conducting 
biological studies and as a potential delivery system for neurons of the host 
tissue. 
Therefore, the specific objectives of this chapter are: 
1-Determine the feasibility of growing primary cortical neurons in a type I collagen 
hydrogel in two-dimensional (2D) cell monolayers. 
2-Determine the capability of maintaining cortical cells within a complex three-
dimensional (3D) microenvironment. 
3-Form an evenly distributed cellular system in a 3D construct. 
4- Examine the safety of using collagen hydrogels as the 3D microenvironment 
for supporting cortical cells growth. 
5-Study the effect of collagen gel and the 3D microenvironment on the 
electrophysiological properties of neurons. 
6-Genetically engineer primary cortical cells in a 3D construct. 
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 5.3. Experimental procedure and analysis 
 
Using collagen hydrogel as a substrate for neuronal cultures whither the culture 
was in the format of 2D monolayer or 3D construct described in (section 
2.6).Immunostaining procedure detailed in (section 2.8.), while the safety 
assessment including cell viability has been described in (section 2.9) and 
neurons signalling and functionality in (section 2.11.2). 
 
 
  5. 4. Results  
 
  5.4.1. Collagen as a substrate for growing cortical cells as a 2D 
monolayer 
The feasibility of growing cortical cells as a monolayer when collagen was utilized 
as a coating substrate was compared to cells produced as a monolayer on a 
coverslip coated with PDL-Laminin (see Chapter Three).  
The growth of cortical cells seeded on a coverslip coated with a collagen hydrogel 
was comparable regarding reproducibility and feasibility to cells seeded as a 
monolayer on coverslips coated with PDL-Laminin. Cell morphology in fluorescent 
micrographs revealed that neurons grew for 7DIV on a glass coverslip coated with 
collagen and demonstrated similar morphological characteristics to those grown 
on PDL-Laminin substrate. Although the morphology of neuron body was typical 
in both models, the neurites were more tangled for neurons grown on collagen 
compared to the neurons grown on PDL-Laminin coated coverslip.   
Cortical cells on collagen coated coverslips were unevenly distributed. In general, 
the cells were concentrated in the centre and a few were spread on the edges 
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(sides) of the coverslips regardless of the protocol used for seeding (Figure 5.1 A 
& B) (Materials and methods figure 2.3).  
Astrocytes displayed an alteration in their morphology and exhibited a small and 
multi-branched cell body, unlike typical astrocytic morphology in a 2D monolayer 
culture which showed a flattened membranous shape (Figure 5.1C & D). 
    
  
153 
 
Figure 5.1: Collagen hydrogel supports primary cortical cell growth as a 2D 
monolayer. Phase contrast images show cortical neurons at 7DIV dispersed as 
individual cells with extended long processes at the side of the coverslip (A), clusters of 
neurons and astrocytes were concentrated at the centre of the coverslip displaying 
maturity characteristics of neurons via high network complexity level  (phase contrast 
image B and fluorescent image D), (C) Fluorescent image revealed that astrocytes 
possess asymmetric characteristics compared to typical astrocytes in a 2D monolayer 
culture and exhibit small soma in the form of branches instead of the typical flat shape.  
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  5.4.2. Cell viability on 2D collagen coated coverslips 
Statistical analysis demonstrated that the use of collagen hydrogel as coating 
substrate for monolayer culture was supportive of primary cortical cell survival. At 
day 7, there was no impact on the percentage of viable cells in comparison to 
3DIV (73.7 % ± 3, 77.3 % ± 8.4, respectively) (Figure 5.2 A and B). 
 
Figure 5.2: Image showing viable cells stained with Calcein (green) and red arrows 
pointing to dead cells stained with Ethidium homodimer (A).( B) shows around 80% 
of cells were viable and no significant differences between 3 and 7 days of growth in 
vitro. (n=3)   
  
155 
 5.4.3. Collagen as substrate for growing cortical cells as a 3D 
construct 
 
  5. 4.3.1. Surface model 
After 3 days of culture the percentage of cell survival was ca. 90 %. At day 7 it 
was slightly reduced to ca. 80 % (Figure 5.3 A & E).The volume of gel construct 
was (~640 µm) at both time pointes. The morphological features of neurons 
cultured in the 3D surface model was not comparable to the neurons grown on 
the 2D monolayer. At day 7, the neurons were closer to a spherical shape in 
comparison to those in 2D culture (Figure 5.3 D). In addition, neurites that 
extended from the cell body were highly tangled to the level that it was difficult to 
recognize their origin and directions. Astrocytes were similar in their morphology 
in 2D monolayer culture when collagen was the coating substrate. From the 
observations of cell localization, the fluorescent micrographs showed some of the 
cells penetrated 10-20 µm depth into construct (Figure 5.3 B & C).   
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Figure 5.3: Three dimensional appearance of cortical cells grown on the surface of 
a collagen hydrogel construct. (A) Bar chart exhibiting the high viability of cortical cells 
at the early (3DIV) and later (7DIV) incubation time points. (B) Cortical cells stained with 
calcein and ethidium homodime show high viability level. (C) Astrocytes distributed within 
a 3D construct and formed multi processed cells (neurons clumped together with 
extended long processes forming a complex network. (D) the cell body of neurons has a 
spherical morphology. (n=3) 
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 5.4.3.2. Entrapped model 
 
 5.4.3.2.1. Collagen gel concentration testing    
Three collagen concentrations (0.4, 1 and 2 mg/ml) were examined. The hydrogel 
with the lowest concentration was semi liquid and cells sank to the bottom of the 
gel. This resulted in the cells attaching onto the coverslip and growing as a 
monolayer (Figure 5.4 A). In contrast, the highest concentration tested (2mg/ml) 
exhibited a high stiffness level, judged by observing the differences in the 
hardness of the gel across the three concentrations and its motility during  
handling, and cells aggregated in different areas, forming clusters. This caused 
difficulty in cell type recognition and counting. Neurons produced few, short 
processes versus the usual length seen 7DIV (Figure 5.4 B). The concentration 1 
mg/ml was the most suitable for cells to grow and disperse through all layers of 
the gel construct (Figure 5.5 A, B, C, and D).   
 
Figure 5.4: Collagen construct concentration affects cell distribution through the 
gel. Phase contrast images shows (A) the cells sink to the bottom in the low 
concentration gel (0.4mg/ml) with the red arrow pointing to the side of coverslip. (B) At a 
gel concentration of 2mg/ml, cells aggregated and formed clusters 7DIV. 
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5.4.3.2.2. 3D construct purity and cell distribution at three and seven 
days in vitro 
Z-stack images captured throughout the gel construct at both the early time point 
(3DIV) and the later incubation time point (7DIV) revealed that the cells distributed 
homogenously throughout the gel construct.   
Statistical analysis showed no significant differences in the percentages of both 
neurons and astrocytes at the side and the centre of each layer of the hydrogel, 
whether these cells were incubated for 3DIV or 7DIV.This indicated the high purity 
of the 3D construct. (Figure 5.5 E). Around 90 % of cells were neurons throughout 
the depth of the gel and at each of the side and the centre of the gel, while 
astrocytes were rarely seen compared to neurons (Figure 5.5 E). Remaining cells 
where un-identified and did not stain with Tuj-1 or GFAP antibodies  (i.e.Tuj-1-
/GFAP-). 
Morphological characterization revealed that neurons possessed their typical 
morphology. However, very few neurites were extended with no evidence of 
network formation (Figure 5.5 A-D) in contrast to counterpart neurons in a 2D 
monolayer culture. 
At seven days incubation, neurons still made up a large proportion of the cell 
population despite the reduction in their percentage to Ca. 70%. Astrocytes 
displayed an increase in number to 30 %. This elevation in astrocyte percentage 
results in a reduction of purity. There were no significant differences between the 
percentages of neurons and astrocytes across all layers, except the middle centre 
(MC) layer (Figure 5.6 E). 
Morphologically neurons, after 7 days in culture, displayed characteristics of more 
mature cells as the neurites were more elongated than neurites of neurons 
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incubated for 3 days. These penetrated through the layers of the gel forming a 
complex network with the neighbour neurons. Astrocytes also were more mature 
and displayed a multi branched cell body (Figure 5.6 A-E).    
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Figure 5.5: Highly pure and homogenous neuronal 3D hydrogel construct at 3 days in vitro. Fluorescent z-stack image series 
throughout the collagen hydrogel construct (distance between each image 10 µm) were divided into 3 groups: top of gel (upper layer), the 
middle of the gel (middle layer) and the bottom of the gel (lower layer). (A-D) Cortical cells were distributed equally through the depth of the 
gel. (E) Bar chart shows the high purity of neurons in the 3D hydrogel construct (P=0.0001). (n=3). 
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Figure 5.6: Pure and homogenous neuronal 3D hydrogel construct at 7 days in vitro. Fluorescent z-stack image series throughout a 
collagen hydrogel construct (distance between each image 10 µm), divided into 3 groups: top of gel (upper layer), the middle of the gel 
(middle layer) and the bottom of the gel (lower layer). (A-D) Cortical cells were distributed almost equally through the depth of the gel. (E) 
Bar chart shows the purity of neurons in the 3D hydrogel construct. (n=3) The hydrogel construct is displayed in a supplementary video in 
the supplied disc.  
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5.4.3.2.3. Cortical cell distribution across the core and the extremity of 
the gel 
Quantification of cells across the width of the gel at 7 DIV demonstrated that the 
percentage of neurons at the sides was 93% and 96% at the core of the 
construct. In contrast, the percentage of astrocytes at the sides was 4% and 2% 
at the core. These findings demonstrated that the 3D construct was pure and 
highly homogenous, i.e. there was no effect of incubation time on the purity and 
homogeneity of the culture (Figure 5 .7). 
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Figure 5.7: Cortical cells distributed homogenously across the gel. (A & B) Selective images of the core and side of the gel matrix at 7 
DIV demonstrate the homogeneity and the cell purity of the gel construct. (C & D) bar chart displaying quantification of cell percentage in the 
extremities and the core of the gel, percentages of astrocytes and neurons across the gel. (E) Schematic illustrates the image localization 
and quantification process: cells in the depth of the two sides of the gel were counted and averaged then compared cells in the core of the 
gel. n=3 
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5.4.3. Assessment of cellular viability of cortical cells in the 3D 
environment 
The percentage of viable cells at 7 DIV were declined to about 70 % comparing to 
their percentage at 3DIV which was about 95% (Figure 5.8 A)&(Figure (5.9 A-C). 
Across all the layers and the depth of the gel, the average percentage of pyknotic 
cells was about 20 % at both 3 and 7 days (Figure 5.8 B) & (Figure 5.9 D & E).  
 
Figure 5.8: Cortical cells exhibited high survival within the 3-dimensional 
environment. Bar charts represent cell health throughout the gel construct. Viable cell 
quantification was conducted on two sides (s) of the gel and at the centre (c) going down 
through the depth of the gel starting from upper layer down to the base lower layer of the 
gel (A). LIVE/DEAD assays show a high proportion of viable cells at 3 days post seeding 
in a 3D collagen hydrogel (blue bars), then cell survival declined at 7 days post gel 
construct setting (red bars). (B) Pyknotic nuclei were quantified in the same manner as in 
the cell viability quantification process and show low percentages of pyknotic cells at both 
time points. 
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Figure 5.9: Collagen hydrogels support cortical cell survival in a 3-dimensional environment. Fluorescent micrographs show dead 
cells stained with Ethidium homodimer (red) (A) and viable cells stained with Calcein (green) (B). Merged micrographs (C) reveal a high 
proportion of viable cells at 3 days post seeding in a 3D collagen hydrogel. D and E show examples of pyknotic nuclei indicated by white 
arrows, and some healthy neurons, stained with neuronal antibody Tuj-1, with extended long processes through the depth of the collagen 
construct. The hydrogel construct is demonstrated in a supplementary video in the supplied disc. 
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5.4.4. Patch-clamp technique for evaluating the safety of the collagen 
hydrogel protocol 
To investigate the feasibility of our 3D construct hydrogel, it was important to 
determine the impact of the hydrogel upon neuron signalling.  
Some technical modifications were required to facilitate the recording from the 
individual neuron (see Methods). These included: (i) angling the surface of the 
hydrogel, i.e. the plane of focus, to allow the observation and recording from 
neurons (Figure 5.10 A), (ii) adding fluorescein dye to the patch pipette which 
permitted precise identification of individual neuron bodies within a clump of cells 
(Figure 5.10 A), and, in some cases, neuronal processes were labelled in addition 
to the cell body (Figure 5.10 B).  
During the process of whole-cell recording, occasionally the soma appeared to 
swell several minutes into recording (Figure 5.10 B). However, this did not impact 
on the recording process or the results.  
The results of patch-clamp recording revealed that signalling in neurons grown on 
the surface of the hydrogel (Figure 5.11 E) were comparible to earlier recordings 
from primary cortical neurons grown on glass coverslips (Evans et al., 2017).The 
step depolarisations in voltage clamp resulted in a biphasic appearance of the 
current which was due to the sequential activation of voltage-gated Na+ and K+ 
currents, resulting  from a fast inward (Na+) current followed by a maintained 
outward (K+) current (Figure 5.11 A, B).  The potential was held at -70 mV, so the 
inward Na+ current was the first potential observed at -50 mV then reached -20 
mV where the maximum amplitude was recorded (Figure 9.11 D), showing rapid 
activation, i.e. within 1 ms at -20 mV (Figure 5.11 B). Blocking Na+ channels with 
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Tetrodotoxin revealed that the current was as expected for Na+ ions, i.e. the 
amplitude of this current became smaller at voltages positive to -20 mV.  
This reduction in size of the current can be attributed to the joint effect of 
activation of the K+ current and the reduction in the driving force of Na+ influx 
(Figure 5.11 D). At about -30 mV, the outward K+ current started to activate 
(Figure 5.11 D) and was maintained throughout the step, often with a slight 
decline (Figure 5.11 A).  
On return to -70 mV, the outward tail currents returned rapidly to baseline (Figure 
5.11 C). We examined the effect of voltage on Na+ current amplitude by using the 
pre-pulse protocol (see Methods). Na+ currents were strongest following a pre-
pulse to -90 mV (at more negative voltages they saturated). At -70 mV they were 
approximately 90% of their maximum amplitude.  
In the current clamp, hyperpolarising current injections revealed transient 
depolarisations which presumably arose from excitatory synaptic activity (Figure 
5.11 E). These depolarisations usually did not elicit action potentials. Action 
potentials were evoked on return to the resting potential following cessation of the 
current injection (Figure 5.11 E and F). The amplitude of the action potentials was 
measured as the difference between the peak and the baseline (resting potential). 
It was typically around 30 mV and was dependent on the extent of the preceding 
hyperpolarisation (Figure 5.11 F), declining steeply positive to -70 mV (Figure 
5.11 G). This decline is due to the increasing steady-state inactivation of the Na+ 
channels as the membrane potential becomes more positive. The slight decline in 
amplitude at the most negative voltages (>-85 mV) probably results from a longer 
transition time to threshold for action potential initiation in this voltage range 
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(Figure 5.11 F) allowing a greater fraction of the channels to inactivate before the 
membrane reaches threshold. The threshold value was not systematically 
investigated but was close to -50 mV (Figure 5.11 F).  
The Na+ and K+ current amplitude and membrane potential (zero current 
potential) of voltage-clamped neurons grown on the surface of hydrogels are 
shown in Table 5.1. For comparison, equivalent measurements from cells 
cultured on glass coverslips taken from a subset of neurons included in an earlier 
study (Evans et al., 2017) are also shown. These data included neurons 
transfected with GFP using magnetic nanoparticles and their controls (non-
transfected neurons). These neurons are included here as one group as there 
were no significant differences between sub-groups (transfected and non-
transfected).  We found that there was a significant difference in the size of the 
Na+ currents between the two groups (hydrogels versus glass, Mann-Whitney U 
test, U = 17.0, p = 0.002). Other measured parameters (K+ current at 0 mV and 
membrane potential at zero current) were not significantly different (K+ current by 
Mann-Whitney U test, U = 46.0, p = 0.215; membrane potential by Student‘s t-
test, p = 0.058). The ratio of median currents (hydrogel/glass) was 6.4 and 1.2 for 
Na+ currents and K+ currents respectively. When data was randomly excluded 
from the larger hydrogel group to ensure equal group sizes (n = 8, see Methods), 
the ratios were 5.8 and 1.3 respectively. This manipulation did not alter any of the 
conclusions concerning the significance of differences between the two groups.  
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Figure 5.10: Recording from cortical neurones on the surface of a hydrogel. 
Examples of high (A) and low densities (B) of neurons within the culture. A transmitted 
light image is shown (left) together with a fluorescence image of the same field (right). 
A fluorescein dye was added to the pipette. 
  
170 
 
Figure 5.11: Voltage-dependent Na
+
 and K
+
 currents, and membrane potential 
recordings, in primary cortical neurons grown on a hydrogel. (A) Whole cell currents 
recorded in voltage clamp (bottom) in response to positive and negative voltage steps 
(top). Holding potential -70 mV. Horizontal bar indicates the section of the recording 
shown in B. (B) Leak-subtracted records shown on fast time scale (bottom) together with 
associated positive voltage steps (top). The inset shows the block of the Na
+
 current 
(red) by a short (0.65s) application of 2 µM TTX (black). Scale 0.5 nA, 5 ms. The voltage 
step from -70 mV to -30 mV is also shown. (C) Tail currents (leak-subtracted) at -70 mV 
following a step to 0 mV. The time constants to the double exponential fit were 0.13 ms 
and 1.45 ms. (D) I-V curve. Currents measured at 40 ms after the beginning of the 
voltage step (K
+
 currents), from records shown in A (black squares). Maximum inward 
currents measured within 2 ms following the start of the voltage step, from records shown 
in B (red squares). E. Current clamp records (bottom) in response to hyperpolarising 
current injections (top). Holding current = 0 pA. The horizontal bar indicates the section of 
the records shown in F on a faster time scale. F. Action potentials evoked by 
depolarization from a hyperpolarised voltage. The current injection stops at 0.85s. Same 
records as D. G. Graph showing action potential amplitude against membrane potential 
measured close to the end of the hyperpolarising step. The red line shows a linear fit to 
the data between -68 mV and -54 mV (gradient = -1.66 mV/mV). All data collected from 
the same neuron with the exception of the TTX experiment (B, inset).  
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Table 5.1: Amplitudes of Na+ and K+ currents, and membrane potential, from 
neurons grown on hydrogels.The holding potential was -70 mV. Currents were 
measured at -30 mV and at 0 mV for Na+ currents and K
+ currents respectively. The Na+ 
current was measured at the peak of the transient inward current. The K
+
 current was 
measured towards the end of the 50 ms voltage step. Values quoted to nearest whole 
number.  
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5.4.5. Genetic engineering of neurons on the surface of the hydrogel 
construct 
These proof of concept experiments have been conducted twice to show that it is 
possible to genetically engineer a cortical cell culture in a soft substrate. 
Microscopic observations revealed that it is possible to genetically engineer 
neurons when they are seeded on the surface of a hydrogel construct. Neurons 
expressed GFP however the transfection efficiency was estimated to be less than 
2%. The observations also revealed that neurons possess typical morphology as 
previously described in chapter 3 (Figure 5.12). 
 
 
Figure 5.12: Magnetofection based transfection of neurons seeded on the surface 
of the gel at 7DIV. (a) Neurons are in the centre of the gel construct. (b) Neurons 
expressing GFP after transfection were seeded on the surface of the hydrogel construct 
and transfected by applying an uniaxial magnet for 30 min then incubated for 24hr post 
transfection. (n=2)  
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 5.4.6. Genetically engineering neurons within hydrogel construct 
Observation of Z-stack images revealed that the magnetic plasmid–IONPs 
complexes can penetrate inside the hydrogel construct and transfect the cortical 
cells in the different layers of the gel construct. Neurons displayed a healthy, 
typical morphology. Astrocytes also showed a healthy morphology however 
tended to have the flat shape which is similar to the 2D culture. Figure 5.13 shows 
evidence of transfection of cortical cells at the three different layers of the 
hydrogel construct. 
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Figure 5.13: Genetically engineered cortical cells in a 3-dimensional hydrogel construct. Series of z-stack images through the 3 
layers of 3 different constructs of hydrogel (described as gel 1, gel 2 and gel 3). Hydrogel constructs were lifted from the coverslip and 
flipped over on to thin rectangle coverslip to facilitate the imaging process. Gel 1 shows the transfected neurons localized in the bottom 
layer of the hydrogel construct. Gel 2 demonstrates that the neurons in the middle of the hydrogel can be transfected while gel 3 shows 
transfected astrocytes localized on the surface of the hydrogel construct. Gels were stained with a – Tuj-1, b – DAPI and c – anti GFP. 
Channels were merged to produce D. You can see the hydrogel construct in a supplementary video in the supplied disc.   
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5. 5. Discussion 
The results show it is possible to deliver neurons into a gel and form an in vitro 
model that mimics the in vivo environment as a platform for scientific research. To 
that extent, development of such a system required overcoming several technical 
challenges. This includes assessing the suitability of collagen I as a 3-D substrate 
for growing primary cortical cells and determining the functionality of the neurons 
via signal recording. Herein these challenges were addressed. 
Growth of primary cortical cells in 2 and 3D constructs within collagen revealed 
that collagen provides an optimal substrate. These findings agreed with other 
studies that showed collagen enhanced cell survival and promoted growth 
(Carbonetto et al., 1983, Flanagan et al., 2002, Cullen et al., 2007b). However, it 
was observed that there is an issue related to cell distribution on a 2D collagen 
substrate, where cells were concentrated in the centre of the coverslip with only a 
few on the edges. In turn, neuronal network complexity varied according to 
cellular localization (i.e. the network was more complicated at the centre of the 
coverslip compared to the edges). The assumption was cell localization was 
affected by the nature of the distribution of collagen over the coverslip. The 
second challenge was obtaining a homogenous 3D construct, i.e. homogenously 
distributed cells throughout a hydrogel. 1mg/ml was shown to be the optimal 
concentration of collagen and, in agreement with other studies that tested lower 
collagen concentrations (0.4 and 0.5 mg/ml), cells settled close to the base of the 
hydrogel construct (O'Connor et al., 2001).   
There was a fundamental impact on the morphological characteristics of cortical 
cells (neurons and astrocytes) grown on collagen hydrogels dependent upon 
whether they were grown in 2D culture or a 3D construct. This finding 
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demonstrated there was a modulation in cell morphology, where the soma of the 
neurons were more rounded with more elaborate extensions. Inversely, 
astrocytes displayed similar morphology, i.e. a small cell soma, stellate 
morphology with a diffuse network of fine extensive processes, to the typical 
flattened astrocytic morphology in glass 2D monolayer culture (Balasubramanian 
et al., 2016). Such modulation may relate to the variation in the extracellular 
mechanical properties of the collagen substrate (Cullen et al., 2007b). The cross-
linking of hydrogel nanofibers are very important for maintaining their phenotypic 
shape and natural behaviour as in the in vivo environment by tethering the 
external nanofibers to the cellular cytoskeleton (Stevens and George, 2005). 
Accordingly, they possess the potential to mimic in vivo counterparts. These 
findings agree with other studies that demonstrated the variation in cellular 
morphology in 2D vs 3D microenvironments regardless the type of the 3D 
construct (Dillon et al., 1998, Irons et al., 2008, Xu et al., 2009, Balasubramanian 
et al., 2016, Tickle, 2017).  
One of obstacles in cell transplantation is low cell survival which can be the cause 
of inhomogeneity of the grafted cells (Pearse et al., 2007).  This study offers a 
promising 3D construct model that demonstrated high survival rate up to 90% that 
remained consistently high across the time course studied.  
The success of forming transplantable neuronal 3D constructs relies on three 
major key factors; (i) cell survival, (ii) cell homogeneity, and (iii) the possibility of 
neurons assembling functional circuitry. The finding of this study demonstrated 
the feasibility of growing neurons on 2D and homogenous 3D collagen hydrogels 
in addition to the capability of neurons to form a functional network associated 
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with evidence of cellular communication. These finding agreed with findings of 
Tao Xu and his colleagues (Xu et al., 2009).  
Ensuring the safety of our protocols was a major concern; therefore, to provide a 
complete picture on the safety of our 3D construct model, an electrophysiological 
study was conducted analysing surface seeded neurons using the whole-cell 
recording technique. Patching neurons on collagen gels presents several 
challenges, mainly that the patch electrode does not adequately penetrate the 
collagen matrix making it necessary to patch cells located at or near the surface 
of the gel (see Material and Method section). 
A simple comparison was made between signals taken from 3D construct model 
(chapter 5) and neurons cultured on hard glass surfaces (chapter 4). Voltage-
dependent currents appeared to be similar in both models however the size of the 
Na+ current was approximately 6 times larger in the hydrogel group, when 
comparing median values, at -30 mV.  Medians provided an appropriate 
comparison given the non-normal distribution of the Na+ and K+ current data. Our 
findings related to Na+ current measurements in 3D constructs were similar to 
those reported in a number of studies using cortical brain slices in rodents. In 
early postnatal rats (0-4 days postnatal), peak Na+ currents were typically 0.5 – 
0.7 nA (Luhmann et al., 2000). Bahrey et al, (2003) reported that the size of  Na+ 
currents in mouse cortical neurons increase during the developing brain from 
around 0.3 nA at E18 to 0.8 nA at P6 (Bahrey and Moody, 2003). The results 
obtained in 3D hydrogel cultures, compared to 2D cultures, show a much larger 
amplitude change in the Na+ current compared to the K+ current. This might be 
due to acceleration in cell development within the 3D construct. This corresponds 
to a recent study where neurons developed at an accelerated rate in 3D 
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compared to 2D cell culture systems (Zhang et al., 2016). In voltage-dependent 
Na+ and K+ currents, neurons from the 3D hydrogel group had developed both 
Na+ and K+ currents by 3 weeks post-differentiation, whereas neurons from the 
2D group had a K+ current but only a negligible Na+ current (Zhang et al., 2016). 
An acceleration in development over this developmental period in 3D hydrogel 
cultures compared to 2D could explain the results described here. Further work, 
however, would be required to confirm how closely this represents the natural 
development of these currents in vivo. The reason behind the increased size of 
the Na+ current is unclear. Most likely it relates to the presence of a higher 
number of Na+ channels present in the membrane. In relation to channel 
numbers, and in particular to channel density, it is worth noting that L-type 
voltage-gated Ca2+ channels have been reported to concentrate into lipid rafts in 
2D but not in 3D primary neuron culture from the superior cervical ganglion (Lai et 
al., 2012). This clustering of Ca2+ channels produced a larger Ca2+ increase in 2D 
cultured neurons in response to depolarisation by high external K+, while 3D 
neuronal cultures provided a similar, smaller response to that found in native 
neurons. While this is the opposite result to that found here for Na+ currents, it 
hints that the underlying mechanism may depend on the interaction of the 
neurons with the substrate and the effect this has on membrane architecture and 
properties (Lai et al., 2012). In the case of 2D cell culture, all cells are in contact 
with a hard substrate, usually plastic or glass, whereas in 3D cell culture the 
substrate is generally softer and, additionally, there is likely to be less contact with 
the substrate. Therefore contact with hard surfaces in cell culture systems could 
influence the membrane and subsequent distribution of ion channel proteins may 
alter, positively or negatively, channel-dependent ion flow across the membrane.  
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There did not appear to be a simple relationship between the size of the Na+ 
current and the chances of evoking action potentials in a neuron or even the size 
of the action potentials. The action potentials evoked in this study were relatively 
small (<30 mV) and they occurred as a single spike, as often found in immature 
neurons (McCormick and Prince, 1987) Within the hydrogel group, neurons with 
large Na+ currents (e.g. > 0.5 nA) invariably did not produce action potentials at 
the cells resting potential. The value of the resting potential appeared to be the 
key determinant influencing spiking since action potentials were not seen in cells 
with resting potentials greater than -35 mV which may reflect the extent of Na+ 
channel inactivation at depolarised voltages.  
The presence of spontaneous membrane depolarisations in some recordings 
indicated that the neurons had formed synaptic connections. Other similar studies 
have also reported synaptic activity in 3D cultured neurons and spiking activity 
(Irons et al., 2008, Xu et al., 2009), although in these cases synaptic activity was 
observed after longer times in culture (21 and 14 DIV respectively). Morphological 
evidence of synaptic contact was also reported (Irons et al., 2008). We also 
observed synaptic activity in our 2D neuronal cultures (Evans et al., 2017), an 
unsurprising result in view of the complexity of the neurite outgrowth in both 
culture systems, however the other studies did not report synaptic activity in their 
2D cultures (Xu et al., 2009). These authors recorded from E18 hippocampal 
neurones after 7 days (and other time points) within the hydrogel, whereas we 
confined our study to neurons on the surface of the hydrogel, but at an equivalent 
developmental age (7 DIV). Their values for mean Na+ current amplitude (2.6 nA 
for their hydrogel data), although larger than ours, could be attributed to the 
different neuronal type and more negative holding potential of -85 mV.  
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As previously discussed, it is important to be able to transfect primary neurons in 
3D construct as it is more representative of the in vivo environment. It has 
previously been reported that transfection of neurons derived from pluripotent 
stem cells is possible using lentiviral constructs (Carlson et al., 2016). In regards 
to transfecting primary cortical cells in a soft substrate, our promising results 
demonstrated for the first time the possibility of genetically engineering cortical 
cells, despite the challenges encountered. The observations revealed a low 
transfection level irrespective of whether the cells were seeded on top of the 
construct or within the hydrogel. Neurons themselves are difficult to transfect, 
however the physio mechanical and chemical properties of hydrogels provided 
additional barriers against the delivery of IONPs to the cells inside the hydrogel. 
Further optimisation of this protocol is still needed. 
Taken together, the findings from the morphological analysis of this study suggest 
that the collagen hydrogel can be used to generate healthy a neuronal 3D 
construct and highlights the importance of choosing the appropriate collagen 
concentration that supports the even distribution of cells throughout the construct. 
Furthermore, these findings confirmed the safety of the protocol used in 
generating healthy and highly pure neuronal constructs in terms of viability, 
morphology end functionality.  
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Chapter 6 
Conclusions and Future Directions 
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6.1. Summary of key thesis findings 
The work presented in this thesis has studied the utility of magnetofection as a 
non-viral gene delivery technique, and hydrogel technology for enhancing survival 
and function of primary neurons. The results obtained in this thesis can be 
summarised as follows: 
 
  Chapter 3: Primary cortical culture optimization 
This chapter was undertaken to generate reproducible primary cortical neuronal 
cultures which to meet the need of the neuronal gene engineering experiments 
and the 3D hydrogel constructs. Therefore the focus in this chapter was on 
developing a successful protocol. 
According to the findings, the NBM-2 protocol was the most suitable for obtaining 
2D monolayer primary cortical culture routinely. Tailoring the culture 
characteristics for neuron distribution, showed that cortical cells were distributed 
evenly on coverslips coated with PDL-Laminin substrates regardless of the cell 
density and the extent of time in culture. There was an apparent influence of 
lowering serum concentration in media from 10% to 1%, in experiments to reduce 
astrocyte contamination. However, there was no noticeable effect of reducing 
serum from 1% to 0%.  
The proportion of neurons in culture was constant over the three time points 
examined and was ca 60% while astrocyte proportions increased from ca 1% at 
3DIV to ca 39 % at 7DIV.   
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Chapter 4: Evaluating the safety of magnetofection for primary 
cortical   neurons 
In this section, the safety of magnetofection as a technique for transfecting 
primary cortical neurons was investigated using morphological characterization, 
viability assays and cellular morphology) using two magnetic assistive devices.  
Neuron electrophysiological properties were also assessed using the single cell 
patch clamp technique (single-cell recording).  
The results from this chapter showed that the transfection efficiency of neurons at 
the two time points 3 and 7DIV was not significantly different when uniaxial 
magnetic field applied comparing to that when biaxial was used as the magnetic 
field. The transfection efficiency of astrocytes was enhanced when exposed to 
biaxial magnetic field at 7 DIV. However, the safety analysis (live/dead) assay 
revealed that the uniaxial magnetic field is a safer magnetofection technique 
versus biaxial. Electrophysiological properties comparison between 
magnetofected versus non-magnetofected cells confirmed the safety of using the 
uniaxial device for magnetofection. As the results showed there is no significant 
difference between ionic current in both cells, this current represented by an early 
inward (Na+) currents followed by late outward (K+) currents when measured by 
using patch clamp technique. 
   
 Chapter 5: Hydrogels are promising neuromimetic substrate for 
primary cortical cells 
The results of this chapter revealed that collagen hydrogel is a supportive coating 
substrate for growing primary cortical 2D monolayer culture. Further, collagen 
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hydrogels at the concentration of 1mg/ml supported the growth of cortical cells on 
both the surface and within the depth of 3D constructs. 
Cortical cells within the 3D construct distributed evenly throughout the gel, and 
neurons were seen to extend their processes. This model showed a high 
percentage of neurons versus astrocytes > ca 90 % neurons. Live/ dead assays 
and electrophysiological analysis demonstrate that our protocol is safe for 
growing neurons in hydrogels. Furthermore, pilot show the feasibility of genetic 
engineering neurons in 3D hydrogel constructs. 
6.2. Future directions 
There are a number of avenues by which the work presented in this thesis could 
be expanded to enhance transfection efficency of neurons by magnetofection in 
both 2D and 3D environments. A lot of labs have abandoned the use of primary 
neuronal culture due to the difficulty of dealing their sensitivity to the environment. 
Hence, most of the generated inforrmation for tissue engineering studies is based 
cell lines.  
1-Relative to what was achieved during my PhD, the primary cortical culture 
could be improved. It is possible to obtain highly pure neuronal culture without the 
need to use antimitotic agents which can be toxic. Enhancing purity can be simply 
by choosing embryonic age 15-16 rather than E18, because astrocytes are 
produced after neurons and are more abundant at the later developmental stages 
and postpartum (Sanes et al., 2011).  
2-In terms of genetic engineering of cells, neurons are the most challenging 
cells to transfected despite extensive research. The findings of this research 
demonstrated the difficulty of enhancing transfection efficiency of neurons even 
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using the efficient and safe magnetofection technique. The magnet field 
frequency (1-4 Hz) and amplitude between 100-1000 µm have an impact on 
transfection efficiency in different neural cell types (Pickard and Chari, 2010a, 
Tickle et al., 2015). Based on these findings, there are other avenues that could 
be explored. The influence of oscillation frequency and amplitude of magnetic 
fields on primary neurons has not yet been investigated for uniaxial and biaxial 
oscillating magnetic fields. 
1) It is worth investigating if the transfection level is neuronal phenotype 
dependent (i.e. the differences in transfection level between GABA 
neurons and glutamatergic neurons?). 
2) What is the uptake mechanism of IONP internalization into neurons and 
what is the subcellular localisation? 
3) Is the uptake mechanism also neuron type dependent?  
 
Testing various IONPs in terms of having various chemical (IONPs fuctionalized 
with various coating layers), and physical properties (size and shape) for neuronal 
transfection would also be valuable. 
3-Growing neurons in 3-dimensional construct was quite challenging. 
However, we were able for the first time in our group to obtain evenly distributed 
neurons in a 3D-construct. Other areas could be further improved relating to 
stiffenesss of the collagen to match a range of reported brain tissue stiffness (ca. 
0.5-3kPa) during neural development, and study its effects on neuronal 
development and physiology (Gefen and Margulies, 2004, Elias and Spector, 
2012). Further, mimicking the CNS structure, there are various types of neurons  
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distributed as layers, so, delivering a multi-neuronal type 3D construct can be a 
sophisticated achievement in regenerative medicine. This achievement can 
provide a solid base for basic research as it will facilitate study of the interaction 
between different types of neurons.  
Additionally, our findings regarding transfecting neurons in hydrogels also need to 
be developed further. Methods need to be involved to improve transfection 
efficiency potentially by using new classes of DNA vectors such as minicircles, 
eventually to deliver neurotrophic factors such as BDNF or NGF.  
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Appendix 
Article published by Nano Research 2017, 10(8): 2881–2890 
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Electrophysiological assessment of primary cortical 
neurons genetically engineered using iron oxidenanoparticles 
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